LIST OF SCIENTIFIC PRESENTATIONS
MONDAY, MAY 17, 1999
Chairperson: J.S. Borer, New York NY, USAOPENING CEREMONY
GREETINGS
Asher Kimchi, USA
Founder and Chairman, International Academy of Cardiology
1st International Congress on Heart Disease
Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Diagnostic Methods
International Academy of Cardiology
1st International Congress on Heart Disease
Clive Rosendorff, USA
Member, Scientific Executive Committee
Chairman, Section of Molecular Cardiology, Basic Research
International Academy of Cardiology
1st International Congress on Heart Disease
Uri Elkayam, USA
Member, Scientific Executive Committee
Chairman, Section of Heart Failure
International Academy of Cardiology
1st International Congress on Heart Disease
John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiac Surgery
International Academy of Cardiology
1st International Congress on Heart Disease
09:30 - 10:15 HALL A
OPENING LECTURE:
Chairperson: M. Gheorghiade, Chicago IL, USA09:30 OPENING LECTURE
INTRODUCTION
M. Gheorghiade, Chicago IL, USA
Member, Scientific Executive Committee
Chairman, Section of Coronary Artery Disease
International Academy of Cardiology
1st International Congress on Heart Disease09:35 OPENING LECTURE
NEW CONCEPTS CONCERNING THE CELL BIOLOGY OF VULNERABLE PLAQUES
J.S. Forrester, Los Angeles CA, USA
MONDAY, MAY 17, 1999
10:45 - 12:30 HALL A
PL01: Plenary Session
MOLECULAR CARDIOLOGY, GENE THERAPY
Chairpersons: J.L. Mehta, Gainesville FL, USA
R.J.A. Trent, Camperdown, Australia10:45 MODIFYING GENETIC FACTORS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B. Yu, R.W. Jeremy, D.R. Richmond, R.J. Trent, Camperdown, Australia11:00 MOLECULAR GENETICS OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
L. Fananapazir, Bethesda MD, USA11:15 VASCULAR GENE THERAPY USING TISSUE INHIBITORS OF METALLOPROTEINASES (Invited Lecture)
A.C. Newby, A.H. Baker, S.J. George, C.T. Lloyd, G.D. Angelini, Bristol, UK11:30 ENGINEERING SKELETAL MYOBLASTS TO CIRCUMVENT IMMUNE REJECTION
J.M. Meuchel, T.R. Jones, D.A. Taylor, Durham NC, USA11:45 ADENOVIRAL-MEDIATED MYOCARDIAL EXPRESSION OF A b-ADRENERGIC RECEPTOR TRANSGENE IMPROVES IN VIVO CARDIAC FUNCTION: A COMPARISON OF IMMUNOSUPPRESSION STRATEGIES
J.A. Hata, D.C. White, A.S. Shah, D.D. Glower, W.J. Koch, Durham NC, USA12:00 THE ROLE OF ANGIOTENSIN II RECEPTOR EXPRESSION IN ISCHEMIA-REPERFUSION INJURY AND THE ROLE OF GENE THERAPY THEREIN (Invited Lecture)
J. Mehta, M.I. Phillips, B.C. Yang, Gainesville FL, USA12:15 A GENOME-BASED STRATEGY FOR IDENTIFYING GENES ASSOCIATED WITH CARDIAC HYPERTROPHY AND HEART FAILURE (Invited Lecture)
A.A. Dempsey, C-C. Liew, Toronto ONT, Canada12:30 L u n c h B r e a k
MONDAY, MAY 17, 1999
10:45 - 12:30 HALL B
PL02: Plenary Session
NEW DEVELOPMENTS IN ECHOCARDIOGRAPHY AND INTRA CORONARY DOPPLER
Chairpersons: D.J. Sahn, Portland OR, USA
J.D. Thomas, Cleveland, OH, USA10:45 ADVANCES IN ECHO ARCHITECTURE: NEW HORIZONS FOR NONINVASIVE DIAGNOSIS (Invited Lecture)
D. Sahn, Portland OR, USA11:00 NEW ECHO METHODS FOR ASSESSING DIASTOLIC FUNCTION (Invited Lecture)
J.D. Thomas, Cleveland OH, USA11:15 THE ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN PATIENTS WITH ATRIAL FIBRILLATION: ITS ROLE IN RISK STRATIFICATION FOR THROMBOEMBOLISM AND SUCCESSFUL CARDIOVERSION (Invited Lecture)
R. Grimm, Cleveland OH, USA11:30 THE ROLE OF 3D ECHOCARDIOGRAPHY IN VALVULAR HEART DISEASE (Invited Lecture)
F.J. Pinto, Lisbon, Portugal11:45 NOVEL THREE-DIMENSIONAL ECHOCARDIOGRAPHY FOR VOLUMETRIC ASSESSMENT IN ONE CARDIAC CYCLE
T.S.M. Tsang, N.M. Rajamannan, Y. Agmon, M.E. Hagen, A. Joseph Jr., B.K. Khandheria, I. Meissner, J.B. Seward, Rochester MN, USA12:00 ANGIOGRAPHIC CORONARY SLOW FLOW PHENOMENON INDICATES MICROVASCULAR DYSFUNCTION: STUDY WITH INTRACORONARY DOPPLER (Invited Lecture)
J. Ge, D. Baumgart, J. Qian, G. Gorge, M. Haude, R. Erbel, Essen, Germany12:15 GENDER DIFFERENCES IN CORONARY SIZE ASSESSED BY INTRAVASCULAR ULTRASOUND
S.E. Sheifer, M.R. Canos, K.P. Weinfurt, U.K. Arora, F.O. Mendelsohn, B.J. Gersh, N.J. Weissman, Washington DC, USA12:30 L u n c h B r e a k
MONDAY, MAY 17, 1999
10:45 - 13:15 HALL C
S67: NEW APPROACHES TO SURGICAL REVASCULARIZATION, MINIMAL INVASIVE SURGERY, ANGIOGENESIS
Chairpersons: S.D. Herman, Newark NJ, USA
N.M. Katz, Washington, DC, USA10:45 THERAPEUTIC ANGIOGENESIS IN ISCHEMIC MYOCARDIUM BY FIBRIN MESHWORK AND GROWTH FACTORS IN PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE IN COMBINATION WITH VINEBERG PROCEDURE
W.D. Johnson, N.N. Kipshidze, Milwaukee WI, USA11:00 PREOPERATIVE AND INTRAOPERATIVE BRAIN SPECT IMAGING: PREDICTORS OF NEUROLOGIC INJURY DURING OPEN HEART SURGERY
R.A. Hall, J.H. Holmes, D. Fordyce, M. Lee, R.P. Anderson, W.G. Campbell, R. Lee, Seattle WA, USA11:15 A DIFFERENTIATED CONCEPT FOR THE TREATMENT OF CORONARY ARTERY DISEASE USING A VARIETY OF MINIMALLY INVASIVE SURGICAL TECHNIQUES
R. Cichon, M. Knaut, V. Gulielmos, T. Ahmadzade, T. Jost, S. Schueler, Dresden, Germany11:30 REPAIR OF LLIAC ANEURYSM BY ENDOVASCULAR ENDOPROSYSTEM I: THE FRENCH EXPERIENCE
J.M. Cardon, A. Cardon, N. Mangialardi, A. Joyeux, D. Noblet, V. Vidal, T. Nguyen, Nimes, France11:45 A HIGH MID-TERM GRAFT PATENCY RATE OBTAINED WITH A NEW NO-TOUCH SAPHENOUS VEIN GRAFT FOR CABG
D. Souza, H. Skoglund, G. Johansson, D. Filbey, V. Bomfim, Orebro, Sweden12:00 PSEUDOANEURYSM OF THE FEMORAL ARTERY: TREATMENT BY THROMBIN INJECTION
H. Sievert, W. Pfeil, A. Baser, A. Fach, H. Merle, H. Spies, R. Ensslen, R. Schrader, D. Scherer, Frankfurt, Germany12:15 CLINICAL EXPERIENCE AND ANGIOGRAPHIC OUTCOME OF PATIENTS UNDERGOING MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFT BY INFERIOR MINISTERNOTOMY TECHNIQUE
F. Guerra, L. Menicanti, E. Mossutto, G. Sangiorgi, L. Inglese, A. Frigiola, Milan, Italy12:30 OFF-PUMP SURGERY FOR SINGLE- AND MULTIVESSEL CORONARY ARTERY DISEASE
R. Cichon, V. Gulielmos, M. Knaut, T. Jost, S. Schueler, Dresden, Germany12:45 MINIMALLY TRAUMATIC CARDIAC SURGERY AN APPROACH TO REDUCE MORBIDITY AND LENGTH OF STAY
S.D. Herman, R. Sahni, C. Delacruz, A. Shehadeh, T. Schwarz, M. Farzin Aliasghapour, J. Haft, D. Bregman, Newark NJ, USA13:00 LONG-TERM FUNCTIONAL CONSEQUENCES OF RADIAL ARTERY REMOVAL: ECHO-DOPPLER AND TRANSCUTANEOUS OXIMETRY ASSESSMENT
P. Pola, M. Serricchio, P. Tondi, M. Gaudino, D. De Martini, A. Gasbarrini, L. Gerardino, R. Pola, A. Santoliquidido, G.F. Possati, Rome, Italy13:15 L u n c h B r e a k
MONDAY, MAY 17, 1999
10:45 - 12:45 HALL E
S57: SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION
Chairpersons: H.R. Superko, San Mateo CA, USA
H.J. Geschwind, Creteil, France10:45 IS THE MINIMAL MYOCARDIAL DAMAGE A NEW DIFFERENT ENTITY IN ACUTE CORONARY SYNDROME?
E.R. Perna, S.M. Macin, V. Mayans, J.P. Cimbaro Canella, D. Tacchi, M. Chacon, M.M. Civetta, E.F. Farias, S.M. Ruveda, J.R. Badaracco, Corrientes, Argentina11:00 SMOKING CESSATION, BUT NOT SMOKING REDUCTION, REDUCES PLASMA HOMOCYSTEINE LEVELS
M. Bushara, P.E. McBride, D.E. Jorenby, T.B. Baker, M.C. Fiore, J.H. Stein, Madison WI, USA11:15 THE EFFECT OF OBESITY ON LDL-CHOLESTEROL LEVELS IN AMERICAN INDIANS: THE STRONG HEART STUDY
D. Hu, J. Hannah, K.A. Jablonski, B.V. Howard, Washington DC, USA11:30 REDUCTION IN TIME DOMAIN INDICES OF HEART RATE VARIABILITY FOLLOWING CAROTID ENDARTERECTOMY OR CAROTID ANGIOPLASTY
R.P. Steeds, A. Sivaguru, K. English, K.S. Channer, Sheffield, UK11:45 DOES HEALTH AFFECT DRINKING BEHAVIOR? PRELIMINARY FINDINGS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY, 1987-95
M. Eigenbrodt, F. Fuchs, R. Hutchinson, C. Paton, D. Goff, D. Couper, Chapel Hill NC, USA12:00 ST DEPRESSION AND NEW LBBB ARE PREDICTORS OF INCREASED IN-HOSPITAL MORTALITY IN ACUTE MYOCARDIAL INFRACTION
R.S. Wright, W.L. Miller, J.P. Grill, S.L. Kopecky, F. Sgura, S. Asirvathamm, Rochester MN, USA12:15 GRAPHICAL PLOTTING OF FRAMINGHAM RISK SCORES FOR OFFICE USE
J.G. Keevil, P. McBride, Madison WI, USA12:30 THE PROGNOSTIC ROLE OF BIPHASIC RESPONSE DURING DIPYRIDAMOLE - ECHOCARDIOGRAPHY TEST IN PATIENTS AFTER UNCOMPLICATED ACUTE MYOCARDIAL INFARCTION
M. Radosavljevic, Z. Vasiljevic, N. Radovanovic, A. Karadzic, J. Kostic, V. Vukcevic, P. Mitrovic, D. Babic, T. Jozic, M.M. Nesovic, Belgrade, Yugoslavia12:45 L u n c h B r e a k
MONDAY, MAY 17, 1999
10:45 - 12:30 HALL F
S62: CARDIOMYOPATHY AND HEART FAILURE, MECHANISMS AND MANAGEMENT
Chairpersons: N.J. Angomachalelis, Thessaloniki, Greece
D.R. Nul, Buenos Aires, Argentina10:45 CARDIAC INVOLVEMENT IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME: A MULTICENTER CLINICAL-PATHOLOGIC-STUDY
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy11:00 MODIFICATION OF POST-INFARCTION REMODELING USING ANGIOTENSIN II RECEPTOR BLOCKADE
B.I. Jugdutt, Edmonton, Alberta, Canada11:15 IMMUNOADSORPTION IMPROVES CARDIAC PERFORMANCE IN PATIENTS WITH SEVERE DILATED CARDIOMYOPATHY
J. Mueller, G. Wallukat, M. Dandel, H. Bieda, M. Hummel, R. Hetzer, Berlin, Germany11:30 THREE DECADES OF FOLLOW-UP OF 1.196 CHAGAS DISEASE PATIENTS WITH COMPLETE AV BLOCK HEART FAILURE AND PACING
O.T. Greco, A. Cardinalli Neto, R. Costa, J. Vitola, S.A.C. Garzon, A.M. Lorga, R.V. Ardito, Sao Paulo, Brazil11:45 INCIDENCE OF CARDIOMYOPATHY AND DETECTION OF HIV IN MYOCARDIAL CELLS OF HIV-POSITIVE PATIENTS
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy12:00 DIFFERENT BASELINE SYMPATHO-VAGAL BALANCE AND IMPAIRED AUTONOMIC RESPONSIVENESS IN ISCHEMIC AND IDIOPATHIC CARDIOMYOPATHY
G. Malfatto, M. Facchini, L. Sala, G.B. Perego, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy12:30 L u n c h B r e a k
MONDAY, MAY 17, 1999
10:15 - 12:45
P111: Poster Session
THE PLAQUE AND ACUTE CORONARY SYNDROMEBoard No.
1 PLAQUE INFLAMMATION OCCURS IN THE ENTIRE CORONARY TREE OF PATIENTS DIED BY ACUTE MYOCARDIAL INFARCTION
A. Mauriello, E. Bonanno, G. Sangiorgi, G. Palmieri, L. Anemona, L.G. Spagnoli, Rome, Italy2 LINKS BETWEEN CAROTID AND CORONARY ATHEROSCLEROSIS
Z. Huang, L. Gong, Z. Shi, Guangzhou, China3 VULNERABILITY OF A PLAQUE SEARCHED BY NONINVASIVE, NOVEL DOPPLER TECHNIQUE
Y. Koiwa, H. Kanai, H. Hasegawa, H-I. Kamada, H. Chikama, K. Shirato, N. Chubachi, E. Fusimi, M. Hayashi, Sendai, Japan4 MELATONIN IN PATIENTS WITH CORONARY ARTERY DISEASE, HYPERTENSIVE HEART DISEASE AND DILATED CARDIOMYOPATHY
P. Lercher, K. Stoschitzky, A. Sakotnik, P. Liebmann, W. Klein, Graz, Austria5 EVOLUTION OF ACUTE CORONARY SYNDROME: A COMPARISON BETWEEN UNSTABLE ANGINA, NON-Q WAVE INFARCTION AND Q WAVE INFARCTION
E.R. Perna, S.M. Macin, J.P. Cimbaro Canella, V. Mayans, D. Tacchi, M. Chacon, J. Parras, E.F. Farias, M. Caceres, J.R. Badaracco, Corrientes, Argentina6 A PRELIMINARY STUDY ON THE PROGNOSTIC VALUE OF TRANSIENT ISCHEMIA FOUND IN 24-HOUR MONITORING IN PATIENTS WITH UNSTABLE ANGINA
O.A. Najos, F. Enrique, B. Posas, A.A. Miranda, M.A.S. Lao, W.G. Dee, M.A.M. Iboleon, R.D. Saavedra, H.B. Calleja, Manila, Philippines7 DIFFERENCE IN THE IN-HOSPITAL CASE-FATALITY RATE OF UNSTABLE ANGINA BETWEEN MEN AND WOMEN
L.C.S. Passos, A.A. Lopes, U. Costa, L. Nascimento, N. Lobo, A. Rabelo Jr., Salvador, Brazil8 ACUTE CORONARY SYNDROMES - DIFFERENCE BETWEEN PATIENTS WITH OBSTRUCTIVE AND NORMAL CORONARY ARTERIES
L.C.S. Passos, A.C. Lopes, A.L. Rosario, N.O. Filho, R.V. Boss, A. Neri, A.R. Junior, Salvador, Brazil9 CHLAMYDIA PNEUMONIAE INFECTION AND ATHEROSCLEROTIC CORONARY DISEASE
M. Penco, A. Varveri, L. Sgorbini, A. Dagianti, E. Biffani, S. Romano, A. Dagianti, R. Sessa, M. Di Pietro, M. Del Piano, Rome, Italy10 DOES THE CORONARY ARTERY SPASM LEAD TO ATHEROSCLEROTIC STENOSIS? LONG-TERM FOLLOW-UP OF PATIENTS WITH VASOSPASTIC ANGINA
M. Watarai, H. Horibe, F. Matsubara, K. Takemoto, S. Shimizu, Y. Shiga, F. Takatsu, Aichi, Japan
MONDAY, MAY 17, 1999
10:15 - 12:45
P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTSBoard No.
11 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TOTAL CORONARY OCCLUSION: THE EFFECT OF RESTENOSIS ON LEFT VENTRICULAR FUNCTION
T. Tukek, V. Akkaya, A.B. Sozen, S. Demirel, Y. Nisanci, Instanbul, Turkey12 DIRECT CORONARY STENTING WITHOUT PREVIOUS BALLOON ANGIOPLASTY
A. Albarran, F. Hernandez, R. Gascuena, J. Tascon, P. Hernandez, M. Lazaro, J. Andreu, M. Alonso, Madrid, Spain13 ELECTIVE AND NON-ELECTIVE INTRACORONARY STENTING: PROSPECTIVE COMPARISON OF CLINICAL OUTCOME
F.R. Amin, M. Yousufuddin, R.H. Stable, D. Francis, W. Shamim, A.S. Kurban, J.S. Clague, U. Sigwart, London, UK14 FEMORAL HAEMOSTASIS AFTER TRANSCATHETER THERAPEUTIC INTERVENTION: A PROSPECTIVE RANDOMISED STUDY OF ANGIO-SEAL VS FEMOSTOP
F.R. Amin, M. Yousufuddin, W. Shamim, R.H. Stables, J. Clague, A.S. Kurban, U. Sigwart, London, UK15 EFFECTS OF DIFFERENT DILATATION-PRESSURES ON THE EXPANSION OF CORONARY STENTS - A COMPARATIVE POSTMORTAL HISTOMORPHOLOGICAL AND MORPHOMETRICAL STUDY
T. Deneke, K.-M. Mueller, J. Barmeyer, S. Holt, P.H. Grewe, Bochum, Germany16 SURFACE-STRUCTURE OF 30 DIFFERENT CORONARY STENTS - A SEM AND MORPHOMETRICAL ANALYSIS
K.-M. Muller, T. Deneke, A. Machraoui, S. Holt, J. Barmeyer, P.H. Grewe, Bochum, Germany17 CHARACTERISTICAL MORPHOLOGICAL FINDINGS AFTER CORONARY STENTING - A HISTOLOGICAL STUDY AFTER POSTMORTEM AND INTRAVITAL STENTING
P.H. Grewe, J. Barmeyer, T. Deneke, S. Holt, K.-M. Mueller, Bochum, Germany18 EMERGENCY REVASCULARIZATION AND HYBRID APPROACHES IN CARDIOGENIC SHOCK
F. Hernandez, P. Hernandez, J.C. Tascon, A. Albarran, M. Alonso, J. Andreu, R. Gascuena, M. Lazaro, J.E. Rodriguez, J.J. Rufilanchas, Madrid, Spain19 SEVEN YEARS' FOLLOW-UP OF 181 CASES OF PRIMARY PTCA
Z. Huang, Y. Hou, M. Jia, Y. Liu, P. Wu, D. Xu, Guangzhou, China20 PERCUTANEOUS CORONARY INTERVENTION (PCI) IN ELDERLY PATIENTS WITH ACUTE MI
N.M. Keller, V. Lazo de la Vega, F. Feit, H. Winer, New York NY, USA21 NEW NITINOL STENT FOR PERCUTANEOUS TREATMENT OF BIFURCATED LESIONS: RESULTS OF A PRELIMINARY STUDY
J.C. Laborde, J.R. Seguin, J. Fajadet, B. Cassagneau, J. Marco, Toulouse, France
MONDAY, MAY 17, 1999
10:15 - 12:45
P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTS (cont)Board No.
22 NOR-I, A BIODEGRADABLE METAL FOR CARDIOVASCULAR IMPLANTS. IN VITRO BIOCOMPATIBILITY AND MECHANICAL PROPERTIES
M. Peuster, P. Wuebbolt, H. Brauer, A. Fischer, G. Hausdorf, Hannover, Germany23 IMPLANTATION OF ePTFE COVERED STENTS IN PATIENTS WITH SAPHENOUS VEIN GRAFT DISEASE: ACUTE AND LONG-TERM FOLLOW-UP
G. Sangiorgi, P. Cioffi, M. Medda, S. Castelvecchio, L. Inglese, Milano, Italy24 THE EFFECT OF CORONARY STENT IMPLANTATION ON PLASMA PLATELET - ACTIVATING FACTOR LEVELS
C. Sekuri, H. Kultursay, L. Can, M. Kayikcioglu, M. Zoghi, O. Yavuzgil, S. Payzin, Izmir, Turkey25 THE EFFECT OF STENT IMPLANTATION PRESSURE ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE ARTERIO-ARTERIAL EX-VIVO SHUNT MODEL
S. Sukavaneshvar, Y. Zheng, J. Danforth, M. Williams, K.A. Solen, F. Mohammad, Provo UT, USA26 OUTCOME OF URGENT CORONARY INTERVENTIONS IN PATIENTS PRESENTING WITH ACUTE NON-Q-WAVE MYOCARDIAL INFARCTION IN A COMMUNITY HOSPITAL SETTING
R. Wolyn, P. Chowdhury, G.C. Timmis, J.A. Goldstein, W.W. O'Neill, Royal Oak MI, USA
MONDAY, MAY 17, 1999
10:15 - 12:45
P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONSBoard No.
27 LP STENT IN A PORCINE MODEL
A. Popov, S. Kaul, N. Sinaii, P.K. Shah, P. Barath, Los Angeles CA, USA28 HPA-3 POLYMORPHISM OF THE PLATELET FIBRINOGEN RECEPTOR IS NOT ASSOCIATED WITH AN INCREASED RISK OF THROMBOSIS OR RESTENOSIS AFTER CORONARY STENT PLACEMENT
C. Bottiger, A. Kastrati, W. Koch, J. Mehilli, N.V. Beckerath, A. Schoemig, Munich, Germany29 ANTIPLATELET AND ANTICOAGULANT THERAPY IN POST-STENTING PATIENTS
Y. Hou, Z. Huang, Y. Liu, M. Jia, Guangzhou, China
MONDAY, MAY 17, 1999
10:15 - 12:45
P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONS (cont)Board No.
30 ADMINISTRATION OF CILOSTAZOL THERAPY AFTER SUCCESSFUL CORONARY STENT IMPLANTATION WAS USEFUL FOR THE PREVENTION OF RESTENOSIS
T. Kunishima, H. Musha, T. Iwasaki, J. Nagahima, Y. Masui, T. So, T. Nakamura, M. Sakakibara, H. Tochiki, M. Murayama, Kawasaki, Japan31 REOPRO DOSAGE REGIMENS: CONFUSION OVER THE INFUSION TO ENHANCE PERFUSION?
D.J. Price, H. Bunce, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK32 ABCIXIMAB IN CORONARY STENTING: ROUTINE USE CANNOT BE JUSTIFIED
D.J. Price, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK33 REALISTIC USE OF ABCIXIMAB IN PERCUTANEOUS CORONARY INTERVENTION
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK34 THE EFFECT OF ABCIXIMAB AND WEIGHT-ADJUSTED HEPARIN ON ACTIVATED CLOTTING TIME IN ASIAN PATIENTS
H.C. Tan, Y.T. Lim, T.C. Yeo, T.T. Lim, A. Cheng, B.L. Chia, Singapore, Singapore
MONDAY, MAY 17, 1999
10:15 - 12:30
P122: Poster Session
HYPERTENSION, BASIC AND CLINICALBoard No.
35 EFFECT OF ANTIPLATELET DRUGS ON ULTRASOUND-INDUCED AGGREGATIONOF PLATELETS IN VITRO
I.E. Adzerikho, A.G. Mrochek, A.B. Samal, Minsk, Belarus36 EFFECTS OF TIME INTAKE OF TRANDOLAPRIL ON HEART RATE VARIABILITY AND BLOOD PRESSURE VALUES IN MODERATE ESSENTAIL HYPERTENSION
A. Campeanu, V. Teodorescu, Bucharest, Romania37 AMBULATORY BLOOD PRESSURE MONITORING AND TARGET-ORGAN DAMAGE IN ESSENTIAL HYPERTENSION
H. Chen, B. Yuru, Y. Liuqin, Fuzhou, China
MONDAY, MAY 17, 1999
10:15 - 12:30
P122: Poster Session
HYPERTENSION, BASIC AND CLINICAL (cont)Board No.
38 MICROCIRCULATION REACTIVITY IN NORMOTENSIVE SUBJECTS WITH A FAMILIAL PREDISPOSITION TO HYPERTENSION
J. Maver, M. Strucl, Ljubljana, Slovenia39 EXERCISE PERFORMANCE IN HYPERTENSIVES: FELODIPINE VS CILAZAPRIL CROSS-OVER STUDY
G. Parrinello, S. Paterna, A. Pinto, P. Amato, E. Capodieci, A. Tuttolomondo, T. Maniscalchi, A. Bova, V. Accardo Palumbo, G. Follone, A. Ortoleva, G. Licata, Palermo, Italy
MONDAY, MAY 17, 1999
10:15 - 12:30
P125: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSISBoard No.
40 THE ELECTROCARDIOGRAM IN MORBID OBESITY
M.A. Alpert, B.E. Terry, Mobile AL, USA41 THE EFFECT OF THE K + AGONIST NICORANDIL ON PERIPHERAL VASCULAR RESISTANCE
M. Brodmann, U. Haiden, L. Schwarzl, R. Gasser, G. Stark, E. Pilger, Graz, Austria42 USE OF STRESS DUPLEX AND ANKLE BRACHIAL INDEX IN THE ASSESSMENT OF PERIPHERAL VASCULAR DISEASE IN PATIENTS WITH DIABETES MELLITUS
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E. del Fuerte, Manila, Philippines43 INFLUENCE OF DIABETES MELLITUS ON EARLY OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil44 CORONARY ARTERY DISEASE IN DIABETIC WOMEN: COMPARISON OF THE SEVERITY OF CORONARY ARTERY DISEASE IN INSULIN DEPENDENT AND NON-INSULIN DEPENDENT DIABETIC WOMEN BY CORONARY ANGIOGRAPHY
A.M. Radwan, H.A. Hajar, Doha, Qatar45 SILENT MYOCARDIAL ISCHAEMIA IN DIABETIC PATIENTS
M. Negrusz-Kawecka, J. Moszczynska-Stulin, D. Zytkiewicz-Jaruga, P. Salomon, Wroclaw, Poland46 EFFECT OF HIGH FIBRE, LOW FAT DIET IN THE PREVENTION OF CORONARY ARTERY DISEASE IN DIABETICS
R. Sharma, New Delhi, India47 DURATION OF DIABETES AFFECTS CARDIAC FUNCTION IN ASYMPTOMATIC, NORMOTENSIVE TYPE 2 DIABETES
B.H. Sung, K. Shah, S. Kidambi, M.F. Wilson, Buffalo NY, USA
MONDAY, MAY 17, 1999
10:15 - 12:30
P127: Poster Session
PRIMARY PREVENTION OF CORONARY ARTERY DISEASEBoard No.
48 HIGH ADMISSION RATES FOR PREMATURE CORONARY ARTERY DISEASE: ARE CURRENT GUIDELINES ON PRIMARY PREVENTION ADEQUATE?
K.O. Akosah, B. Gower, La Crosse WI, USA49 THE TIME DEPENDENT EFFECT OF WATER HARDNESS ON HEART MUSCLE IN THE RATS
V. Bada, J. Kucharska, A. Gvozdjakova, Z. Braunova, j. Gvozdjak, Bratislava, Slovak Republic50 THE FLAVONOIDS IN PROVEX CV® SIGNIFICANTLY INHIBIT EXPERIMENTAL THROMBOSIS IN STENOSED AND DAMAGED CANINE CORONARY ARTERIES
J. Folts, H. Osman, J. Reed, Madison WI, USA51 FLAVONOIDS IN PROVEX CV®, INHIBIT HUMAN EX VIVO PLATELET AGGREGATION AND IN VITRO LDL OXIDATION
J. Folts, D. Shanmuganayagam, D. Wiebe, Madison WI, USA52 STUDY OF HEART RATE VARIABILITY IN THE CHARACTERIZATION OF ANAEROBIC THRESHOLD (AT) IN DISCONTINUOUS DYNAMIC EXERCISE TESTS (DDET)
V.R.F.S. Maraes, E. Silva, T.F. Ribeiro, J. Petto, M.S.A. Moura, A.M. Catai, L. Oliveira, L.C. Trevelin, L. Gallo Jr., Sao Carlos, Brazil53 ASSOCIATION OF RISK FACTORS IN A TEN-YEAR SURVEY MONICA PROGRAMME
M. Marin-Tarlea, C. Carp, E. Apetrei, I. Serban, C. Ceck, M. Patrascoiu, N. Florica, D. Mihaescu, Bucharest, Romania54 PHYSICIAN PERSONAL COMPLIANCE TO NCEP GUIDELINES AND PRESENCE OF ADDITIONAL CAD RISK FACTORS
H.R. Superko, R.M. Krauss, P.T. Williams, San Mateo CA, USA55 ATT (AGGREGATION, THROMBOSIS, THROMBOLYSIS) MODEL FOR TESTING PATIENTS WITH ATHEROTHROMBOTIC DISEASES, ITS PREDICTIVE, DIAGNOSTIC ROLE IN MONITORING & ASSESSING DISEASE & THERAPY IN INDIVIDUAL SUBJECTS
M.H. Wiener, F. Wiener, M. Burke, I. Yust, A. Iana, Tel Aviv, Israel
MONDAY, MAY 17, 1999
10:15 - 12:45
P138: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKERBoard No.
56 LOSARTAN VS. DELAPRIL IN PATIENTS WITH HEART FAILURE
O. Biadi, N. Gigli, R. Della'Anna, G. Musumeci, L. Papi, R. Mariotti, M. Mariani, Pisa, Italy57 COMBINED TREATMENT WITH EPROSARTAN AND AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN CHRONIC HEART FAILURE
A. Lazar, A. Salajan, V. Salajan, O. Burta, L. Lazar, M. Popescu, Oradea, Romania58 LISINOPRIL VERSUS ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART FAILURE
M. Otljanska, B. Sidovska, M. Nospal, E. Srbinovska, S. Jovanova, Skopje, Macedonia
MONDAY, MAY 17, 1999
10:15 - 12:30
P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICALBoard No.
59 PROARRHYTHMIC EFFECTS OF FLECAINIDE DEPENDS ON CORONARY PATENCY AFTER THROMBOLYSED Q WAVE MYOCARDIAL INFARCTION
K.G. Adamian, A.V. Astvatsatrian, a.L. Chilingarian, A.Z. Garibgeanian, Yerevan, Armenia60 HIGH-DOSE IV AMIODARONE IN THE CONVERSION TO SINUS RHYTHM OF PAROXISMAL ATRIAL FIBRILLATION. WHEN IS IT NECESSARY?
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy61 GENDER AND BETA-BLOCKER USE PREDICT SINUS RHYTHM MAINTENANCE AFTER ELECTIVE CARDIOVERSION FOR ATRIAL FIBRILLATION
J. Chakrabarti, S.D. Piraino, J.R. Cook, Springfield MA, USA62 QT-DISPERSION IN PATIENTS WITH BRAIN INJURY OR SUBARACHNOID HEMORRHAGE
V. Dimitroula, G.F. Grekas, V.G. Koulouras, C.G. Siogas, D.A. Sideris, G. Nakos, Ioannina, Greece63 APPLICATION OF HEART RATE VARIABILITY IN CHAGAS' DISEASE
A.S. Menezes Jr., C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, Goiania, Brazil64 REACTION OF CARDIOVASCULAR SYSTEM TO THE PHYSICAL LOAD IN PATIENTS WITH ISCHEMIC HEART DISEASE, COMPLICATED BY ATRIAL FIBRILLATION
A. Mrochek, A. Bulgak, V. Duda, A. Prystrom, M. Zakherevsky, Minsk, Belarus65 TRANSMURAL DISPERSION OF REPOLARISATION AS A PREDICTOR OF VENTRICULAR ARRHYTHMIAS INDUCTION IN POST-MYOCARDIAL PATIENTS
A.Z. Pietrucha, D. Mroczek-Czernecka, W. Piwowarska, Cracow, Poland
MONDAY, MAY 17, 1999
10:15 - 12:30
P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICAL (cont)Board No.
66 CARDIAC MANIFESTATIONS OF ACUTE CARBAMATE AND ORGANOPHOSPHATE POISONING
A.M. Saadeh, N.A. Farsakh, M.K. Al-Ali, Irbid, Jordan67 CLINICAL CHARACTERISTICS AND LONG-TERM COURSES IN 5 PATIENTS WITH ATRIAL STANDSTILL
S. Tsuji, N. Kotooka, K. Yoshida, T. Morooka, K. Kidou, T. Ryu, K. Yoshida, T. Ogata, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan68 THE COMBINATION OF REDUCED DOSES OF PROPAFENONE WITH MEXILETINE IS MORE EFFICACIOUS THAN PROCAINAMIDE PLUS MEXILETINE IN SUPPRESSING VENTRICULAR ARRHYTHMIAS
E. Zaimi, V. Gjini, G. Ndrepepa, E. Maci, S. Qirko, P. Cina, Tirana, Albania
MONDAY, MAY 17, 1999
10:15 - 12:30
P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATIONBoard No.
69 RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FLUTTER IN HEART TRANSPLANTED PATIENTS
S. Boveda, P. Lagrange, M. Galinier, N. Prouteau, E. Espaliat, A. Lagrange, P. Massabuau, M. Delay, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France70 INCIDENCE OF ATRIAL FIBRILATION AFTER RADIOFREQUENCY CATHETER ABLATION FOR COMMON ATRIAL FLUTTER
S. Boveda, P. Lagrange, N. Prouteau, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France71 RECURRENCE OF ATRIAL ARRHYTHMIAS AFTER SUCCESSFUL RADIOFREQUENCY CATHETER ABLATION OF COMMON ATRIAL FLUTTER: SOME POSSIBLE FACTORS
S. Boveda, P. Lagrange, A. Pathak, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, Toulouse, France72 LONG-TERM RESULTS OF THE SURGICAL ABLATION GUIDED BY SINUS RHYTHM INTRAOPERATIVE MAPPING IN PATIENTS WITH VENTRICULAR TACHYCARDIA AFTER MYOCARDIAL INFARCTION
J. Bytesnik, J. Pirk, V. Vancura, K. Lefflerova, Prague, Czech Republic
MONDAY, MAY 17, 1999
10:15 - 12:30
P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATION (cont)Board No.
73 OBSERVATION TIME AFTER A SUCCESSFUL RADIOFREQUENCY ABLATION IN AV ACCESSORY PATHWAYS
J.A. Gomez Guindal, J.L. Merino, R. Peinado, J. Perea, A. Sanchez, N. Sobrino, J.A. Sobrino, Madrid, Spain74 RADIOFREQUENCY CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN RIGHT VENTRICULAR CARDIOMYOPATHY. IDENTIFICATION OF THE TARGET SITES BY CONCEALED ENTRAINMENT
E.E. Lazaris, A.G. Katsivas, A.G. Manolis, C. Vassilopoulos, D. Karatza, N. Louvros, Athens, Greece75 CORONARY SINUS ABNORMALITIES IN PATIENTS WITH PARASEPTAL PATHWAYS
K.K. Talwar, R. Juneja, A.K. Chopra, P. Kamath, New Delhi, India
MONDAY, MAY 17, 1999
10:15 - 12:30
P145: Poster Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASEBoard No.
76 DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN A 12-YEAR-OLD PATIENT WITH LARGE CELL LYMPHOMA: INTERVENTIONAL RECANALIZATION WITH THE AMPLATZ THROMBECTOMY DEVICE
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany77 LUNG FUNCTION BEFORE AND AFTER SURGERY FOR ATRIAL SEPTAL DEFECT AND TETRALOGY OF FALLOT
J. Sulc, A. Zapletal, J. Hruda, B. Hucin, M. Samanek, Prague, Czech Republic78 BRONCHIAL HYPERREACTIVITY IN PATIENTS WITH CORRECTED CHT. COULD THESE PATIENTS DEVELOP ASTHMA?
J. Sulc, J. Hruda, A. Zapletal, B. Hucin, M. Samanek, Prague, Czech Republic79 INTERVENTRICULAR COMMUNICATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan
MONDAY, MAY 17, 1999
13:45 - 15:30 HALL A
PL03: Plenary Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY
Chairperson: B.J. Maron, Minneapolis MN, USA
D.E. Wigle, Toronto, Ontario, Canada13:45 STRATEGIES FOR THE MANAGEMENT AND RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B.J. Maron, Minneapolis MN, USA14:00 ASSESSMENT AND TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (Invited Lecture)
W.H. Spencer III, Houston TX, USA14:15 HYPERTROPHIC REMODELING OF THE LEFT VENTRICLE AND THE IMPLICATIONS OF RELATIVE WALL THICKNESS (Invited Lecture)
W.H. Gaasch, Burlington MA, USA14:30 LEFT VENTRICULAR HYPERTROPHY AND MYOCARDIAL DAMAGE (Invited Lecture)
M. Ballester, Barcelona, Spain14:45 THE SCIENTIFIC BASIS FOR EXCESS CARDIOVASCULAR MORTALITY IN LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
G.A. Mensah, Augusta GA, USA15:00 TREATMENT OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
P.R. Liebson, Chicago IL, USA15:15 PATHOLOGIC FIBROSIS AND CONNECTIVE TISSUE MATRIX IN LEFT VENTRICULAR HYPERTROPHY DUE TO CHRONIC ARTERIAL HYPERTENSION IN MAN
M.A. Rossi, Sao Paulo, Brazil15:30 C o f f e e B r e a k
MONDAY, MAY 17, 1999
13:45 - 16:00 HALL B
PL04: Plenary Session
ARRHYTHMIAS MECHANISMS, ANTIARRYTHMIC DRUGS AND IMPLANTABLE ANTIARRYTHMIC DEVICES
Chairpersons: M.E. Cain, St. Louis MO, USA
B. Luderitz, Bonn, Germany13:45 MECHANISMS OF ATYPICAL RIGHT ATRIAL FLUTTER (Invited Lecture)
J. Cheng, W. Cabeen, M.M. Scheinman, Syracuse NY, USA14:00 RECENT ADVANCES AND FUTURE DIRECTIONS IN THE TREATMENT OF ATRIAL FIBRILLATION - PHARMACOLOGICAL AND NON-PHARMACOLOGICAL ALTERNATIVES (Invited Lecture)
G.K. Feld, San Diego, CA, USA14:15 QUALITY OF LIFE IN ATRIAL FIBRILLATION (Invited Lecture)
B. Luderitz, W. Jung, Bonn, Germany14:30 INCIDENCE OF SPONTANEOUS ATRIAL TACHYARRHYTHMIAS IN PATIENTS TREATED WITH A COMBINED ATRIOVENTRICULAR DEFIBRILLATOR (Invited Lecture)
W. Jung, C. Wolpert, B. Luderitz, Bonn, Germany14:45 PARENTERAL ANTIARRHYTHMIC DRUGS FOR SUPRAVENTRICULAR OR VENTRICULAR ARRHYTHMIAS (Invited Lecture)
P. Kowey, R.A. Marinchak, S.J. Rials, D.B. Bharucha, Wynnewood PA, USA15:00 SUDDEN DEATH AND ARRHYTHMIAS IN TRANSGENIC MOUSE MODELS OF HEART DISEASE (Invited Lecture)
J. Jalife, Syracuse NY, USA15:15 NONINVASIVE DETECTION OF THE ELECTROPHYSIOLOGIC FINGERPRINT THAT INCREASES SUSCEPTIBILITY TO SUSTAINED VENTRICULAR ARRHYTHMIAS (Invited Lecture)
M.E. Cain, H.D. Ambos, R.M. Arthur, St. Louis MO, USA15:30 AMIODARONE PLUS BETA BLOCKERS, FAR FROM BEWILDERMENT, IN HIGH RISK SUDDEN DEATH PATIENTS (Invited Lecture)
D.R. Nul, Buenos Aires, Argentina15:45 NEW DETECTION ALGORITHMS IN DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (Invited Lecture)
C. Wolpert, W. Jung, B. Luederitz, Bonn, Germany16:00 C o f f e e B r e a k
MONDAY, MAY 17, 1999
13:45 - 15:30 HALL C
S56: INTERVENTIONAL CARDIOLOGY: STENTS
Chairpersons: P.C. Block, Portland OR, USA
J.W. Moses, New York, NY, USA13:45 IN-VIVO ASSESSMENT OF AN ACTIVATED PROTEIN C-ELUTING STENT
R.S. Foo, K. Hogrefe, J.H. Baron, D.P. de Bono, A.H. Gershlick, Leicester, UK14:00 PERCUTANEOUS DIRECT MYOCARDIAL REVASCULARIZATION GUIDED BY BIOSENSE LEFT VENTRICULAR MAPPING IN PATIENTS WITH REFRACTORY CORONARY ISCHEMIC SYNDROMES
R. Kornowski, J. Moses, D.S. Baim, M.K. Hong, A. Stine, R.E. Kuntz, M.B. Leon, Washington DC, USA14:15 THE SAFETY AND FEASIBILITY OF STENTING SMALL CORONARY ARTERIES: THE ACUTE AND MID TERM RESULTS OF BESTENT SMALL AND NIR-7
R. Moer, Y. Myreng, P. Molstad, K. Ytre-Ame, P.A. Simes, S. Golf, Feiring, Norway14:30 REDUCED 6 MONTH ANGIOGRAPHIC RESTENOSIS RATE AFTER TREATMENT OF SAPHENOUS VEIN GRAFT DISEASE WITH THE WIKTOR HEPARIN COATED STENT
G. Van Langenhove, P. Vermeersch, D. Stockman, C. Convens, F. Van den Branden, P. Van den Heuvel, Antwerp, Belgium14:45 CATHETER-BASED CORONARY INTERVENTIONS IN ATHEROSCLEROTIC CORONARY ARTERY ANEURYSMS: SHORT AND LONG-TERM CLINICAL OUTCOMES
S. Fuchs, R. Kornowski, H. Faraj, L.F. Satler, A.D. Pichard, A. Negoita, K.M. Kent, M.B. Leon, Washington DC, USA15:00 CAROTID-PTA: STENT IMPLANTATION BEFORE BALLOON DILATATION MAY PREVENT THROMBOEMBOLIC COMPLICATIONS
H. Sievert, W. Pfeil, H-J. Schultze, H. Spies, H. Merle, R. Ensslen, R. Theis, K-F. Beykirch, A. Fach, C. Rubel, J. Peters, Frankfurt, Germany15:15 STENTING OF TRUE BIFURCATION LESIONS WITH WIKTOR STENT: IMMEDIATE AND LONG TERM RESULTS
F. Airoldi, A. Anzuini, S. Rosanio, V. Legrand, H. Bonnier, M. Tocchi, M. Carlino, I. Sheiban, C. Di Mario, A. Colombo, Milan, Italy15:30 C o f f e e B r e a k
MONDAY, MAY 17, 1999
13:45 - 15:45 HALL E
S66: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY / CONGENITAL HEART DISEASE
Chairpersons: M. Hauser, Munich, Germany
H. Sievert, Frankfurt, Germany13:45 MORPHOMETRIC ANALYSIS OF COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan14:00 TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE (PFO) IN 90 PATIENTS WITH SIX DIFFERENT OCCLUSION SYSTEMS
H. Sievert, U. Krumsdorf, P. Keppeler, R. Schrader, S. Rux, J. Dirks, U.U. Babic, R. Ensslen, A. Fach, H. Merle, D. Scherer, H. Spies, Frankfurt, Germany14:15 STRESS-TESTING IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES AFTER ARTERIAL SWITCH OPERATION: EXERCISE CAPACITY, VENTRICULAR FUNCTION AND MYOCARDIAL PERFUSION
M. Hauser, A. Kuhn, S. Braun, M. Schwaiger, J. Hess, Munich, Germany14:30 COMPARISON OF CAPTOPRIL AND PROPRANOLOL THERAPY IN INFANTS WITH SEVERE CONGESTIVE HEART FAILURE DUE TO CONGENITAL HEART DISEASE
R. Buchhorn, M. Hulpke Wette, D. Bartmus, R. Schulz, A. Wessel, J. Buersch, Goettingen, Germany14:45 CONVERSION OF ATRIOPULMONARY OR LATERAL ATRIAL TUNNEL CAVOPULMONARY ANASTOMOSIS TO EXTRACARDIAC CONDUIT CAVOPULMONARY ANASTOMOSIS
J.A.M. van Son, H. Hess, J. Hambsch, P. Schneider, G.S. Haas, F.W. Mohr, Leipzig, Germany15:00 PREDICTION OF PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS WITH OPERATED CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, F.C. Verhulst, H.J. Duivenvoorden, F.J. Meijboom, R.A.M. Erdman, J. Hess, Rotterdam, The Netherlands15:15 POST REPAIR FOLLOW UP OF TETRALOGY OF FALLOT
O. Milanesi, R. Biffanti, S. Salvadori, G. Svaluto Moreolo, S. Secchieri, M. Rubino, G. Stellin, Padova, Italy15:30 CHANGES IN SUPERIOR VENA CAVA VELOCITY PATTERNS IN NORMAL NEONATES
M. Tamura, K. Harada, G. Takada, Akita, Japan15:45 C o f f e e B r e a k
MONDAY, MAY 17, 1999
13:45 - 15:45 HALL F
S53: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH I
Chairpersons: J.M. Hare, Baltimore MD, USA
H. Schroder, Halle (Saale), Germany13:45 LASER MYOCARDIAL REVASCULARIZATION ENHANCES EXPRESSION OF ANGIOGENIC CYTOKINES IN A PORCINE MODEL OF CHRONIC MYOCARDIAL ISCHEMIA
S. Fuchs, Y. Vodovotz, M.B. Leon, R. Kornowski, Washington DC, USA14:00 INHIBITION OF RESTENOSIS BY AN ORALLY AVAILABEL CELL CYCLE INHIBITOR
J. Ruef, K. Peter, C. Bode, C. Patterson, Heidelberg, Germany14:15 ACE INHIBITOR ENALAPRIL AND PROPIONYL-I-CARNITINE INDUCE APOPTOSIS IN RAT AORTIC SMOOTH MUSCLE CELLS THROUGH DIFFERENT MECHANISMS
A. Orlandi, M. Marcellini, G. Di Biagio, L.G. Spagnoli, Rome, Italy14:30 INCREASE RATE OF SPONTANEOUS CELL DEATH CHARACTERIZES THE VESSEL WALL STRUCTURAL CHANGES ASSOCIATED WITH EARLY CORONARY ATHEROSCLEROSIS IN PORCINE CORONARY ARTERIES
G. Sangiorgi, D. Hasdai, A. Mauriello, D.R. Holmes Jr., R.S. Schwartz, A. Lerman, L.G. Spagnoli, Rome, Italy14:45 PERSISTENT ELEVATION OF sP-SELECTIN, TNF-a AND TNF-a RECEPTOR IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY EDEMA
P. Somasundaram, B.H. Sung, S.A. Mousa, M.F. Wilson, Buffalo NY, USA15:00 STANDARDIZED B-MODE IMAGING OF CAROTID AND FEMORAL ARTERY WALLS PROVE INTIMA-MEDIA THICKNESS MEASUREMENTS AS VALID SURROGATE ENDPOINTS IN ATHEROSCLEROSIS STUDIES
E. de Groot, A. Wiegman, A.D.M. Swijndregt, A.F.W. van der Steen, R.J.G. Peters, R.G.A. Ackerstaff, J.J.P. Kastelein, A.V.G. Bruschke, Amsterdam, The Netherlands15:15 MICROVASCULAR VASOCONSTRICTION DURING RESTING ISCHEMIA IN PATIENTS WITH UNSTABLE ANGINA
M. Marzilli, G. Sambuceti, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy15:30 ANTIGEN-PRESENTING DENDRITIC CELLS ARE PRESENT IN AORTIC ATHEROSCLEROTIC LESIONS IN RATS WITH DIET-INDUCED HYPERCHOLESTEROLAEMIA
J. Ozmen, Y.V. Bobryshev, R.S.A. Lord, Sydney, Australia15:45 C o f f e e B r e a k
MONDAY, MAY 17, 1999
16:00 - 18:00 HALL A
PL05: Plenary Session
HYPERTENSION, BASIC AND CLINICAL
Chairpersons: W.H. Gaasch, Burlington MA, USA
I. Rubinstein, Chicago, IL, USA16:00 HYPERTENSION - DISEASE OR SYMPTOM? A NEW UNDERSTANDING FROM THE MOLECULAR VIEWPOINT (Invited Lecture)
R. Gasser, M. Brodmann, E. Kickenweiz, S. Barth, W. Klein, Graz, Austria16:15 INTERRELATIONS BETWEEN STRUCTURE AND FUNCTION IN LARGE ARTERIES
(Invited Lecture)
C. Pitsavos, Athens, Greece16:30 ULTRASONIC MYOCARDIAL TEXTURE AND HYPERINSULINEMIA IN ESSENTIAL HYPERTENSION
V. Di Bello, O. Giampietro, R. Pedrinelli, E. Matteucci, D. Giorgi, M.T. Caputo, A. Bertini, E. Boldrini, E. Talini, M. Paterni, C. Giusti, Pisa, Italy16:45 RENOVASCULAR HYPERTENSION REDUCES b-ADRENERGIC MEDIATED CORONARY VASODILATION IN CONSCIOUS DOGSfs
G.P. Kline, M.A. Williams, P.A. Gwirtz, Fort Worth TX, USA17:00 SYMPATHETIC ACTIVATION IN HYPERTENSION AND IN HEART FAILURE
(Invited Lecture)
G. Grassi, G. Mancia, Monza (Milan), Italy17:15 THE HALLS HARBOUR SPONTANEOUSLY HYPERTENSIVE HAMSTER (4H): A NEW RODENT MODEL OF ESSENTIAL HYPERTENSION (Invited Lecture)
I. Rubinstein, Chicago IL, USA17:30 SUBGROUP AND PER-PROTOCOL ANALYSIS OF THE RANDOMIZED EUROPEAN TRIAL ON ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY
J.A. Staessen, R. Fagard, L. Thijs, H. Celis, W.H. Birkenhager, C.J. Bulpitt, P.W. DeLeeuw, Leuven, Belgium17:45 STATE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AT SUDDEN CARDIAC DEATH IN ESSENTIAL HYPERTENSIVE SUBJECTS WITH ALCOHOL INTOXICATION
V. Volkov, R. Sokolova, A. Vikhert, V. Zhdanov, Moscow, Russia
MONDAY, MAY 17, 1999
16:00 - 18:00 HALL B
PL06: Plenary Session
ANTITHROMBOTIC AND ANTIPLATELET THERAPY FOR CORONARY DISEASE AND POOR VENTRICULAR FUNCTION
Chairpersons: M.D. Ezekowitz, New Haven CT, USA
J.E. Tcheng, Durham, NC, USA16:00 ANTITHROMBOTIC THERAPY FOR LEFT VENTRICULAR DYSFUNCTION (Invited Lecture)
M.D. Ezekowitz, New Haven CT, USA16:15 THE PLATELET GP IIb/IIIa INHIBITORS: WHY, WHEN, AND WHICH? (Invited Lecture)
J.E. Tcheng, Durham NC, USA16:30 GP IIb/IIIa INHIBITORS IN ACUTE CORONARY SYNDROMES; WHAT HAVE WE LEARNED? (Invited Lecture)
P.C. Block, Portland OR, USA16:45 THE RATIONALE OF MAGNESIUM AS ANTITHROMBOTIC TREATMENT FOR PATIENTS WITH CORONARY ARTERY DISEASE (Invited Lecture)
M. Shechter, Tel Hashomer, Israel17:00 LOCAL DRUG DELIVERY ENHANCES ReoPro BINDING TO THE VESSEL WALL IN NON-HUMAN PRIMATES
B. Sundell, S. Verheye, K. Robinson, J. Cui, S. Ishiwata, D. Forestner, T. Pertile, N.A.F. Chronos, L.A. Harker, S.R. Hanson, Atlanta GA, USA17:15 SAFETY AND EFFICACY OF CLOPIDOGREL COMPARED TO TICLOPIDINE FOR INTRACORONARY STENTING
N.E. Lepor, S.B. Gross, S.P. Luko, N.A. Buchbinder, Los Angeles CA, USA17:30 EFFECT OF HEPARIN, TICLOPIDINE, AND AGGRASTAT ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE EX-VIVO ARTERIO-ARTERIAL SHUNT MODEL
Y. Zheng, S. Sukavaneshvar, F. Mohammad, K. Solen, Provo UT, USA17:45 INFARCT ANGIOPLASTY: ABCIXIMAB AFTER RECENT THROMBOLYTIC THERAPY IS SAFE
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK
MONDAY, MAY 17, 1999
16:00 - 17:45 HALL C
S76: NEW FRONTIERS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: B. Pieske, Gottingen, Germany
U. Thadani, Oklahoma City, OK, USA16:00 SAFETY STUDY OF NESIRITIDE (HUMAN B-TYPE NATRIURETIC PEPTIDE) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH ACUTELY DECOMPENSATED CHF
U. Elkayam, M. Neibaur, H. Haught, D.P. Horton, Los Angeles CA, USA16:15 EFFECT OF NESIRITIDE VERSUS DOBUTAMINE FOR TREATMENT OF ACUTELY DECOMPENSATED HEART FAILURE ON CARDIOVASCULAR ADVERSE EVENTS
A.J. Burger, A. Johnson, D. Horton, Boston MA, USA16:30 INTERACTION BETWEEN SOLUBLE AND PARTICULATE GUANYLATE CYCLASES ON PULMONARY RESISTANCE VESSELS IN VIVO: THE ROLE OF ANP
H. Lippton, A. Hyman, New Orleans LA, USA16:45 COMBINED ANGIOTENSIN II AND ENDOTHELIN-1 RECEPTOR BLOCKADE IN HEART FAILURE: EFFECT ON EXERCISE PERFORMANCE
C-P. Cheng, Winston-Salem NC, USA17:00 RELEVANCE OF VENTRICULAR REMODELING TO CHANGES IN EXERCISE CAPACITY IN PATIENTS WITH CHRONIC HEART FAILURE
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, D.G. Gibson, A.J.S. Coats, London, UK17:15 INACTIVATION OF RENIN ANGIOTENSIN SYSTEM IN TISSUE PREVENTS EXCESS HYPERTROPHY CONTRIBUTING TO TRANSITION TO HEART FAILURE
Y. Sakata, T. Masuyama, K. Yamamoto, T. Kondo, H. Mano, R. Doi, K. Ono, T. Kuzuya, M. Hori, Suita, Japan17:30 LOSARTAN PREVENTS CONTRACTILE DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION IN RATS
M.C.G. Daniels, R.S. Keller, P.P. de Tombe, Ben Bosch, The Netherlands
MONDAY, MAY 17, 1999
16:00 - 17:45 HALL F
S54: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH II
Chairpersons: H.M. Hoffmeister, Tubingen, Germany
P.K. Singal, Winnipeg, Canada16:00 LDL STIMULATES MKP-1 EXPRESSION INDEPENDENT OF LDL RECEPTORS IN VASCULAR SMOOTH MUSCLE CELLS
B. Metzler, C. Li, Y. Hu, Q. Xu, Innsbruck, Austria16:15 INHIBITION OF RESTENOSIS BY ALDOSE REDUCTASE ANTAGONISM
J. Ruef, T.K. Nordt, C. Bode, C. Patterson, Heidelberg, Germany16:30 ANGIOGRAPHICALLY NORMAL INTERNAL MAMMARY ARTERIES SHOW NEOINTIMA FORMATION IN LATE-STATE CHD
N. Al-Fakhri, B. Huang, M. Heidt, B. Hinrichs, F.W. Hehrlein, N. Katz, Giessen, Germany16:45 LOCAL OR SYSTEMIC DELIVERY OF AN ANTISENCE INHIBITS C-MYC EXPRESSION FOLLOWING BALLOON ANGIOPLASTY
P. Iverson, V. Skrinska, E. Keane, D. Stein, D. Weller, P. Chawla, A. Tamarkin, N.N. Kipshidze, Milwaukee WI, USA17:00 INHIBITION OF PLATELET FUNCTION BY PURPLE GRAPE JUICE IN VITRO AND IN VIVO
J. Freedman, L. Deak, R. Sauter, J.D. Folts, C. Parker, Washington DC, USA17:15 EFFECT OF CORONARY ANGIOPLASTY ON CORONARY MICROVASCULAR RESPONSE TO TACHYCARDIA
G. Sambuceti, M. Marzilli, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy17:30 CHARACTERIZATION OF THE CARDIOVASCULAR SYSTEM IN A NEW EXPERIMENTAL MODEL OF STRESS-SENSITIVE ARTERIAL HYPERTENSION (ISIAH RAT STRAIN)
N.A. Machanova, A.L. Markel, Novosibirsk, Russia
MONDAY, MAY 17, 1999
19:30 - 21:30 BLUE ROOM
SAT: Satellite Symposium
ATHEROSCLEROSIS UPDATE: CAUSES, CONSEQUENCES AND CLINICAL MANAGEMENT OF CORONARY DISEASE
This Symposium is sponsored by the Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine
This Symposium is made possible in part by an unrestricted educational grant from Pfizer Inc.Chairperson: M. Bodenheimer, New Hyde Park NY, USA
19:30 INTRODUCTION
M. Bodenheimer, New Hyde Park NY, USA19:35 THE AGING HEART: CURRENT CONCEPTS AND CLINICAL COROLLARIES IN PATIENTS WITH CORONARY DISEASE
C.M. O'Connor, Durham NC, USA20:00 TRADITIONAL AND NEWER IMAGING TECHNIQUES IN THE EVALUATION OF CORONARY DISEASE AND ITS TREATMENT
S. Nissen, Cleveland OH, USA20:25 NEW DIRECTIONS IN THE MANAGEMENT OF ATHEROSCLEROSIS: CLINICAL TRIAL UPDATE
B. Pitt, Ann Arbor MI, USA20:50 NEW MECHANISMS OF CYTOPROTECTION IN CARDIOVASCULAR DISEASE
R.P. Mason, Pittsburgh PA, USA21:15 Discussion
21:25 CONCLUDING REMARKS
M. Bodenheimer, New Hyde Park NY, USA
MONDAY, MAY 17, 1999
13:45 - 17:30
P101: Poster Session
MOLECULAR CARDIOLOGY, BASIC RESEARCHBoard No.
1. DIFFERENTIAL EXPRESSION PATTERNS OF CARDIAC PROTEIN KINASE C ISOFORMS IN SEVERE DILATED CARDIOMYOPATHY AND IN AORTIC STENOSIS - A PIVOTAL ROLE FOR PKC-b?
S.K. Briem, S. Lichte, R. Lange, S. Hagl, W. Kuebler, R.H. Strasser, Heidelberg, Germany2. ANTIISCHEMIA DRUG PREDUCTAL AS SELECTIVE, ACTIVATOR OF Cu,Zn-SUPEROXIDE DISMUTASE
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia3. A NEW METHOD FOR SUCCESSFUL CULTURE OF HUMAN CARDIOMYOCYTES
K. Macfelda, T. Wild, S.C. Beutelspacher, A.M. Groeger, B. Kapella, U. Losert, E. Wolner, R. Seitelberger, Vienna, Austria4. ENDOTHELIN INTERACTS WITH ADENYLATE CYCLES AND MODIFIES ELECTROPHYSIOLOGICAL EFFECTS OF ISOPROTERENOL ON ISOLATED CANINE VENTRICULAR MYOCYTES
A. Mohacsi, J. Magyar, T. Banyasz, P. Nanasi, Debrecen, Hungary5. THE MORPHOLOGIC CHARACTERISTICS OF CARDIAC MYOCYTES AND COLLAGEN MATRIX IN PATIENTS WITH END-STAGE HEART FAILURE
J.J. Shyu, S.H. Chu, S.S. Wang, N.K. Chou, S.K. Liu, Taipei, Taiwan-R.O.C.6. ANGIOTENSIN-CONVERTING ENZYME GENE INSERTION/DELETION POLYMORPHISM AND OBSTRUCTIVE SLEEP APNEA
J. Zhang, R. Hui, Gesangluobu, M. Xu, J. Ye, W. Pei, Y. Sun, B. Liu, L. Liu, Beijing, China
MONDAY, MAY 17, 1999
13:45 - 17:30
P109: Poster Session
NUCLEAR CARDIOLOGYBoard No.
7. NON INVASIVE ESTIMATION OF INVASIVE TREATMENT RESULTS OF PATIENTS WITH CORONARY ARTERY STENOSIS
B. Birkenfeld, E. Plonska, R. Gil, J. Goracy, E. Slovinska, M. Puchala, A. Wojtarowicz, Szczecin, Poland8. DETECTION OF VIABLE MYOCARDIUM: A STUDY OF PERFUSION, BEFORE AND AFTER SURGICAL REVASCULARIZTION, IN SUBJECTS WITH PREVIOUS MYOCARDIAL INFARCT
W.A. Chalela, P.J. Moffa, J.F. Ramires, A.P. Moraes, J. Soares Jr., C. Meneghetti, Sao Paulo, Brazil
MONDAY, MAY 17, 1999
13:45 - 17:30
P109: Poster Session
NUCLEAR CARDIOLOGY (cont)Board No.
9. DUAL ISOTOPES (TI-201 AND I-123-BMIPP) SPECT STUDIES IN DETECTING MYOCARDIAL SALVAGE EFFECTS OF ACUTE MYOCARDIAL INFARCTION WITH VARIOUS REPERFUSION THERAPIES
T. Furuta, T. Kondo, M. Sarai, A. Matsuba, S. Motoyama, M. Tokuda, H. Yokoi, Y. Abo, Y. Watanabe, Nagoya, Japan10. PROGNOSTIC VALUE OF THE MYOCARDIUM PERFUSION STUDIES WITH 99Tcm-SESTAMIBI SPECT
F.G. Gallego, J. Pereira, J. Perea, P. Robles, D. Hernandez, Madrid, Spain11. COMPARISON OF RADIONUCLIDE ANGIOGRAPHY AND TWO - DIMENSIONAL ECHOCARDIOGRAPHY WITH CONTRAST ANGIOGRAPHY IN DETECTION OF VENTRICULAR ANEURYSM
C.T. Ginghina, E. Apetrei, G. Jovin, B. Fotiade, I. Ene, I. Kulcsar, D. Qeshta, Bucharest, Romania12. EFFECT OF CHAMBER SIZE ON ACCURACY OF DUAL ISOTOPE MYOCARDIAL PERFUSION SPECT
E.Y. Kimchi, X. Kang, H.C. Lewin, J.D. Friedman, G. Germano, R. Hachamovitch, D.S. Berman, Los Angeles CA, USA13. VISUALIZATION OF SUBENDOCARDIAL ISCHEMIA / INFARCTION BY SERIAL ECG-GATED DUAL (TE-99m-TETROFOSMIN (Tf) MYOCARDIAL AND Tc-99mm-HSAD CARDIAC POOL) SPECT
T. Kondo, M. Sarai, J. Wang, M. Tokuda, S. Motoyama, A. Matsuba, H. Shinozaki, E. Ishikawa, K. Ohshima, Y. Nakamura, T. Furuta, J. Ishii, H. Kurokawa, H. Naruse, Y. Watanabe, S. Tachiki, Toyoake, Japan14. COMPARISON OF THE CK-MB LEVEL AFTER CABG WITH Tc-99m-MIBI SPECT AND RADIONUCLIDE VENTRICULOGRAPHY IN PREDICTING THE EFFICACY OF REVASCULARISATION
P. Kwinecki, A. Baszko, M. Jemielity, P. Buczkowski, K. Blaszyk, M. Ruchala, A. Cieslinski, A. Ponizynski, J. Sowinski, Poznan, Poland15. THE VALIDATION OF RISK AREA ASSESSMENT BY ECG AT HOSPITAL ARRIVAL OBTAINED BEFORE REPERFUSION THERAPY IN ACUTE MYOCARDIAL INFARCTION. -COMPARISON WITH SCINTIGRAPHICAL AREA AT RISK
K. Watanabe, H. Matsuo, K. Sano, K. Suzuki, Y. Hashimoto, I. Murata, K. Hayakawa, S. Tanihata, T. Matsubara, Y. Matsuno, S. Watanabe, Gifu, Japan
MONDAY, MAY 17, 1999
13:45 - 17:30
P117: Poster Session
LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTIONBoard No.
16. EXERCISE INDUCED QRS PROLONGATION IS A PREDICTOR OF POSTINFARCTION REMODELING
K.G. Adamian, A.L. Chilingarian, A.V. Astvatsatrian, A.Z. Garibgeanian, Yerevan, Armenia17. EFFECTS OF REVASCULARIZATIONOF TOTALLY OCCLUDED CORONARY ARTERIES ON LEFT VENTRICULAR PERFORMANCE IN PATIENTS AFTER MYOCARDIAL INFARCTION
S. Ozgul, Kahramanmaras, Turkey18. DECREASED SENSITIVITY TO b-ADRENERGIC STIMULATION OF VENTRICULAR L-TYPE CALCIUM CURRENT IN INFARCT-INDUCED HYPERTROPHY IN RATS
R.M. Saraiva, M.O. Masuda, Rio de Janeiro, Brazil19. CHRONIC HEART FAILURE IN REMODELING AFTER MYOCARDIAL INFARCTION: SELECTIVE REGULATION OF THE ISOZYMES OF PROTEIN KINASE C
G. Simonis, J. Honold, C. Weinbrenner, U. Oehl, R.H. Strasser, Heidelberg, Germany
MONDAY, MAY 17, 1999
13:45 - 17:30
P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATIONBoard No.
20. EPIDEMIOLOGICAL STUDY OF HYPERTENSION IN FOUR MOSCOW SUBURBAN TOWNS. RESULTS OF DEMOGRAPHY, SOCIAL AND MEDICAL SCREENING OF 1998
A. Britov, A. Deev, S. Shalnova, N. Eliseeva, R. Oganov, Moscow, Russia21. THE IMPACT OF SILENT ISCHEMIA ON CARDIAC ENZYMES AND WALL MOTION IN PATIENTS UNDERGOING AEROBIC EXERCISE
D. Dobies, K. Tobin, H. Friedman, P. Marcovitz, M. Pica, W. O'Neill, B. Franklin, Royal Oak MI, USA22. DOES LOW FLUID INTAKE INCREASE THE RISK OF STROKE? FINDINGS FROM THE ADVENTIST HEALTH STUDY
S.F. Knutsen, J. Chan, Loma Linda CA, USA23. DETERMINANTS OF THE AMOUNT OF AUTONOMIC RESPONSE TO REHABILITATION AFTER MYOCARDIAL INFARCTION
G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy24. QUALITY OF LIFE IMPROVEMENT AFTER MYOCARDIAL REVASCULARISATION
B. Mihajlovic, M. Potic, Z. Potic, M. Popov, Z. Konstantinovic, S. Popovic, D. Jakovljevic, N. Radovanovic, Novi Sad, Yugoslavia
MONDAY, MAY 17, 1999
13:45 - 17:30
P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION (cont)Board No.
25. PROGNOSTIC FACTORS OF RECURRENT MYOCARDIAL INFARCTION
R. Radisauskas, Kaunas, Lithuania26. TIME TRENDS OF THE HEALTH PROFILE AND MORTALITY IN THE MALE POPULATION OF TALLINN, ESTONIA
O. Volozh, A. Deev, T. Kalyuste, R. Kaup, E. solodkaya, J. Abina, G. Goldsteine, A. Olferiev, Tallinn, Estonia
MONDAY, MAY 17, 1999
13:45 - 17:30
P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASEBoard No.
27. IS MILD HYPERCHOLESTEROLEMIA WITHOUT MULTIPLE RISK FACTORS BENIGN IN YOUNG ADULTS? THE GUNDERSEN PREMATURE CORONARY DISEASE REVIEW
K.O. Akosah, B. Gower, La Crosse WI, USA28. LOWER INCIDENCE OF CORONARY DISEASE IN PUERTO RICO (USA ISLAND) THAN IN THE CONTINENTAL USA: A POSSIBLE PROTECTIVE EFFECT OF A LOWER LDL/HDL LIPOPROTEIN RATIO
P.I. Altieri, E. Rodriguez, N. Escobales, R. Gonzalez, H. Banch, M.J. Crespo, J. Rodriguez, San Juan, Puerto Rico29. SHORT-TERM TREATMENT WITH HIGH-DOSE SIMVASTATIN IMPROVES WIDESPREAD VASCULAR PERMEABILITY IN SUBJECTS WITH OVERT ATHEROSCLEROTIC DISEASE
S. Bandinelli, G. dell'Omo, L. Pucci, M. Mariani, R. Navalesi, R. Pedrinelli, G. Penno, Pisa, Italy30. SAFETY AND EFFICACY OF FIBRATES IN DIABETIC AND NON-DIABETIC PATIENTS WITH REFRACTORY COMBINED HYPERLIPIDEMIA
M. Kayikcioglu, F. Ozerkan, O. Yavuzgil, M. Zoghi, C. Gurgun, H. Kultursay, L. Can, C. Turkoglu, Izmir, Turkey31. PURPLE GRAPE JUICE PROTECTS LDL FROM OXIDATION IN CORONARY ARTERY DISEASE PATIENTS TAKING VITAMIN E
J.G. Keevil, D. Wiebe, J.D. Folts, Madison WI, USA32. CORRELATION OF LIPOPROTEIN(A), HOMOCYSTEINE AND MYOCARDIAL STRESS THALLIUM SCINTIGRAPHY IN CHD PATIENTS
G. Lupattelli, B. Palumbo, D. Siepi, C. Casciari, P.F. Anniboletti, A. Bianchi, L. Pasqualini, G. Schillaci, R. Palumbo, E. Mannarino, Perugia, Italy
MONDAY, MAY 17, 1999
13:45 - 17:30
P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE (cont)Board No.
33. ORALLY APPLIED ENTEROCOCCUS FAECIUM M-74 IN PREVENTIVE CARDIOLOGY
Z. Mikes, M. Ferencik, L. Ebringer, E. Jahnova, I. Ciznar, Bratislava, Slovak Republic34. PREVALENCE OF DYSLIPIDEMIA DURING IN-HOSPITAL PHASE OF THE ACUTE CORONARY SYNDROMES
L.C.S. Passos, R. Santos-Jesus, D. Flores, U. Costa, N. Lobo, A. Rabelo Jr., Salvador, Brazil
MONDAY, MAY 17, 1999
13:45 - 17:30
P126: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSISBoard No.
35. WEIGHT LOSS, WEIGHT MAINTENANCE AND IMPROVEMENT IN CARDIOVASCULAR RISK AFTER 2 YEARS OF ORLISTAT THERAPY
A.E. Meinders, Leiden, The Netherlands36. BODY HABITUS IN ACUTE HEART FAILURE PATIENTS: OBESITY PREDICTS IMPROVED OUTCOMES
D. Milzman, R. Samaddar, K. Samaddar, J. Morissey, L. Moscowitz, Washington DC, USA37. DIABETES MELLITUS - AN INCREASED RISK FACTOR FOR ISCHEMIC HEART DISEASE IN FEMALE?
M. Monteiro, A. Felix, V. Mendes, C. Barradas, A. Sousa, I. Joao, J. Sa Nogueira, A. Aleixo, A. Sales Luis, Lisbon, Portugal38. RELATION OF HEART RATE VARIABILITY AND LEFT VENTRICLE DIASTOLIC FUNCTION TO SILENT ISCHEMIA DURING 24 HOUR AMBULATORY ECG IN PATIENT WITH NON-INSULIN DEPENDENT DIABETES MELLITUS
A. Mrochek, D. Goncharik, Minsk, Belarus
MONDAY, MAY 17, 1999
13:45 - 17:30
P129: Poster Session
HORMONE THERAPY IN POSTMENOPAUSAL WOMENBoard No.
39. TIBOLONE EFFECT ON BLOOD PRESSURE AND PLASMA LIPIDS IN HYPERTENSIVE WOMEN
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Wierzbicki, G. Jackson, London, UK40. CORONARY ARTERY LESIONS AND LEFT VENTRICULAR FUNCTION IN FEMALE PATIENTS WITH CORONARY ARTERY DISEASE
S. Ozgul, Kahramanmaras, Turkey
MONDAY, MAY 17, 1999
13:45 - 17:30
P130: Poster Session
CARDIAC INVOLVEMENT IN HIV INFECTIONBoard No.
41. DIASTOLIC DYSFUNCTION IS AN EARLY MARKER OF CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, M. Pombo, R. Dalmau, C.S. de la Calzada, Madrid, Spain42. ECHOCARDIOGRAPHY DETECTS IMMUNE-RELATED ASYMPTOMATIC CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, P. Hernandez, R. Gascuena, M. Lazaro, C.S. de la Calzada, Madrid, Spain
MONDAY, MAY 17, 1999
13:45 - 17:30
P131: Poster Session
NITRIC OXIDE AND NITRIC OXIDE SYNTHASE IN HEART FAILUREBoard No.
43. NO DOES NOT MEDIATE CORONARY VASODILATION SECONDARY TO SIMULATED ISCHEMIA: A STUDY ON KATP -CHANNELS AND NW -NITRO-1-ARGININ ON CORONARY PERFUSION PRESSURE IN ISOLATED LANGENDORFF-PERFUSED GUINEA PIG HEARTS
E. Kickenweiz, M. Brodmann, R. Gasser, H. Brussee, W. Klein, Graz, Austria
MONDAY, MAY 17, 1999
13:45 - 17:30
P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL CORONARY ARTERY DISEASEBoard No.
44. SURGICAL REVASCULARIZATION OF POSTERIOR CORONARY ARTERIES WITHOUT CARDIOPULMONARY BYPASS
J.G. Lobo Filho, J.M.A.C. de Albuquerque, C. Bellini, G. Gomes, M.C. Letiao, E.B. Pinheiro, J.N. Paes Jr., R.P. de Siqueira, M.M. Landim, R.R.M. Oliveira, Fortaleza, Brazil45. OUTCOMES IN A RANDOMIZED COMPARISON OF MINIMALLY INVASIVE CABG WITH CONVENTIONAL CABG AND PTCA STENT; THE OCTOPUS STUDY
E. Buskens, Utrecht, The Netherlands46. LONG TERM SURVIVAL IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING: IMPACT OF ARTERIAL REVASCULARIZATION
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France
MONDAY, MAY 17, 1999
13:45 - 17:30
P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE (cont)Board No.
47. PREDICTORS OF LONG TERM SURVIVAL AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS UNDER 65 YEARS
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France48. HYBRID REVASCULARIZATION: MINIMALLY INVASIVE SURGERY PLUS ANGIOPLASTY, INITIAL RESULTS IN 16 PATIENTS
R. Gascuena, A. Albarran, F. Hernandez, E. Rodriquez, M.J. Lopez, J. Tascon, J. Andreu, M. Alonso, M. Lazaro, P. Hernandez, Madrid, Spain49. CORONARY ARTERY SURGERY WITHOUT CARDIOPULMONARY BYPASS IN PATIENTS OVER 80 YEARS OF AGE
G. Lobo Filho, C.B.G. Gomes, J.M.A.C. de Albuquerque, A. Feitosa, M.C. Leitao, E.B. Pinheiro, J.N. Paes Junior, R.M. Landim, R.P. de Siqueira, R.M. Oliveira, Fortaleza, Brazil50. SURGICAL TREATMENT OF DIFFUSE AND DISTAL CORONARY ARTERY DISEASE - EXPERIENCE IN OVER 3,000 OPERATED PATIENTS
N. Radovanovic, L. Petrovic, S. Nicin, J. Selestiansky, Z. Jonjev, J. Lavac, M. Fabri, P. Kovacevic, M. Mijatov, V. Scekic, S. Popovic, Z. Konstantinovic, M. Preradovic, Novi Sad, Yugoslavia
MONDAY, MAY 17, 1999
13:45 - 17:30
P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULTBoard No.
51. IMMEDIATE AND LONG TERM OUTCOME AFTER AORTIC VALVE REPLACEMENT AMONG PATIENTS WITH SEVERE AORTIC STENOSIS AND LEFT VENTRICULAR SYSTOLIC DYSFUNCTION PHILIPPINE HEART CENTER EXPERIENCE
A.M.L.A. Delos Reyes-Javier, P. Palmes, S.M. Lacson, R.D. Jara, R.J. Santos, A. Rico, Manila, Philippines52. THE VALUE OF CARDIAC TROPONIN IN THE DIAGNOSIS OF RHEUMATIC FEVER
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E.S. del Fuerte, Manila, Philippines53. AIRWAY FUNCTION DISTURBANCES AFTER SUCCESSFUL CORRECTION OF A MITRAL VALVE DISEASE. LONG TERM FOLLOW UP
T. Hryniewiecki, I. Rawczynska-Englert, R. Malinowski, P. Gutkowski, Warsaw, Poland
MONDAY, MAY 17, 1999
13:45 - 17:30
P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont0Board No.
54. SURGICAL OUTCOME AND LONG-TERM RESULTS AFTER AORTIC VALVE REPLACEMENT IN OCTOGENARIANS
P. Kolh, L. Lahaye, P. Gerard, R. Limet, Liege, Belgium55. EFFECTIVE MITRAL REGURGITANT ORIFICE AREA. COMPARISON OF THREE ECHOCARDIOGRAPHIC METHODS
C.S. Berensztein, D.J. Pineiro, M.M. Marcotegui, R.L. Brunoldi, G. Lanosa, J. Lerman, Buenos Aires, Argentina56. EVOLUTION OF AORTIC REGURGITATION AFTER PERCUTANEOUS BALLOON MITRAL VALVULOTOMY
A. Popa, E. Apetrei, C. Ginghina, M. Iacob, I. Coman, C. Carp, Bucharest, Romania57. LEFT ATRIAL KINETIC ENERGY IN NORMAL SUBJECTS AND IN PATIENTS WITH MITRAL STENOSIS
S. Qirko, T. Goda, A. Dibra, Tirana, Albania
MONDAY, MAY 17, 1999
13:45 - 17:30
P154: Poster Session
PRACTICE GUIDELINES, COST CONTAINMENTBoard No.
58. ANALYSIS AND COMPARISON OF CORONARY CARE UNIT COST PROCESS IN TWO CONSECUTIVE YEARS
J.A. Gomez, I. Roldan, I.G. Maqueda, J. Perea, A. Sanchez, E.R. Armada, H. Navarro, L.M. Jadraque, H. La Paz, Madrid, Spain59. CARDIO-RESPIRATORY PATTERNS OF THE OBESE SUBJECT DURING EXERCISE IN THE PERSPECTIVE OF A TRAINING PROGRAM
A. Salvadori, P. Fanari, F. Nibbio, A. Saezza, E. Longhini, Verbania, Italy60. FEASIBILITY AND SAFETY OF EARLY EXERCISE TESTING USING THE BRUCE PROTOCOL AFTER ACUTE MYOCARDIAL INFARCTION
M.P. Senaratne, G.A. Smith, Edmonton, Alberta, Canada61. MANAGEMENT OF 1700 HYPERTENSIVE DIABETIC OUTPATIENTS AND GUIDELINES USE IN GENERAL PRACTICE
A. Zaninelli, A. Filippi, Florence, Italy
MONDAY, MAY 17, 1999
13:45 - 17:30
P156: Poster Session
MISCELLANEOUSBoard No.
62. GRAPE SEED PROCYANIDINS: ISOLATION, IDENTIFICATION, AND ENDOTHELIUM-DEPENDENT VASORELAXING ACTIVITY
D.F. Fitzpatrick, B. Bing, D. Maggi, D. Fries, R. O'Malley, Tampa FL, USA63. ECHOCARDIOGRAPHY BEFORE AND AFTER PERICARDIECTOMY IN PATIENTS WITH CONSTRICTIVE PERICARDITIS - COULD BE ONLY ONE METHOD TO EXPLORE?
C.T. Ginghina, E. Apetrei, I. Stoian, I. Kulcsar, D. Qeshta, I. Ene, C. Matei, Bucharest, Romania64. GRAVITATIONAL STRESS (GS) IN SYSTEMIC SCLEROSIS (SS)
E.S. Isasi, A. Cassinelli, R. Vignale, M.E. Isasi, Montevideo, Uruguay65. CARDIAC INVOLVEMENT IN ANTIPHOSPHOLIPID SYNDROME
I. Moyssakis, M. Tektonidou, K. Boki, F. Triposkiadis, M. Gofa, M. Kyriakidis, Athens, Greece66. CHANGES OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
I. Moyssakis, F. Triposkiadis, V. Vasiliou, M. Gofa, G. Anastasiadis, M. Kyriakidis, Athens, Greece67. ABNORMAL SYSTOLIC BLOOD PRESSURE RESPONSE IN THE RECOVERY PHASE OF EXERCISE TESTING AS A PREDICTOR OF CORONARY ARTERY DISEASE
A. Zarife, E. Camara, F. Galvao, L. Viana, O. Marques, W. Freitas, C. Macedo, M. Santos, M. Guimaraes, A. Rabelo Jr., Salvador, Brazil
TUESDAY, MAY 18, 1999
08:30 - 10:45 HALL A
PL07: Plenary Session
NEW INSIGHTS INTO THE MECHANISMS OF HEART FAILURE
Chairpersons: W.C. Little, Winston-Salem NC, USA
H.N. Sabbah, Detroit MI, USA08:30 DIASTOLIC DYSFUNCTION: CONTRIBUTION TO EXERCISE INTOLERANCE
(Invited Lecture)
W. Little, Winston-Salem NC, USA08:45 INHIBITION OF DOPAMINE BETA-HYDROXYLASE AS A THERAPEUTIC TARGET IN THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah, S. Goldstein, Detroit MI, USA09:00 ALTERED EXCITATION-CONTRACTION COUPLING IN HEART FAILURE (Invited Lecture)
G. Hasenfuss, B. Pieske, J. Prestle, Freiburg, Germany09:15 APOPTOSIS AND CARDIAC DISEASES - NEW OPPORTUNITIES FOR NOVEL THERAPEUTICS (Invited Lecture)
G.Z. Feuerstein, Wilmington DE, USA09:30 AGONIST STIMULATED NITRIC OXIDE PRODUCTION AND MYOCARDIAL CONTRACTILITY (Invited Lecture)
J.M. Hare, Baltimore MD, USA09:45 CLINICAL USE OF INHALED NITRIC OXIDE IN ADULT CARDIAC SURGICAL PATIENTS (Invited Lecture)
K.J. Ramsay, M.A.E. Ramsay, K. Lynch, H.A.T. Hein, D.M. Meyer, Dallas TX, USA10:00 OXIDATIVE STRESS AND HEART FAILURE: ROLE OF VITAMIN A (Invited Lecture)
V. Palace, M. Hill, I. Danelisen, P.K. Singal, Manitoba, Winnipeg, Canada10:15 BASIC ASPECTS OF HEART FAILURE: HUMAN MYOCARDIUM (Invited Lecture)
C.J.F. Holubarsch, Freiburg, Germany10:30 SARCOPLASMIC RETICULUM FUNCTION IN HEART FAILURE
P. Neary, A.M. Duncan, G.L. Smith, S.M. Cobbe, Glasgow, UK10:45 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
08:30 - 10:00 HALL B
PL08: Plenary Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE
Chairpersons: C. Rosendorff, New York NY, USA
Y. Stein, Jerusalem, Israel08:30 REVERSE CHOLESTEROL TRANSPORT - A NEW METHOD FOR QUANTITATIVE ASSESSMENT OF CHOLESTEROL EFFLUX IN VIVO (Invited Lecture)
Y. Stein, O. Stein, Jerusalem, Israel08:45 LDL CHOLESTEROL AND VASCULAR STRUCTURE AND FUNCTION (Invited Lecture)
C. Rosendorff, New York NY, USA09:00 NON-HDLC DOES NOT REFLECT THE PRESENCE OF SMALL LDL PATTERN B
(Invited Lecture)
H.R. Superko, R.M. Krauss, San Mateo CA, USA09:15 TISSUE O2 AVAILABILITY IS A FUNCTION OF THE PLASMA CHOLESTEROL (Invited Lecture)
H. Buchwald, H.J. Menchaca, V.N. Michalek, B.A.T.D. Rohde, T.J. O'Dea, Minnesota MN, USA09:30 THE INFLUENCE OF LIPIDS ON THE INCIDENCE OF THROMBOCYTOSIS FOLLOWING MYOCARDIAL REVASCULARIZATION
J.T. Christenson, Geneva, Switzerland09:45 AN IN VITRO STUDY ON THE ANTIOXIDANT CAPACITY OF STATINS
F. Franzoni, F. Regoli, F. Galetta, Pisa, Italy10:00 EFFECTS OF ATORVASTATIN ON PLASMA HOMOCYSTEINE LEVELS IN SUBJECTS WITH FAMILIAL HYPERCOLESTEROLEMIA
L. Pucci, S. Bandinelli, G. Penno, M. Pilo, R. Navalesi, A. Bertolotto, Pisa, Italy10:15 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
08:30 - 10:15 HALL C
S77: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE
Chairperson: M. Hauser, Munich, Germany08:30 CORONARY FLOW RESERVE ASSESSED BY POSITRON EMISSION TOMOGRAPHY (PET) IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES (TGA) AFTER ANATOMICAL CORRECTION
M. Hauser, A. Kuhn, M. Beckmann, F. Bengel, M. Schwaiger, J. Hess, Munich, Germany08:45 CATHETER CLOSURE OF INTER-ATRIAL DEFECTS IN ADULTS WITH SELF-CENTERING DEVICES
H. Sievert, U. Krumsdorf, P. Keppeler, S. Rux, R. Schrader, A. Fach, D. Scherer, R. Ensslen, H. Merle, H. Spies, H. Zeplin, Frankfurt, Germany09:00 PSYCHOPATHOLOGY IN YOUNG ADULTS WITH CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, H.J.M. Versluis, F.C. Verhulst, F.J. Meijboom, E. Bos, J.R.T.C. Roelandt, J. Hess, Rotterdam, The Netherlands09:15 PULMONARY ARTERY SLING: REIMPLANTATION VERSUS ANTETRACHEAL TRANSLOCATION
J.A.M. van Son, G.S. Haas, H. Hess, J. Hambsch, P. Schneider, F.W. Mohr, Tampa, USA09:30 STENT IMPLANTATION FOR THE TREATMENT OF EARLY POSTOPERATIVE THROMBOSIS OF MODIFIED BLALOCK-TAUSSIG-SHUNTS
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany09:45 PREDISPOSING FACTORS OF VALVE REGURGITATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S. Mimori, T. Kikuchi, Y. Takahashi, Y. Murakami, Tokyo, Japan10:00 THE RESULTS OF THE REPAIR OF ATRIAL SEPTAL DEFECT WITH OR WITHOUT PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION IN PATIENTS OVER 40 YEARS OLD. ECHOCARDIOGRAPHIC AND CLINICAL STUDY
L. Paluszkiewicz, M. Jemielity, B. Perek, P. Buczkowski, A. Szyszka, W. Dyszkiewicz, A. Ponizynski, Poznan, Poland10:15 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
08:30 - 10:15 HALL E
S78: ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY- BASIC AND CLINICAL
Chairpersons: J. Jalife, Syracuse NY, USA
S. Schaefer, Davis CA, USA08:30 QUANTITATIVE COMPARISON OF ATRIAL FIBRILLATION AND VENTRICULAR FIBRILLATION IN THE SAME ANIMALS
G.L. Pierpont, C.C. Gornick, J.A. Hauck, B.D. Pederson, J.J. Alwin, J.M. Weigenant, Minneapolis MN, USA08:45 CHANGES OF AUTONOMIC NERVOUS SYSTEM ACTIVITY IN UREMIC PATIENTS ON HEMODIALYSIS
F. Franzoni, A. Cupisti, A. Caprioli, C. Giusti, G. Barsotti, F. Galetta, Pisa, Italy09:00 OUABAIN PROMOTES DELAYED AFTERDEPOLARIZATION DEPENDENT TRIGGERED ACTIVITY IN THE HYPETROPHIED BUT NOT IN THE NON-HYPERTROPHIED CANINE HEART
M. De Groot, M. Vos, J. Leunissen, M. Schoenmakers, H.J.J. Wellens, Maastricht, The Netherlands09:15 RADIOFREQUENCY CATHETER ABLATION OF CENTRAL SUPERHIGH WAY OF ATRIAL CONDUCTION IS EFFECTIVE IN TERMINATING SUSTAINED ATRIAL FIBRILLATION IN DOGS
D. Hu, T. Liu, X. Yang, C. Guo, Beijing, China09:30 IMPLANTATION OF PERMANENT PACEMAKERS GUIDED BY TRANSTHORACIC ECHOCARDIOGRAPHY
G. Diaz, P. Pacheco, H. Acuna, A. Diaz, Chiclayo, Peru09:45 INTRACARDIAC ECHOCARDIOGRAPHIC EVALUATION OF RADIOFREQUENCY LESION EFFECTS IN ATRIAL AND VENTRICULAR MYOCARDIUM
J.-F. Ren, D.J. Callans, D. Schwartzman, J.J. Michele, K.S. Li, F.E. Marchlinski, Pittsburgh PA, USA10:00 NEW-ONSET ATRIAL FIBRILLATION IN Q WAVE ANTERIOR MYOCARDIAL INFARCTION; PROGNOSTIC SIGNIFICANCE OF RECURRENCES OF ATRIAL FIBRILLATION
M. Asanin, J. Perunicic, V. Vukcevic, A. Arandjelovic, D. Orlic, P. Mitrovic, B. Sreckovic, M. Nesovic, M. Matic, Z. Vasiljevic, D. Boskovic, Belgrade, Yugoslavia10:15 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
08:30 - 10:45 HALL F
S73: ECHOCARDIOGRAPHY, PHARMACOLOGIC STRESS TESTING
Chairpersons: J. Ge, Essen, Germany
F.J. Pinto, Lisboa, Portugal08:30 MULTICENTER VIDEODENSITOMETRIC ASSESSMENT OF EFFECTS OF BIOLOGICAL FACTORS ON EFFICACY OF OPTISON AND ALBUNEX® IN DIFFICULT-TO-IMAGE PATIENTS
E. Hausnerova, J.S. Gottdiener, D.E. Bruns, H. Dittrich, J.L. Cohen, J.C. Pezzullo, Washington DC, USA08:45 DETERIORATION OF MYOCARDIAL FUNCTION DURING DOBUTAMINE ECHOCARDIOGRAPHY DOES NOT EXCLUDE IMPROVEMENT AFTER SURGICAL REVASCULARIZATION
L. Paluszkiewicz, M. Jemielity, A. Szyszka, A. Baszko, A. Cieslinski, Poznan, Poland09:00 EXERCISE ECHOCARDIOGRAPHY: ITS ACCURACY AND VALUE IN THE PROGNOSIS OF PATIENTS WITH KNOWN OR SUSPECTED CORONARY ARTERY DISEASE (CAD)
J.T. Baltasar, O.P. Saniel, E.B. Baello, Jr., Quezon city, Philippines09:15 LOW-DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN CHILDREN AND YOUNG ADULTS
D. De Wolf, B. Suys, L. Foubert, H. Verhaaren, Y. Taeymans, D. Matthys, Gent, Belgium09:30 STRESS TESTING OF PATIENTS WITH LEFT BUNDLE BRANCH BLOCK EVALUATED IN A CHEST PAIN CENTER FOR ACUTE CARDIAC ISCHEMIA
M.G. Mikhail, S. Frederiksen, Ann Arbor MI, USA09:45 STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH POOR ACOUSTIC WINDOWS: IS MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY ESSENTIAL?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany10:00 IS A PACEMAKER INDICATED FOR VASOVAGAL PATIENTS WITH SEVERE CARDIO-INHIBITORY REFLEX AS IDENTIFIED BY THE ATP TEST? A PRELIMINARY RANDOMIZED TRIAL
D. Flammang, M. Antiel, T. Church, D. Hamani, E. Donal, Angouleme, France10:15 PREDICTIVE VALUE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY FOR CARDIAC EVENTS IN PATIENTS PRESENTING WITH CHEST PAIN
A.J. McNeill, P. Seydak, M. McBurney, S.H. Barr, H.M. Dunn, J.A. Purvis, Londonderry N. Ireland, UK10:30 CONTRIBUTION OF HEAD-UP TILT TEST AND ATP TEST IN ASSESSING THE MECHANISMS OF VASOVAGAL SYNDROME. INFERENCES TO THE THERAPEUTIC STRATEGY
D. Flammang, D. Hamani, E. Donal, M. Erickson, T. Church, Angouleme, France10:45 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
10:45 - 12:45 HALL A
PL09: Plenary Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY
Chairpersons: M.D.J. Antunes, Coimbra, Portugal
J.S. Borer, New York NY, USA10:45 THE BIOLOGY OF REGURGITANT VALVULAR DISEASES (Invited Lecture)
J. Borer, New York NY, USA11:00 THE DIRECTIONS OF MITRAL REGURGITATION: THE "INS" AND "OUTS" OF THE MITRAL VALVE (Invited Lecture)
E.D. Wigle, Toronto ONT, Canada11:15 OPEN MITRAL COMMISSUROTOMY (Invited Lecture)
M.D. Antunes, M.J. Antunes, Coimbra, Portugal11:30 AORTIC VALVE SURGERY: A PROSPECTIVE AND RANDOMIZED STUDY OF MINISTERNOTOMY VERSUS CONVENTIONAL SURGERY
R.R. Dias, N.A.G. Stoff, Sao Paulo, Brazil11:45 LEFT VENTRICULAR REMODELLING AFTER AORTIC VALVE REPLACEMENT WITH A FREESTYLE STENTLESS BIOPROSTHESIS
L.H.B. Baur, Y. Houdas, C.H. Peels, A. Prat, A.P. Kappetein, J. Braun, E.E. van der Wall, H.A. Huysmans, Leiden, The Netherlands12:00 POISEUILLE'S MODEL (POIS-M) IS LESS FLOW-DEPENDENT AND MORE USEFUL IN DESCRIBING CIRCULATORY IMPAIRMENT IN AORTIC STENOSIS (AS) THAN TORRICELLI'S MODEL (TORR-M)
A. Malavasi, A. Tucconi, G. Di Girolamo, L. Cassisa, M. Pala, C. Poddighe, P. Masala, C. Denurra, A. Muretto, E. Solinas, Sassari, Italy12:15 BALLOON MITRAL VALVULOPLASTY USING MODIFIED TECHNIQUE - OUR EXPERIENCE
C.N. Manjunath, K.H. Srinivas, C.B. Patil, H.V. Venkatesh, T.S. Bhoopal, C. Dhanalakshmi, S. Jayadeva, Bangalore, India12:30 LONG-TERM OUTCOME OF OPERATED PATIENTS WITH CHRONIC AORTIC REGURGITATION AND EXTREME LEFT VENTRICULAR DILATATION
B. Ivanovic, D. Kalimanovska, D. Simic, D. Matic, B. Vujisic, D. Nikcevic, P. Djukic, Belgrade, Yugoslavia12:45 L u n c h B r e a k
TUESDAY, MAY 18, 1999
10:45 - 12:45 HALL B
PL10: Plenary Session
CLINICAL ASPECTS OF CORONARY ARTERY DISEASE
Chairpersons: R.O. Cannon, III, Bethesda MD, USA
J.S. Forrester, Los Angeles CA, USA10:45 Na-H EXCHANGE INHIBITION IN LIMITING ISCHEMIC INJURY - CLINICAL IMPLICATIONS (Invited Lecture)
S. Schaefer, Davis CA, USA11:00 HEMOSTASIS AND INFLAMMATION IN ACUTE CORONARY SYNDROMES (Invited Lecture)
H.M. Hoffmeister, Tubingen, Germany11:15 ASPIRIN INCREASES FERRITIN SYNTHESIS IN ENDOTHELIAL CELLS: A NOVEL ANTIOXIDANT PATHWAY (Invited Lecture)
H. Schroder, Halle (Saale), Germany11:30 ARE NEW PHARMACOLOGICAL AGENTS SUPERIOR TO OLD DRUGS FOR TREATING PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE? EFFECTS ON SURVIVAL AND FUNCTIONAL STATUS (Invited Lecture)
U. Thadani, Oklahoma City OK, USA11:45 IMPACT OF A HOSPITAL DISCHARGE PROTOCOL ON CORONARY ARTERY DISEASE TREATMENT UTILIZATION AND CLINICAL OUTCOMES (Invited Lecture)
G. Fonarow, Los Angeles CA, USA12:00 VASCULAR EFFECTS OF ESTROGEN IN POSTMENOPAUSAL WOMEN AT RISK FOR CORONARY ARTERY DISEASE (Invited Lecture)
R.O. Cannon III, Bethesda MD, USA12:15 ESTROGENS FOR THE PREVENTION OF CORONARY HEART DISEASE (Invited Lecture)
J.E. Rossouw, Bethesda MD, USA12:30 CONTINUOUS COMBINED HORMONE REPLACEMENT DOES NOT INFLUENCE POSTPRANDIAL TRIGLYCERIDES IN WOMEN WITH CORONARY ATHEROSCLEROSIS
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Weizbicki, G. Jackson, London, UK12:45 L u n c h B r e a k
TUESDAY, MAY 18, 1999
10:45 - 12:45 HALL C
S70: SURGERY FOR LV DYSFUNCTION
Chairpersons: V.S. Chekanov, Milwaukee WI, USA
W. Piccione Jr., Chicago IL, USA10:45 LEFT VENTRICULAR DILATATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY SHOULD NOT EXCLUDE SURGICAL REVASCULARIZATION
R.W. Kim, B.S. Ugurlu, D.A. Tereb, G. Tellides, J.A. Elefteriades, New Haven CT, USA11:00 QUALITY OF LIFE ASSESSMENT AFTER PARTIAL LEFT VENTRICULECTOMY
G. Bhat, M.A. Laureano, R.D. Dowling, P. Cerrito, Louisville KY, USA11:15 DIASTOLIC FUNCTION IMPROVES PRIOR TO SYSTOLIC FUNCTION IN CRYOINJURED RABBIT HEARTS AFTER CELLULAR CARDIOMYOPLASTY
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA11:30 TRANSPLANTED SKELETAL MYOBLASTS, BUT NOT FIBROBLASTS, EXPRESS CARDIAC AND SKELETAL CHARACTERISTICS AND IMPROVE PERFORMANCE OF INJURED MYOCARDIUM
K.A. Hutcheson, B.Z. Atkins, M.C. Reedy, D.D. Glower, D.A. Taylor, Durham NC, USA11:45 LONG-TERM SURVIVAL AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICE FOR END-STAGE PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, B. Mihajlovic, S. Nicin, V. Torbica, M. Popov, D.D. Zecevic, A. Milosavljevic, S. Susak, B. Kozic, M. Golubovic, A. Redzek, Novi Sad, Yugoslavia12:00 HEMODYNAMIC AND CLINICAL IMPROVEMENT AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICES IN END-STAGE HEART FAILURE IN PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, S. Nicin, B. Mihajlovic, M. Mijatov, S. Popovic, M. Popov, Z. Konstantinovic, D.D. Zecevic, S. Susak, A. Redzek, Novi Sad, Yugoslavia12:15 DIFFERENTIAL EFFECTS OF MYOCARDIAL CRYOINJURY ON GLOBAL AND REGIONAL VENTRICULAR INDICES OF PERFORMANCE IN THE RABBIT HEART
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA12:30 PREDICTION OF REGIONAL LEFT VENTRICULAR IMPROVEMENT AFTER CABG SURGERY: COMPARISON OF LOW DOSE DOBUTAMINE ECHOCARDIOGRAPHY (LDE) AND LOW DOSE DOBUTAMINE VENTRICULOGRAPHY (LDV)
L. Dalla Vecchia, T. Storti, P. Danna, C. Cogliati, S. Guzzetti, P. Di Biasi, R. Scrofani, A. Malliani, Milano, Italy12:45 L u n c h B r e a k
TUESDAY, MAY 18, 1999
10:45 - 13:15 HALL E
S55: BASIC RESEARCH, MOLECULAR CARDIOLOGY
Chairpersons: L. Fananapazir, Bethesda MD, USA
A.C. Newby, Bristol, UK10:45 IDENTIFICATION OF DENDRITIC CELLS IN AORTOCORONARY SAPHENOUS VEIN BYPASS GRAFTS: A POTENTIAL CAUSE OF GRAFT FAILURE
S.M. Cherian, Y.V. Bobryshev, S.J. Inder, R.S.A. Lord, H. Liang, A.E. Farnsworth, Sydney NSW, Australia11:00 INDUCTION OF INTRACELLULAR ANTIOXIDANT ENZYMES SYSTEM BY GLUTIN - METABOLIC DRUG WITH ANTIISCHEMIC ACTION
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia11:15 THE INSERTION/DELETION POLYMORPHISM WITHIN THE ANGIOTENSIN CONVERTING ENZYME AND REACTIVITY OF ISOLATED RESISTANCE ARTERIES
R.P. Steeds, L. O'Toole, K. English, K.S. Channer, Sheffield, UK11:30 LOCAL OVEREXPRESSION OF PROSTACYCLIN INHIBITS NEOINTIMAL FORMATION AFTER ARTERIAL INJURY: PROSTACYCLIN SYNTHASE GENE TRANSFER VS EXOGENOUS BERAPROST SODIUM
M. Harada, Y. Toki, Y. Numaguchi, T. Ito, K. Okumura, Nagoya, Japan11:45 INTRACORONARY PROUROKINASE GENE TRANSFER WITH PROTEIN-COATED STENT PREVENTS CORONARY RESTENOSIS IN MINI-SWINE
R. Gao, J. Yuan, R. Shi, Beijing, China12:00 OXIDATIVE AGENTS INDUCE APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS BUT NOT FROM WISTAR-KYOTO RATS
E. Bonanno, L. Ghibelli, A. Mauriello, L. Anemona, L.G. Spagnoli, Rome, Italy12:15 IMMUNOHISTOCHEMISTRY IN THE IDENTIFICATION OF FIBRONECTIN DEPOSITS AND ICAM-I EXPRESSION IN INFLAMED MYOCARDIUM
V. Maravic-Stojkovic, M. Bojic, Belgrade, Yugoslavia12:30 QUINAPRIL, A NON-SH-CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR PREVENTS LIPID PEROXIDES GENERATION IN CHOLESTEROL-FED RABBITS
M. Stajszczyk, J. Gminski, W. Wojakowski, K. Siemianowicz, M. Goss, M. Machalski, Katowice, Poland12:45 THE IMPORTANCE OF ENDOCARDIAL ENDOTHELIUM ON THE EFFECTS OF db-cAMP ON THE POTASSIUM CONTENT IN THE ISOLATED RIGHT VENTRICLE OF RAT HEART
M.T. Nesic, M.R. Pavlovic, V.S. Jankovic, Belgrade, Yugoslavia13:00 I/D POLYMORPHISM OF THE ACE GENE PREDICTS LEFT VENTRICULAR FUNCTION IN PATIENTS WITH CORONARY HEART DISEASE BUT NOT C/A POLYMORPHISM OF THE ANGIOTENSIN II TYPE 1 RECEPTOR GENE
L. Mierzejewski, W. Dubaniewicz, R. Targonski, M. Gruchala, W. Sobiczewski, D. Ciecwierz, K. Ochman, P. Romanowski, Gdansk, Poland13:15 L u n c h B r e a k
TUESDAY, MAY 18, 1999
10:45 - 12:30 HALL F
S64: RECENT ADVANCES AND FUTURE DIRECTIONS IN THE TREATMENT OF ARRHYTHMIAS
Chairpersons: A. Caspi, Rehovot, Israel
M. Shechter, Tel Hashomer, Israel
10:45 ATRIAL STIMULATION USING FLOATING ELECTRODE AND A COUNTER ELECTRODE IN THE VENA CAVA SUPERIOR
A.S. Menezes Jr., C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, U. Bernardes, M. Schaldach, M. Taskiran, Goiana, Brazil, Erlangen, Germany11:00 DOES THE DEFIBRILLATION THRESHOLD PREDICTS DEFIBRILLATION SUCCESS?
B. van Veen, B. Gerritse, Maastricht, The Netherlands11:15 EFFECTIVE ATRIAL CONTRIBUTION IN SEQUENTIALLY PACED PATIENTS WITH IMPAIRED VENTRICULAR FUNCTION
J. Kvasnicka, M. Mest'an, V. Rozsival, M. Tauchman, J. Jandik, I. Gajdosova, P. Rejchrt, P. Stransky, Kralove, Czech Republic11:30 TWO DIFFERENT SINGLE LEAD DDD PACING SYSTEMS COMPARATIVE STUDY
A.S. Menezes, C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, U. Bernardes, M. Schaldach, M. Taskiran, Goiania, Brazil, Erlangen, Germany11:45 TREATMENT OF CARDIAC FAILURE IN PATIENTS WHO RECEIVE DUAL-CHAMBER ICDs WITH RARE-ADAPTIVE PACING FUNCTIONS
M. Achtelik, P. Pfitzner, B. Voigt, L. Obergassel, H.J. Trappe, Herne, Germany12:00 OCCURRENCE PROBABILITY OF FATAL VENTRICULAR ARRHYTHMIA - CHAGAS DISEASE X NON-CHAGAS DISEASE
M.F. Martinelli, H.B. Moreira, S. Siqueira, A.A.A. Pedrosa, S.A.D. Nishioka, R. Costa, M. Scanavacca, A. d'Avila, E.A. Sosa, Sao Paulo, Brazil12:15 SYNCHRONIZATION OF ATRIAL DEPOLARIZATION BY ATRIAL SEPTAL PACING IN PATIENTS WITH DELAYED INTERATRIAL CONDUCTION
A. Katsivas, E. Lazaris, A.G. Manolis, G. Kazamias, D. Karatza, C. Vassilopoulos, N. Louvros, Athens, Greece12:30 L u n c h B r e a k
TUESDAY, MAY 18, 1999
08:30 - 12:30
P102: Poster Session
VASCULAR BIOLOGY, BASIC RESEARCHBoard No.
1. THROMBOSIS EFFECT ON VASCULAR REMODELING AT OCCLUDED ANGIOPLASTY ARTERY IN RABBIT MODEL
Z.-Q. Chen, H.V. Anderson, R. Pakala, C.R. Benedict, Houston TX, USA2. GRAVITATIONAL STRESS: A STIMULATOR OF ENDOGENOUS PGI2 SYNTHESIS AND ENDOTHELIAL CELL DESQUAMATION
M.E. Isasi, E.S. Isasi, D. Mancioni, Montevideo, Uruguay3. STUDY ON CHANGES OF PLASMA ADRENOMEDULLIN AND ENDOTHELIN IN ESSENTIAL HYPERTENSIVE PATIENTS
L.-X. Jiang, N.-L. Sun, C.-S. Tang, Y.-Z. Pang, Beijing, China4. EXPRESSION OF EXTRACELLULAR SUPEROXIDE DISMUTASE AND INDUCIBLE NITRIC OXIDE SYNTHASE IN HUMAN AND RABBIT ATHEROSCLEROTIC LESIONS
J.S. Luoma, S. Yla-Herttuala, A.I. Virtanen, Kuopio, Finland
TUESDAY, MAY 18, 1999
08:30 - 12:30
P103: Poster Session
PHARMACOLOGIC MODULATION OF VASCULAR - ENDOTHELIAL FUNCTIONBoard No.
5. CHRONIC FEEDING OF PURPLE GRAPE JUICE REDUCES CHOLESTEROL ENHANCE PLATELET ACTIVITY AND DEVELOPMENT OF ATHEROSCLEROSIS IN RABBITS
D. Shanmuganayagam, T. Warner, J. Folts, Madison WI, USA
TUESDAY, MAY 18, 1999
08:30 - 12:30
P104: Poster Session
GENETIC DETERMINANTS OF CORONARY ARTERY DISEASE / CARDIOMYOPATHIES, GENE THERAPYBoard No.
6. IS PLA POLYMORPHISM OF PLATELET GLYCOPROTEIN IIIA ASSOCIATED WITH CORONARY ARTERY DISEASE OR ACUTE MYOCARDIAL INFARCTION
C. Bottiger, A. Kastrati, W. Koch, J. Mehilli, N. v. Beckerath, A. Schoemig, Munich, Germany
TUESDAY, MAY 18, 1999
08:30 - 12:30
P104: Poster Session
GENETIC DETERMINANTS OF CORONARY ARTERY DISEASE / CARDIOMYOPATHIES, GENE THERAPY (cont)Board No.
7. ASSOCIATION OF APOLIPOPROTEIN (a) PHENOTYPES WITH HISTORY OF MYOCARDIAL INFARCTION IN YOUNG MEN
M.V. Ezhov, A.A. Lyakishev, O.I. Afanasieva, G.F. Benevolenskaya, S.N. Pokrovsky, Moscow, Russia8. ANGIOTENSIN-CONVERTING ENZYME GENOTYPE IN HYPERTROPHIC CARDIOMYOPATHY AND HYPERTROPHY IN HYPERTENSION
M. Gao, J. Lu, D. Hu, B. Xiao, Z. Xu, Beijing, China9. MUTATION DETECTION IN THE MITOCHONDRIAL DNA OF PATIENTS WITH DCM: COMPARISON OF DIDEOXY-FINGERPRINTING AND DIRECTED TERMINATION PCR
V. Ruppert, B. Maisch, Marburg, Germany10. INCREASED TIME DOMAIN PARAMETERS OF HEART RATE VARIABILITY IN ASSOCIATION WITH THE D ALLELE OF THE ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM
R.P. Steeds, A. Sivaguru, A. English, K.S. Channer, Sheffield, UK11. THE 4G/5G INSERTION/DELETION POLYMORPHISM IN THE PROMOTER REGION OF THE PAI-1 (TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR) GENE IS RELATED TO MYOCARDIAL INFARCTION AND OTHER ARTERIAL THROMBOSIS IN THE ANTIPHOSPHOLIPID SYNDROME
D. Tassies, G. Espinosa, F.J. Munoz-Rodriguez, J.C. Reverter, J. Font, C. Freire, G. Escolar, M. Ingelmo, A. Ordinas, Barcelona, Spain12. LIPOSOME-MEDIATED GENE TRANSFER WITH BCL-2, VEGF-165, bFGF AND cT-1 FOR TREATMENT OF ISCHEMIC AND DILATIVE CARDIOMYOPATHY: FIRST RESULTS
T. Wild, S.C. Beutelspacher, W. Barusch, K. Macfelda, B. Kappella, A.M. Groeger, E. Wolner, U. Losert, R. Seitelberger, Vienna, Austria13. INTRAVASCULAR LOCAL GENE TRANSFER MEDIATED BY PROTEIN-COATED METALLIC STENT
J. Yuan, R. Gao, R. Shi, Beijing, China
TUESDAY, MAY 18, 1999
08:30 - 12:30
P108: Poster Session
PHARMACOLOGIC STRESS TESTING - ECHOCARDIOGRAPHYBoard No.
14. CLINICAL APPLICATION OF EXERCISE STRESS ECHOCARDIOGRAPHY: SUPINE BICYCLE OR POST TREADMILL?
A. Dagianti, M. Penco, L. Sgorbini, F. Fedele, Rome, Italy15. MULTIPLANE TRANSESOPHAGEAL STRESS ECHOCARDIOGRAPHY: IS ENDOCARDIAL VISUALISATION DIFFERENT IN THE VARIOUS STANDARD PROJECTIONS?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany16. STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH POOR ACOUSTIC WINDOWS: IS MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY APPLICABLE?
J. Gude, H.J. Mueller, E. Horstmann, H.K. Beyer, H.J. Trappe, Herne, Germany17. INCREASED DIASTOLIC LEFT VENTRICULAR WALL THICKNESS AND HETEROGENEITY OF REGIONAL WALL THICKENING DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY
E. Hausnerova, J.S. Gottdiener, G.M. Hecht, P.F. Hausner, R. Chavko, Washington DC, USA18. PROGNOSTIC IMPACT OF DOBUTAMINE ECHOCARDIOGRAPHY AND EXERCISE-REDISTRIBUTION-REINJECTION THALLIUM SPECT IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND SEVERE LEFT VENTRICULAR DYSFUNCTION
A.G. Economou, S. Feggos, G. Kazianis, A. Gournizakis, P. Economopoulos, G. Avgeropoulos, Athens, Greece19. CAN DOBUTAMINE ECHOCARDIOGRAPHY INDUCE MYOCARDIAL DAMAGE IN PATIENTS WITH DYSFUNCTIONAL BUT VIABLE MYOCARDIUM SUPPLIED BY A SEVERELY STENOTIC CORONARY ARTERY?
J. Meluzin, J. Toman, L. Groch, I. Hornacek, J. Sitar, B. Fischerova, Brno, Czech Republic20. DOBUTAMINE ECHOCARDIOGRAPHY STUDY OF AUTO AND HOMOGRAFTS AND ROSS PROCEDURE
H.H. Filho, R. Pinton, W. Lemke, F.D.A. Costa, Santa Casa de Curitiba, PR, Brazil21. SYNERGISTIC EFFECTS OF PROPRANOLOL IN THE INDUCTION OF MYOCARDIAL ISCHAEMIA DURING DOBUTAMINE-STRESS-ECHOCARDIOGRAPHY
P. Piovesana, F. De Conti, N. Lafisca, A. Pantaleoni, Padova, Italy22. BALLOON MITRAL COMMISSUROTOMY: LONG-TERM RESULTS
I. Riecansky, V. Fridrich, P. Chnupa, I. Simkova, M. Grozajova, S. Mizera, Bratislava, Slovak Republic
TUESDAY, MAY 18, 1999
08:30 - 12:30
P112: Poster Session
MYOCARDIAL STUNNING, HIBERNATION AND PRECONDITIONINGBoard No.
23. DELAYED MYOCARDIAL PROTECTION FOLLOWING EXERCISE-INDUCED ISCHEMIA IN HUMANS
M. Bilinska, S. Rudnicki, A. Beresewicz, Warsaw, Poland24. APPEARANCE OF SHOCK AFTER DECOMPRESSION IN CARDIAC TAMPONADE CAN BE EXPRESSION OF MYOCARDIAL STUNNING AFTER THE CHRONIC HIBERNATING IN SUBENDOCARDIAL ZONE
C. Carp, V. Candea, C. Ginghina, A. Popa, C. Macarie, A. Carp, M. Tarlea, D. Gherghiceanu, R. Vasile, V. Iliescu, B. Rotareasa, Bucharest, Romania25. EXERCISE ECHOCARDIOGRAPHY FOR MYOCARDIAL VIABILITY ASSESSMENT
A. Dagianti Jr., L. Sgorbini, A. Varveri, Rome, Italy26. IS THERE ANY DIFFERENCE IN THE DOPPLER MYOCARDIAL IMAGING CHARACTERISTICS IN ACUTE AND CHRONIC ISCHAEMIC MYOCARDIAL WALL SEGMENTS?
I. Hegedus, L. Voith, Z. Koszegi, Debrecen, Hungary27. PROGNOSTIC VALUE OF THE AMOUNT OF DYSFUNCTIONAL BUT VIABLE MYOCARDIUM IN REVASCULARIZED PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION
J. Meluzin, J. Cerny, M. Frelich, F. Stetka, J. Popelova, R. Stipal, Brno, Czech Republic
TUESDAY, MAY 18, 1999
08:30 - 12:30
P118: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATIONBoard No.
28. COAGULATION SCREENING IN PATIENTS WITH CHEST PAIN
O. Biadi, L. Papi, M. Cecchini, N. Gigli, G. Musumeci, L. Ruocco, M. Tassi, A. Lofaro, R. Mariotti, M. Mariani, Pisa, Italy29. RE-ATTACK OF MYOCARDIAL INFARCTION AND RISK FACTORS IN YOUNG PATIENTS
S. Eguchi, N. Ohtake, T. Ryu, T. Ogata, S. Tsuji, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan30. HEART RATE VARIABILITY, BAROREFLEX SENSITIVITY, CATECHOLAMINE OF THE PATIENTS WITH MYOCARDIAL INFARCTION
Z. Fan, N. Wu, Beijing, China31. SPURIOUS ELEVATION OF PLASMA HOMOCYSTEINE LEVELS ASSOCIATED WITH ACUTE MYOCARDIAL INFARCTION
J.M. Griffiths, J. Nagendran, M.P. Senaratne, Edmonton, Alberta, Canada
TUESDAY, MAY 18, 1999
08:30 - 12:30
P118: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION (cont)Board No.
32. NEW APPROACHES ON HEMODYNAMICS OF CORONARY ARTERY DISEASE DURING WARM WATER BATH
J. Lukac, L. Adamovic, J. Celko, A. Makis, Teplice, Slovak Republic33. COMPLIANCE TO THE PRESCRIBED LIFESTYLE CHANGES MAINTAINS THE FAVORABLE AUTONOMIC BALANCE INDUCED BY REHABILITATION AFTER MYOCARDIAL INFARCTION
G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy34. CHOLESTEROL METABOLISM IN POSTMENOPAUSAL WOMEN WITH CORONARY ARTERY DISEASE
R.A. Rajaratnam, H. Gylling, T.A. Miettinen, Helsinki, Finland35. RATE OF GASTROINTESTINAL IRRITATION AND OCCULT BLOOD LOSS WITH D,L,-LYSINE-MONO-ACETYLSALICYLATE AND ASPIRIN
A.A. Schoneberger, E. Lipinski, C. Raschka, Koenigstein, Germany36. PLASMA HOMOCYST(E)INE: A RISK FACTOR FOR ACUTE CORONARY SYNDROME
S. Soifer, F. Basilico, H.A. Cercos, H.G. Torres, O. Fridman, J.L. D'Eramo, A. Bronstein, A.E. Finkelstein, Buenos Aires, Argentina37. TEMPORAL TRENDS INFLUENCE HOSPITAL LENGTH OF STAY IN ACUTE MYOCARDIAL INFARCTION INDEPENDENT OF CLINICAL AND TREATMENT STRATEGIES IN A DEFINED GEOGRAPHIC POPULATION
R.S. Wright, F.A. Sgura, J.P. Grill, G.S. Reeder, S.L. Kopecky, Rochester MN, USA
TUESDAY, MAY 18, 1999
08:30 - 12:30
P123: Poster Session
HYPERTENSION, BASIC AND CLINICALBoard No.
38. 24 HRS. AMBULATORY BLOOD PRESSURE MONITORING: MEANING OF THE LOSS OF CIRCADIAN RHYTHM
O. Biadi, N. Gigli, G. Musumeci, L. Papi, M. Cecchini, G. Valente, R. Mariotti, M. Marini, Pisa, Italy39. A-II RECEPTOR BLOCKADE WITH VALSARTAN AND CORRELATIONS BETWEEN METABOLIC AND HAEMODYNAMIC PARAMETERS IN ESSENTIAL HYPERTENSIVE PATIENTS
I. Notaristefano, R. Costa, M. Crippa, E. Chiari, R. Fariello, Brescia, Italy40. RELATION OF LEFT ATRIAL EJECTION FORCE TO LEFT VENTRICULAR FUNCTION IN ARTERIAL HYPERTENSION
S. Qirko, T. Goda, L. Rroku, Tirana, Albania41. THE SHORT-TERM AND CIRCADIAN BLOOD PRESSURE VARIABILITY IN THE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND HYPERTENSION
J. Zhang, R. Hui, Y. Sun, X. Ni, M. Xu, B. Zhao, X. Wang, L. Liu, Beijing, China
TUESDAY, MAY 18, 1999
08:30 - 12:30
P134: Poster Session
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSIONBoard No.
42. IS CARDIOPULMONARY TEST USEFUL IN EVALUATION OF PATIENTS AFFECTED BY CORONARY HEART DISEASE?
O. Biadi, M. Cecchini, G. Musumeci, N. Gigli, L. Papi, R. Mariotti, M. Mariani, Pisa, Italy43. CHEST COLOR DOPPLER SONOGRAPHY WITH ECHO CONTRAST AGENTS OF UNCLEAR PERIPHERAL LUNG LESIONS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
R. Bitschnau, G. Mathis, O. Gehmacher, A. Kopf, M. Scheier, Hohenems, Austria44. PREVALENCE AND SHORT TERM PROGNOSIS OF LATENT HEMODYNAMIC COMPROMISE IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
S. Grifoni, I. Olivotto, F. Pieralli, P. Cecchini, A. Camaiti, G. Cagliarelli, A. Conti, G. Berni, Florence, Italy45. CLINICAL OUTCOME OF CATHETER FRAGMENTATION AND SPIRATION THERAPY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
S. Hiramatsu, A. Ogihara, T. Sasaki, T. Ishikawa, K. Hayashi, M. Fuse, J. Muramatsu, T. Izumi, Namazu Shizuoka, Japan
TUESDAY, MAY 18, 1999
08:30 - 12:30
P134: Poster Session
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION (cont)Board No.
46. VALUE OF CLINICAL ASSESSMENT IN THE DIAGNOSIS OF PULMONARY EMBOLISM
M. Miniati, B. Formichi, R. Prediletto, C. Marini, G. Di Ricco, L. Tonelli, G. Allescia, M. Pistolesi, Pisa, Italy47. BRONCHIAL HYPERREACTIVITY IN HEALTHY LUNGS LONG TERM AFTER CONVENTIONAL MECHANICAL VENTILATION. IMPLICATION FOR PATIENTS AFTER REPAIR OF CHD?
J. Sulc, K. Dlask, J. Hruda, J. Stuj, A. Zapletal, B. Petrak, K. Chamoutova, Prague, Czech Republic48. ADRENOMEDULLIN REDUCES THE RISK FOR PULMONARY HYPERTENSION IN RATS
P. Vijay, J.W. Brown, T.G. Sharp, Indianapolis IN, USA
TUESDAY, MAY 18, 1999
08:30 - 12:30
P136: Poster Session
EXERCISE PHYSIOLOGY IN HEART FAILUREBoard No.
49. CARDIOPULMONARY STRESS TEST IN PATIENTS WITH HEART FAILURE
O. Biadi, M. Cecchini, L. Papi, N. Gigli, R. Dell'Anna, G. Musumeci, R. Mariotti, M. Mariani, Pisa, Italy50. PLASMA CATECHOLAMINES, POTASSIUM AND CARDIAC FUNCTION IN OBESE SUBJECTS DURING EXERCISE
P. Fanari, A. Salvadori, E. Giacomotti, M. Fontana, E. Longhini, Verbania, Italy51. MODULATION OF NEURAL AND METABOLIC HEART RATE RESPONSE TO EXERCISE BY A BAROREFLEX MECHANISM
K. Oikawa, N. Fukuma, T. Tsuchida, N. Aisu, M. Tomimura, Y. Fukuma, J. Sano, T. Saitoh, Y. Kusama, K. Munakata, H. Kishida, Tokyo, Japan52. ENDOTHELIUM-DEPENDENT AND INDEPENDENT VASCULAR RESPONSES AND BLOOD FLOW IN THE BRACHIAL ARTERY OF HEART FAILURE PATIENTS: RELATIONSHIP TO PEAK OXYGEN CONSUMPTION AND LEFT VENTRICULAR EJECTION FRACTION
M. Yousufuddin, W. Shamim, J.S. Chamber, S.D. Anker, A.J.C. Coats, London, UK53. NON-INVASIVE ASSESSMENT OF EXERCISE INDUCED ALTERATIONS OF COUNDUIT ARTERY VASOMOTOR TONE IN HEALTHY SUBJECTS AND PATIENTS WITH CHRONIC HEART FAILURE: RELATIONSHIP WITH ENDOTHELIN-1 AND NOR-EPINEPHRINE
M. Yousufuddin, W. Shamim, J.S. Chamber, F.R. Amin, S.D. Anker, M. Kemp, A.J.C. Coats, London, UK
TUESDAY, MAY 18, 1999
08:30 - 12:30
P140: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC AND CLINICALBoard No.
54. LONG-TERM SURVIVAL OF PATIENTS TREATED WITH INTRAVENOUS AMIODARONE FOR LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IS INDEPENDENT OF DRUG DOSE OR DEFIBRILLATOR IMPLANTATION
C. Baessler, M. Schuster, S.E. Hessen, S.P. Kutalek, Philadelphia PA, USA55. THE TREATMENT BY LOW-DOSE AMIODARONE AND DIGOXIN IN PATIENTS OF ATRIAL FIBRILLATION WITH CONGESTIVE HEART FAILURE
G.-P. Jong, S.L. Lin, Taichung, Taiwan-R.O.C.56. EFFECTS OF INTRAVENOUS DOFETILIDE AND AMIODARONE ON SYMPATHETIC ACTIVATION AND CORONARY BLOOD IN HEART FAILURE PATIENTS
M.F. Rousseau, P.E. Massart, L. Galanti, S.A. Ahn, J. Etienne, H.G. Pouleur, Brussels, Belgium57. THE DISTURBANCE OF AUTONOMIC BALANCE, DETECTED BY THE ANALYSIS OF HEART RATE VARIABILITY, IS A VERY COMMON TRIGGER OF PAROXISMAL ATRIAL FIBRILLATION IN PATIENTS WITHOUT STRUCTURAL HEART DISEASE
A. Sinani, V. Gjini, V. Paparisto, G. Ndrepepa, P. Cina, S. Qirko, Tirana, Albania58. PREDICTORS OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS SURGERY
M. Sniezek-Maciejewska, A. Dziatkowiak, J. Kopacz, Cracow, Poland59. RADIOFREQUENCY CATHETER ABLATION OF THE ATRIA TO TERMINATE SUSTAINED ATRIAL FIBRILLATION INDUCED WITH METHACHOLINE IN DOGS
X. Yang, T. Liu, C. Guo, D. Hu, Beijing, China60. EFFECT OF RISPERIDONE ON QT INTERVAL AND QT DISPERSION IN THE ELDERLY
M. Yerrabolu, E. Delgado, I. Hussain, M. Tawam, K. Krishna, S. Prabhudesai, L. Costello, M. Kamalesh, L. Winter, Danville IL, USA
TUESDAY, MAY 18, 1999
08:30 - 12:30
P142: Poster Session
SUDDEN DEATH, SYNCOPEBoard No.
61. EXERCISE INDUCED QRS WIDENING CORRELATES WITH SCORE INDEX CONTRACTILITY AND LEFT VENTRICULAR MASS BUT NOT WITH NUMBER AND SEVERITY OF DISEASED VESSELS
K.G. Adamian, A.L. Chilingarian, A.V. Astvatsatrian, A.Z. Garibgeanian, Yerevan, Armenia62. CARDIOPULMONARY RESUSCITATION WITH INTERPOSED ABDOMINAL COMPRESSION IN PROLONGED CARDIAC ARREST
G. Falsini, D. Rossini, M. Romel, S. Amidei, M. Forzoni, M. Grazzini, W. Vergoni, Arezzo, Italy
TUESDAY, MAY 18, 1999
08:30 - 12:30
P142: Poster Session
SUDDEN DEATH, SYNCOPE (cont)Board No.
63. LESIONS OF AORTICOPULMONARY PARAGANGLIA RELATED TO SUDDEN DEATH: HISTOPATHOLOGIC CONSIDERATIONS
S.G. Ramos, L. Matturri, G. Ottaviani, L. Rossi, M.A. Rossi, Sao Paulo, Brazil64. LONG TERM EFFICACY OF ETILEPHRINE VERSUS ATENOLOL IN PATIENTS WITH NEURALLY MEDIATED SYNCOPE
B. Xhaxho, G. Ndrepepa, A. Kastrati, G. Bajraktari, P. Cina, A. Dibra, Tirana, Albania65. DIAGNOSTIC ACCURACY OF A LOW-DOSE NITROGLYCERINE SUBLINGUAL HEAD-UP TILT TESTING PROTOCOL
B. Xhaxho, G. Ndreppa, A. Kastrati, P. Cina, G. Bajraktari, L. Bica, A. Dibra, Tirana, Albania66. HEAD-UP TILT TEST IN EVALUATING SYNCOPE IN PATIENTS WITH MITRAL VALVE PROLAPSE
B. Xhaxho, G. Ndrepepa, A. Kastrati, G. Bajraktari, P. Cina, L. Muka, L. Bica, Tirana, Albania
TUESDAY, MAY 18, 1999
08:30 - 12:30
P155: Poster Session
COMPUTERS IN CARDIOLOGYBoard No.
67. MACHINE LEARNING IMPROVES THE ACCURACY OF CORONARY ARTERY DISEASE DIAGNOSTIC METHODS
C. Groseli, J.J. Fettich, I. Kononenko, Ljubljana, Slovenia68. A MODEL FOR INDIVIDUALIZED EDUCATION OF DIFFERENT USER GROUPS IN CARDIAC SURGERY USING ONLINE DATABASE SUPPORT
R. Friedl, M. Preisack, M. Schefer, J. Albers, W. Klas, T. Rose, A. Hannekum, Ulm, Germany69. AN EXPERT SYSTEM FOR DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION WITH ECG ANALYSIS
A. Rabelo Jr., A.R. Rocha, A. Souza, A.C. Freitas, B. Pessoa, C. Andrade, I. Olivaes, K. Oliveira, L.C. Carvalho, N. Lobo, P. Cox, S. Sampaio, Salvador, Brazil
TUESDAY, MAY 18, 1999
08:30 - 12:30
P157: Poster Session
MISCELLANEOUSBoard No.
70. IMPROVEMENT IN HRV IS SEEN WITHIN 24 HOURS OF TREATMENT OF CONGESTIVE HEART FAILURE
H.B. Sherman, A.J. Burger, Boston MA, USA71. ACTIONS OF PROSTACYCLIN AND b-ENDORPHINE ON THE DISTURBANCES OF CARDIOVASCULAR SYSTEM DURING ANAPHYLACTIC SHOCK
P. Cibas, B. Ruta, J. Ivaskeviciene, R. Obeleniene, Kaunas, Lithuania72. INVESTIGATION OF CARDIOVASCULAR DEATH IN CONNECTION WITH WEATHER
S. Gall, B. Szekacs, E. Dinya, Budapest, Hungary73. ZCLINICAL PREDICTION OF LEFT VENTRICULAR EJECTION FRACTION USING CHEST X-RAY VOLUMETRY AND ECG LV MASS ANALYSIS
M.J.D. Garcia, R.A. Naranjilla, R.V. Anastacio, D.R. Flores Jr., C. Mendoza, A.C. DeLara, Manila, Philippines74. AORTIC DISTENSIBILITY IN SYSTEMIC SCLEROSIS
I. Moyssakis, F. Triposkiadis, M. Gofa, G. Anastasiadis, V. Vasiliou, M. Kyriakidis, Athens, Greece75. RIGHT AND LEFT VENTRICULAR FILLING IN CARDIAC ASYMPTOMATIC SYSTEMIC LUPUS ERYTHEMATOSUS. THE INFLUENCE OF ANTIPHOSPHOLIPID ANTIBODIES
I. Moyssakis, F. Triposkiadis, K. Boki, P. Vlahoyannopoulos, M. Kyriakidis, H. Moutsopoulos, Athens, Greece76. ELECTROCARDIOGRAPHIC DIAGNOSIS OF PREVIOUS MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK (LBBB)
F.S. Silveira, A.J. Zago, L. Nucci, R.T.F. Ludwig, M. Both, M.C. Bozzetti, J.P. Ribeiro, Porto Alegre, Brazil
TUESDAY, MAY 18, 1999
08:30 - 12:30
P161: Poster Session
DIGOXIN AND OTHER INOTROPIC AGENTS IN HEART FAILUREBoard No.
77. ASSESSMENT OF RIGHT VENTRICULAR INOTROPIC RESERVE DURING DOBUTAMINE INFUSION IN PATIENTS WITH SECONDARY PULMONARY HYPERTENSION
C.D. Vizza, A. Di Roma, C. Lacobini, G. Benedetti, S. Sciomer, B. Pezza, D. Ricci, G. Della Rocca, F. Pugliese, F. Venuta, E.A. Redina, T. Di Giacomo, S. Quattrucci, F. Fedele, Rome, Italy78. RESPONSE OF THE INTRACARDIAC IMPEDANCE TO INOTROPIC EFFECTIVE DRUGS (BETABLOCKER AND DIGITALIS) DURING VVIR PACING
O.T. Greco, R.V. Ardito, A. Cardinalli Neto, J.P. Stroebel, M. Schaldach, Sao Paulo, Brazil
TUESDAY, MAY 18, 1999
08:30 - 12:30
P161: Poster Session
DIGOXIN AND OTHER INOTROPIC AGENTS IN HEART FAILURE (cont)Board No.
79. POSITIVE EFFECT OF DOBUTAMINE ON LEFT VENTRICULO-ARTERIAL COUPLING DURING ACUTE MYOCARDIAL ISCHEMIA
P. Kolh, B. Lambermont, C. Gomes, P. Gerard, R. Limet, V. D'Orio, Liege, Belgium80. ACTION OF A SYNTHETIC DIGITALIS DERIVATIVE 14b, 17b CYCLOCETOESTER-3b-OH-ANDROSTANE (INCICH-D7) ON Na+,K+ -ATPase
O.M. Ramirez, M.L. Del Valle, H.G. Pastelin, Mexico, Mexico
TUESDAY, MAY 18, 1999
08:30 - 12:30
P162: Poster Session
BETA-BLOCKERS AND BETA-ADRENERGIC RECEPTORS IN HEART FAILUREBoard No.
81. CARVEDILOL ELIMINATES MORTALITY AND CARDIO-RENAL HISTOPATHOLOGY AND IMPROVES CARDIAC FUNCTION ASCERTAINED BY ULTRASOUND AND MRI AND RENAL FUNCTION IN SEVERE HYPERTENSION
R.W. Coatney, A.H. Nelson, W.G. Campbell, E.H. Ohlstein, S. Chandra, D.P. Brooks, G.Z. Feuerstein, F.C. Barone, King of Prussia PA, USA82. COMBINATION THERAPY WITH METOPROLOL AND FELODIPINE LEADS TO IMPAIRED EXERCISE HEMODYNAMICS AS COMPARED WITH METOPROLOL ALONE IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE
F. Edelmann, M. Knapp, G. Simonis, C. Weinbrenner, M.U. Braun, C. Schwencke, F.J. Meyer, R. Wipplinger, R.H. Strasser, Heidelberg, Germany83. STUDY ON THE MECHANISM FOR THE POSITIVE INOTROPIC EFFECTS OF HIGENAMINE
Q. Ke, H. Terada, S. Sugiyama, H. Satoh, H. Hayashi, Hamamatsu, Japan84. CARVEDILOL INFLUENCE ON BAROREFLEX SENSITIVITY IN SUBJECTS WITH CHRONIC HEART FAILURE
G. Piccirillo, P. Raganato, A. Mariano, M. Lionetti, A. Moise, R. Leonetti Luparini, V. Celli, V. Marigliano, Rome, Italy
TUESDAY, MAY 18, 1999
13:45 - 15:45 HALL A
PL11: Plenary Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES
Chairpersons: M. Gheorghiade, Chicago IL, USA
H.P. Schultheiss, Berlin, Germany13:45 1999 UPDATE: CHRONIC HEART FAILURE AS A MANIFESTATION OF CORONARY ARTERY DISEASE (Invited Lecture)
M. Gheorghiade, R.O. Bonow, Chicago IL, USA14:00 MULTIPLE INDICES OF LEFT ATRIAL PERFORMANCE IN CARDIOMYOPATHY AND VALVULAR HEART DISEASE (Invited Lecture)
H. Boudoulas, Columbus OH, USA14:15 NEW STRATEGIES IN THE DIAGNOSIS AND THERAPY OF INFLAMMATORY CARDIOMYOPATHY (Invited Lecture)
H.-P. Schultheiss, Berlin, Germany14:30 IS APOPTOSIS A MECHANISM OF CELL DEATH OF CARDIOMYOCYTES IN CHRONIC CHAGASIC MYOCARDITIS? (Invited Lecture)
M.A. Rossi, Sao Paulo, Brazil14:45 ENDEMIC INFESTATIONS AS A CAUSE OF HEART FAILURE (Invited Lecture)
O. Abdel-Aziz, Cairo, Egypt15:00 ACROMEGALY AND CARDIOMYOPATHY. A RADIONUCLIDE DIAGNOSTIC CONSIDERATION (Invited Lecture)
N.J. Angomachalelis, G. Foroglou, N. Salem, A. Hourzamanis, E. Serasli, Thessaloniki, Greece15:15 DILATED CARDIOMYOPATHY AS A RESULT OF VIRAL MYOCARDITIS (Invited Lecture)
N.N. Kipshidze, Tbilisi, Georgia15:30 GENETIC CAUSES OF CARDIOMYOPATHIES (Invited Lecture)
K. Schwartz, Paris, France15:45 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
13:45 - 15:45 HALL B
PL12: Plenary Session
INTERVENTIONAL CARDIOLOGY: STENTS, PREVENTION OF RESTENOSIS
Chairpersons: D.C. Cumberland, Sheffield, UK
J.W. Moses, New York NY, USA13:45 HOW TO INFORM HEART DISEASED PATIENTS ON THE POTENTIAL USE OF NEW DIAGNOSTIC AND THERAPEUTIC TECHNIQUES? (Invited Lecture)
H.J. Geschwind, Creteil, France14:00 ANGIOGRAPHIC AND CLINICAL OUTCOME OF PATIENTS UNDERGOING "STENTING AFTER OPTIMAL LESION DEBULKING" THE "SOLD" REGISTRY (Invited Lecture)
J.W. Moses, I. Moussa, C. Di Mario, A. Colombo, New York NY, USA14:15 PERMANENT IMPLANTS IN CARDIOLOGY - NEED FOR FURTHER IMPROVEMENT (Invited Lecture)
B. Heublein, Hannover, Germany14:30 POLYMER COATED STENTS - CLINICAL POTENTIAL (Invited Lecture)
D.C. Cumberland, J. Gunn, N. Malik, C. Holt, J. Armstrong, Sheffield, UK14:45 DRUG ELUTING STENTS (Invited Lecture)
I. De Scheerder, Leuven, Belgium15:00 CORONARY STENTING FOR LONG LESIONS (LESION LENGTH > 20mm) IN NATIVE CORONARY ARTERIES: COMPARISON OF THREE DIFFERENT TYPES OF STENT
(Invited Lecture)
M. Nobuyoshi, H. Yokoi, Y. Nakagawa, Kitakyushu, Japan15:15 PREVENTION OF RESTENOSIS: AN IVUS LOOK (Invited Lecture)
R. Bonan, D. Meerkin, Montreal PQ, Canada15:30 LOCAL DELIVERY OF ANTISENCE PHOSPHORODIAMIDATE COMPOUND - RESTIN NG INHIBITS MYOINTIMAL HYPERPLASIA FOLLOWING BALLOON ANGIOPLASTY
P. Iverson, V. Skrinska, E. Keane, D. Stein, D. Weller, P. Chawla, A. Tamarkin, N.N. Kipshidze, Milwaukee WI, USA15:45 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
13:45 - 15:45 HALL C
S71: CARDIAC TRANSPLANTATION
Chairperson: M. Ballester, Barcelona, Spain13:45 DISAPPEARANCE OF PERSISTENT CARDIAC REJECTION LATE (>1 YEAR) AFTER TRANSPLANTATION AFTER CHANGING FROM AZATHIOPRINE TO MYCOPHENOLATE MOFETIL (MMF): SERIAL ASSESSMENT BY MYOCARDIAL UPTAKE OF 111ln-LABELED MONOCLONAL ANTIMYOSIN ANTIBODIES
M. Ballester, V. Brossa, L. Tuneu, M. Camprecios, M. Puig, M.R. Aymat, J.M. Padro, I. Carrio, Barcelona, Spain14:00 SERUM CONCENTRATION OF SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 AND RISKS OF SUBSEQUENT CORONARY ARTERY DISEASE OR GRAFT FAILURE IN HEART TRANSPLANT RECIPIENTS
C.A. Labarrere, D.R. Nelson, J.M. Nieto, J. Conner, S.J. Miller, D. Pitts, P. Kirlin, H. Halbrook, Indianapolis IN, USA14:15 RENAL HEMODYNAMIC EFFECTS OF L-ARGININE AND SODIUM-NITROPRUSSIDE IN HEART TRANSPLANT RECIPIENTS
J. Koller-Strametz, M. Wolzt, C. Koppel, D. Putz, W. Wisser, C. Mensik, H.G. Eichler, G. Laufer, L. Schmetterer, Vienna, Austria14:30 STANDARD VERSUS BICAVA TECHNIQUE IN HEART TRANSPLANTATION. IS THERE ANY BENEFICIAL EFFECT ON FUNCTIONAL CAPACITY?
R. Fabregas, M.G. Crespo, J.A. Rodriguez, M.A. Regueiro, J.M. Vazquez-Rodriguez, J.J. Cuenca, J. Muniz, J. Peteiro, N. Alvarez, A. Juffe, A. Castro-Beiras, La Coruna, Spain14:45 PLASMA LEVELS OF OXIDIZED LDL PREDICT DEVELOPMENT OF CORONARY ARTERY DISEASE IN HEART TRANSPLANT PATIENTS
P. Holvoet, J. Van Cleemput, D. Collen, J. Vanhaecke, Leuven, Belgium15:00 HIGH TOTAL PLASMA HOMOCYSTEINE IN HEART TRANSPLANT RECIPIENTS IS ASSOCIATED WITH TIME OF FOLLOW UP, RENAL FUNCTION AND GRAFT VASCULAR DISEASE
L. Potena, S. Sassi, G. Magnani, L. Marinucci, F. Semprini, N. Galie, A.M. Bargossi, C. Magelli, S. Coccheri, A. Branzi, Bologna, Italy15:15 PEDIATRIC HEART TRANSPLANTATION: IMPROVING RESULTS IN HIGH-RISK PATIENTS
J.G. Coles, Toronto ONT, Canada15:30 HEART PRESERVATION OF NON-HEART-BEATING DONORS BY IN-SITU-PERFUSION: COMPARISON OF THE ARTIFICIAL OXYGEN CARRIER PERFLUOROCARBONES WITH UW-SOLUTION IN A BIG ANIMAL MODEL
A.M. Scheule, J. Pappas, C. Strotmann, U. Vogel, S. Miller, S. Reuter, H.P. Wendel, G. Ziemer, Ulm, Germany15:45 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
13:45 - 16:00 HALL E
S74: DIAGNOSTIC METHODS: NUCLEAR CARDIOLOGY, EBCT, ECHOCARDIOGRAPHY
Chairpersons: E. Hausnerova, Washington DC, USA
G. Sambuceti, Pisa, Italy13:45 HEART INVOLVEMENT IN SYSTEMIC SCLEROSIS: AN ULTRASONIC TISSUE CHARACTERIZATION STUDY
V. Di Bello, C. Ferri, D. Giorgio, A. Martini, F.A.A. Storino, M.T. Caputo, A. Bertini, M. Paterni, E. Talini, G. Pasero, C. Giusti, Pisa, Italy14:00 DIRECT COMPARISON OF SHADED SURFACE DISPLAY AND CURVED MULTIPLANAR RECONSTRUCTIONS FOR THE EVALUATION OF CONTRAST-ENHANCED ELECTRON BEAM COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES
S. Achenbach, D. Ropers, J. Nossen, W. Moshage, G. Muschiol, W.G. Daniel, Erlangen, Germany14:15 USEFULNESS OF ELECTRON BEAM COMPUTED TOMOGRAPHY IN CHILDREN WITH HETEROTAXY SYNDROME
S-J. Chen, Y-W. Li, J-K. Wang, M-H. Wu, I-S. Chiu, C-I. Chang, S-C. Hsieh, C-T. Su, J.C-Y. Hsu, H-C. Lue, Taipei, Taiwan-R.O.C.14:30 FUZZY CLUSTER ANALYSIS OF POSITIVE STRESS TESTS: COMPARISON WITH OTHER MODALITIES IN PATIENTS WITH TRIPLE VESSEL AND LEFT MAIN CORONARY DISEASE
R.M. Peters, Long Island NY, USA14:45 ROLE OF FLUMAZENIL IN OUTPATIENTS TRANSESOPHAGEAL ECHOCARDIOGRAPHY
T.S.M. Tsang, M. Martin, K.R. Bailey, J.B. Seward, Rochester MN, USA15:00 MYOCARDIAL VIABILITY ASSESSED BY 99MTc-MIBI-SPECT AND LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY (LDDE) IN PATIENTS WITH OR WITHOUT IMPROVEMENT OF REGIONAL CONTRACTILITY AFTER SURGICAL REVASCULARIZATION
E.N. Khodareva, M.A. Saidova, Y.N. Belenkov, V.B. Sergienko, A.A. Shiryaev, Moscow, Russia15:15 PHASE-CONTROLLED SMALL-AMPLITUDE VIBRATION AT DIASTOLE AUGMENTS HUMAN CORONARY BLOOD FLOW
T. Naya, Y. Koiwa, H. Honda, H-I. Kamada, K. Shirato, S. Kibira, M. Miura, Sendai, Japan15:30 THE CORRECTION OF HYPOKALEMIA IMPROVES DIASTOLIC FUNCTION OF LEFT VENTRICLE. AN ECHOCARDIOGRAPHIC STUDY
E. Maci, V. Fjini, T. Goda, L. Muka, S. Qirko, Tirana, Albania15:45 TIME COURSE OF LEFT ATRIAL AND LEFT ATRIAL APPENDAGE MECHANICAL RECOVERY AFTER TEMPORARY INTERNAL CARDIOVERSION IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION: ECHOCARDIOGRAPHIC STUDY
G. Montanari, V. Mariotti, A. Mariani, P. Volpe, A. Dormi, M. Brun, M. Giunti, A. Andraghetti, N. Ciampani, Senigallia, Milano, Italy16:00 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
13:45 - 16:00 HALL F
S52: MOLECULAR BIOLOGY, BASIC RESEARCH
Chairpersons: R.N.A. Gasser, Graz, Austria
C.E. Pitsavos, Athens, Greece13:45 RISK FACTORS AND ATHEROSCLEROSIS IN YOUTH
A.W. Zieske, J.P. Strong, New Orleans LA, USA14:00 REGIONAL AND TEMPORAL COMPARISON OF ATRIAL AND BRAIN NATRIURETIC PEPTIDE GENE EXPRESSION IN AN OVINE MODEL OF MYOCARDIAL INFARCTION
V.A. Cameron, M.T. Rademaker, E.A. Espiner, M.G. Nicholls, A.M. Richards, Christchurch, New Zealand14:15 CARDIAC GENE EXPRESSION OF ANGIOTENSIN II RECEPTORS SUBTYPES AT1 AND AT2 FOLLOWING ACUTE MYOCARDIAL INFARCTION UNDER PRETREATMENT WITH LOSARTAN
Y.Z. Zhu, Y.C. Zhu, J. Li, T. Yao, H.S. Lee, T. Unger, Singapore, Singapore14:30 INDIRECT LECTIN-HISTOCHEMICAL STAINING OF THE INFILTRATED LYMPHOID CELLS IN THE MYOCARDIUM
V. Maravic-Stojkovic, L. Verner, Hannover, Germany14:45 EXPRESSION OF PERFORIN AND FAS LIGAND IN INFILTRATING CELLS OF MURINE MYOCARDIUM INFECTED WITH COXSACKIEVIRUS B3
Y. Yang, D. Xiong, Y. Su, H. Chen, Shanghai, China15:00 APOPTOSIS IN THE LEFT VENTRICLES OF CHRONIC ISCHEMIC HEART FAILURE SHEEP IS ASSOCIATED WITH AN ELEVATED EXPRESSION OF CASPASES
L. Jiang, Y. Huang, T. Yuasa, S. Hunyor, C.G. dos Remedios, Sydney NSW, Australia15:15 IDENTIFICATION OF A VASOACTIVE AND GROWTH STIMULATING SUBSTANCE FROM PORCINE CARDIAC TISSUE
J. Luo, J. Jankowski, M. Tepel, W. Zidek, H. Schluter, Herne, Germany15:30 ULTRASONIC MYOCARDIAL TEXTURAL ANALYSIS OF HYPERTENSIVE HEART: COMPARISON WITH PULSED DOPPLER ANALYSIS OF TRANSMITRAL FLOW
V. Di Bello, R. Pedrinelli, D. Giorgi, A. Bertini, M.T. Caputo, E. Talini, G. Valenti, M.F. Romano, G. Dell'Omo, C. Giusti, Pisa, Italy15:45 FIBRONECTIN DEPOSITS IN THE EXTRACELLULAR MATRIX AND CD68 + MONOCYTE/MACROPHAGES IN PATIENTS WITH ACTIVE MYOCARDITIS
V. Maravic-Stojkovic, M. Miric, B. Radevic, Belgrade, Yugoslavia16:00 C o f f e e B r e a k
TUESDAY, MAY 18, 1999
16:00 - 17:45 HALL A
PL13: Plenary Session
NEW DIAGNOSTIC METHODS FOR ASSESSMENT OF CARDIAC AND CIRCULATORY FUNCTION
Chairpersons: P.R. Liebson, Chicago IL, USA
E.E.van der Wall, Leiden, The Netherlands16:00 CARDIAC MRI IN CONGENITAL HEART DISEASE (Invited Lecture)
T. Geva, Boston MA, USA16:15 CONSTRICTIVE PERICARDITIS VS RESTRICTIVE CARDIOMYOPATHY: DIFFICULT DIFFERENTIAL DIAGNOSIS (Invited Lecture)
D.H. Spodick, Worcester MA, USA16:30 IMAGING OF ATHEROSCLEROSIS: IS THERE A CLINICAL NEED? (Invited Lecture)
E.E. van der Wall, Leiden, The Netherlands16:45 THE CLINICAL IMPACT OF MYOCARDIAL VIABILITY ON LONG TERM OUTCOME OF PATIENTS WITH ADVANCED ISCHEMIC LEFT VENTRICULAR DYSFUNCTION
(Invited Lecture)
P. Marzullo, Presented by: G. Sambuceti, Pisa, Italy17:00 PREDICTORS OF HARD EVENTS IN PATIENTS SCREENED WITH ELECTRON BEAM COMPUTED TOMOGRAPHY
P. Raggi, T.Q. Callister, D.J. Russo, N.J. Lippolis, Nashville TN, USA17:15 NON-INVASIVE ASSESSMENT OF THE CULPRIT VESSEL BY CONTRAST-ENHANCED ELECTRON-BEAM CT IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION
S. Achenbach, D. Ropers, J. Nossen, W. Moshage, G. Muschiol, W.G. Daniel, Erlangen, Germany17:30 INFARCT-AVID AGENT ENHANCED MRI: AN IN VIVO GOLD STANDARD FOR DETERMINATION OF ACUTE MYOCARDIAL INFARCTION
Y. Ni, H. Bosmans, Y. Miao, S. Dymarkowski, J. Bogaert, W. Semmler, G. Marchal, Leuven, Belgium
TUESDAY, MAY 18, 1999
16:00 - 18:00 HALL B
S75: INTERVENTIONAL CARDIOLOGY, PREVENTION OF RESTENOSIS AFTER ACUTE INTERVENTION
Chairpersons: I.K. De Scheerder, Leuven, Belgium
B. Heubelin, Hannover, Germany16:00 PRESENT AND FUTURE ROLE OF "HYBRID PROCEDURES" COMBINING MINIMALLY INVASIVE BYPASS-SURGERY AND TRANSLUMINAL INTERVENTIONS IN THE TREATMENT OF CORONARY ARTERY DISEASE (Invited Lecture)
W. Voelker, R. Hauerwass, J. Strotmann, F.U. Sack, C. Roll, S. Hagl, G. Ertl, Wurzburg, Germany16:15 ANGIOPLASTY AND PRIMARY STENTING OF THE SUBCLAVIAN, INNOMINATE, AND COMMON CAROTID ARTERIES IN 83 PATIENTS
T.M. Sullivan, B.H. Gray, J.M. Bacharach, J. Perl III, M.B. Childs, L. Modzelewski, E.G. Beven, Cleveland OH, USA16:30 NEOINTIMAL PROLIFERATION FOLLOWING BALLOON ANGIOPLASTY IS REDUCED BY HIGH DIETARY POTASSIUM INTAKE IN THE PIG
N.T. Srivastava, D.B. Young, P.G. Anderson, G. Ma, T.N. Skelton, Jackson MS, USA16:45 IVUS BASED DOSIMETRIC ANALYSIS OF INTRACORONARY RADIATION THERAPY (ICRT)
D. Meerkin, I.R. Crocker, A. Arsenault, T. Fox, J.-C. Tardif, R. Bonan, Montreal PQ, Canada17:00 VERAPAMIL TREATMENT OF PROGRESSIVE PERIPHERAL OCCLUSIVE ARTERIAL DISEASE AFTER ANGIOPLASTY
J. Schweizer, W. Kirch, R. Koch, A. Muller, K. Uhlmann, Chemnitz, Germany17:15 UPTAKE AND RETENTION DYNAMICS AND ABSORBED DOSES OF 99MTC-HEXAMETHYL PROPYLENAMINE OXIME (HM-PAO, CERETEC) AFTER INTRAMURAL DELIVERY WITH THE IRRADIATO/INFILTRATOR ANGIOPLASTY BALLOON CATHETER (IABC) DEVICE
P. Barath, A. Popov, J. Gerlach, E. Corday, P.K. Shah, D. Berman, Los Angeles CA, USA17:30 TRAPIDIL FOR PREVENTION OF IN-STENT RESTENOSIS - THE TRAPIST TRIAL
M.J. Pieper, A.A. v.d. Bos, P.W. Serruys, C. Macaya, F. Kiemeney, Kreuzlingen, Switzerland17:45 ANGIOGRAPHIC AND CLINICAL FOLLOW UP AFTER INTRAVASCULAR RED LASER LIGHT THERAPY AND STENTING
H. Sahota, I. De Scheerder, U. Kaul, B. Singh, S. Lee, J.M. Mao, M.H. Keelan, N. Kipshidze, Bellflower CA, USA
TUESDAY, MAY 18, 1999
16:00 - 17:30 HALL C
S69: MECHANICAL SUPPORT, LEFT VENTRICULAR ASSIST DEVICES
Chairpersons: J.A. Elefteriades, New Haven CT, USA
R.E. Hobbs, Cleveland OH, USA16:00 EXPANDING APPLICATIONS FOR A VERSATILE VENTRICULAR ASSIST SYSTEM: EXPERIENCE IN 1000 THORATEC VAD PATIENTS
D.J. Farrar, J.D. Hill, Pleasanton CA, USA16:15 EFFECT OF ENHANCED EXTERNAL COUNTERPULSATION ON LIPID PEROXIDATION IN CORONARY DISEASE
X.-X. Qian, W.-K. Wu, Z.-S. Zheng, B.-Y. Yu, H.-C. Lou, W.E. Lawson, J.C.K. Hui, Stony Brook NY, USA16:30 PRE-CLINICAL EVALUATION OF A TOTALLY IMPLANTABLE INTRATHORACIC VENTRICULAR ASSIST DEVICE
T. Mussivand, P.J. Hendry, R.G. Masters, W.J. Keon, Ottawa ONT, Canada16:45 INR SELF-DETERMINATION ENABLES LONG TERM OUT-OF-HOSPITAL EXPERIENCE FOR PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES
H. Mair, A. Schuetz, G. Gillrath, C. Schmitz, C. Detter, B. Reichart, Munich, Germany17:00 MECHANICAL CIRCULATORY SUPPORT IN CHILDREN WITH CARDIAC DISEASE
B.W. Duncan, V. Hraska, R.A. Jonas, D.L. Wessel, P.J. Del Nido, P.C. Laussen, J.E. Mayer, R.A. Lapierre, J.M. Wilson, Boston MA, USA17:15 TESTS WITH A PERCUTANEOUS CARDIAC ASSIST DEVICE IN A LEFT VENTRICULAR FAILURE MODEL
O. Reitan, H. Ohlin, S. Steen, Lund, Sweden
TUESDAY, MAY 18, 1999
16:00 - 17:00 HALL F
S58: THE PLAQUE AND ACUTE CORONARY SYNDROMES, BIOCHEMICAL MARKERS, PRECONDITIONING
Chairpersons: A. Caspi, Rehovot, Israel
S. Fuchs, Washington DC, USA16:15 PROGNOSTIC VALUE OF CARDIAC TROPONIN I LEVELS FOLLOWING CATHETER-BASED CORONARY INTERVENTIONS
S. Fuchs, R. Kornowski, R. Mehran, A.J. Lansky, L.F. Satler, A.D. Pichard, K.M. Kent, C.E. Clark, G.W. Stone, M.B. Leon, Washington DC, USA16:30 CLINICAL USEFULNESS OF BEDSIDE TEST AND QUANTITATIVE DETERMINATION OF t-TROPONINA FOR RISK STRATIFICATION IN UNSTABLE ANGINA
S.M. Macin, E.R. Perna, E.F. Farias, J.P. Cimbaro Canella, M.M. Civetta, J. Garcia, J.R. Badaracco, M. Brizuela, F. Medina, E. Jantus, Corrientes, Argentina16:45 ISCHEMIC PRECONDITIONING PROVIDES CARDIOPROTECTION THROUGH PKC-DEPENDENT AS WELL AS PKC-INDEPENDENT PATHWAYS
D.K. Das, N. Maulik, R.M. Engelman, M. Sato, P.S. Ray, Farmington CT, USA
TUESDAY, MAY 18, 1999
13:45 - 17:30
P105: Poster Session
BIOCHEMICAL MARKERS OF ACUTE ISCHEMIABoard No.
1. SINGLE MEASUREMENT OF CARDIAC TROPONIN I FOR ASSESSMENT OF INFARCT SIZE IN ACUTE MYOCARDIAL INFARCTION
G. Belotti, M. Biffi, C. Gatti, A. Locatelli, E.F. Vigano, G. Tommasini, Treviglio, Italy2. ULTRAFAST DIAGNOSIS OF AMI BY ANALYSIS OF MYOGLOBIN KINETICS
G. Belotti, M. Biffi, C. Poluzzi, G. Penati, E.F. Vigano, G. Tommasini, Treviglio, Italy3. EARLY ASSESSMENT OF INFARCT SIZE BY CK, CK-MB AND TnT AFTER REPERFUSION IN ACUTE MYOCARDIAL INFARCTION
M. Zhao, D. Hu, L. Cui, Z. Xu, H. Wang, Beijing, China4. INTRAOPERATIVE RELEASE OF TROPONIN T AND LEFT VENTRICULAR RECOVERY AND OXIDATIVE METABOLISM FOLLOWING CORONARY ARTERY SURGERY
J. Hooper, M. Kemp, T.W. Koh, F.D. Ferdinand, D.G. Gibson, J.R. Pepper, London, UK5. MACROPHAGE CHEMOATTRACTANT PROTEIN-1 LEVEL IN PERICARDIAL FLUID IN PATIENTS WITH CORONARY HEART DISEASE
M. Hyogo, A. Azuma, M. Tsukamoto, H. Yaku, H. Sugihara, M. Nakagawa, Kyoto, Japan6. BIOCHEMICAL MARKERS IN THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION. A PROPOSAL STRATEGY
M. Zaninotto, S. Altinier, M. Lachin, M. Plebani, Padova, Italy7. ROLE OF CARDIAC MARKERS FOR EVALUATING CORONARY ARTERY DISEASE (CAD) IN RENAL TRANSPLANT PATIENTS
G.A. Porter, J.S. Stevens, T.L. Norton, J. Lindsey, W.B. Bennett, Portland OR, USA8. CARDIAC TROPONIN I RELEVANCE IN ACUTE MYOCARDIAL INFARCTION DIAGNOSIS
I.A. Rivis, C. Dogaru, D. Burghina, D. Vasiluta, M. Mihalas, R. Popa, G. Ciobotaru, C. Domide, O. Tunea, Timisoara, Romania9. PLASMA CONCENTRATION OF NEUROPEPTIDE Y IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AFTER THROMBOLYTIC THERAPY
B. Halawa, P. Salomon, Wroclaw, Poland10. LIPID PEROXIDATION AND VITAMIN E IN ISCHEMIC HEART DISEASE
M. Sharma, N. Nand, N. Budhiraja, G.P. Singh, H.K. Aggarwal, P.B. Sharma, Rohtak, India11. FIBRINOGEN, C-REACTIVE PROTEIN AND THE ALBUMIN-GLOBULIN RATIO AS RISK FACTORS IN STROKE
G.N. Ziakas, A.J. Hatzitolios, A.D. Kounanis, Ch.G. Savopoulos, N.H. Markoglou, D.J. Prokopidis, A.G. Ziakas, Thessaloniki, Greece
TUESDAY, MAY 18, 1999
13:45 - 17:30
P106: Poster Session
CONTRAST ECHOCARDIOGRAPHYBoard No.
12. ULTRASONIC MYOCARDIAL TEXTURE IN SUBCLINICAL HYPOTHYROIDISM
V. Di Bello, F. Monzani, A. Bertini, D. Giorgi, N. Caraccio, A. Cioppi, F. Cinotti, E. Talini, A. Casolaro, M.T. Caputo, C. Giusti, Pisa, Italy13. LEFT VENTRICULAR FUNCTION IN SUBCLINICAL HYPOTHYROIDISM: COMPARISON BETWEEN ECHO-DOPPLER AND ULTRASONIC VIDEODENSITOMETRY
V. Di Bello, F. Monzani, A. Bertini, D. Giorgi, N. Caraccio, E. Talini, A. Casolaro, M.T. Caputo, A. Cioppi, C. Giusti, Pisa, Italy14. THE DIFFERENCE BETWEEN PRE AND POST OPERATIVE REGIONAL WALL MOTION FOR LITA GRAFT PATIENTS AND THEIR RELATION TO POST OPERATIVE MYOCARDIAL CONTRAST OPACIFICATION
H. Kihara, Y. Kihara, T. Kihara, H. Takahashi, A. Ono, M. Fukunishi, M. Tanigushi, K. Nakayama, N. Kajiwara, Tokyo, Japan
TUESDAY, MAY 18, 1999
13:45 - 17:30
P107: Poster Session
PHARMACOLOGIC STRESS TESTING - ECHOCARDIOGRAPHYBoard No.
15. THE EXAMINATION OF THE LEFT VENTRICULAR CONTRACTILE RESERVE WITH DOPPLER MYOCARDIAL IMAGING TECHNIQUE
T. Fulop, I. Hegedus, Debrecen, Hungary16. DETECTION OF ISCHEMIA: IS CORRECTNESS OF MULTIPLANE TRANSESOPHAGEAL STRESS ECHOCARDIOGRAPHY DEPENDING ON THE LOCATION OF THE STENOSIS?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany17. AUTOMATIC BACKSCATTER ANALYSIS OF REGIONAL RIGHT VENTRICULAR SYSTOLIC FUNCTION AFTER ANTERIOR ACUTE MYOCARDIAL INFARCTION USING COLOR KINESIS
T. Kurum, C. Korucu, F. Ozcelik, H. Eker, E. Oztekin, G. Ozbay, Edime, Turkey18. SAFETY OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE ROUTINE CLINICAL PRACTICE
E. Plonska, H. Szwed, B. Birkenfeld, L. Batalia, A. Raczynska, M. Demczuk, J. Kadlowski, J. Ptasinski, A. Spring, J. Kasprzak, Szczecin, Poland19. DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK WITHOUT CORONARY ARTERY DISEASE
E.G. Zakynthinos, P. Skiathitis, C. Evdoridis, M. Calachanis, P. Nihoyannopoulos, London, UK
TUESDAY, MAY 18, 1999
13:45 - 17:30
P110: Poster Session
DIAGNOSTIC METHODSBoard No.
20. PERICARDIAL EFFUSION AFTER ACUTE MYOCARDIAL INFARCTION
M. Alam, M. Gunda, F. Khaja, S. Borzak, G. Devine, H. Sabbah, L. Graham, S. Goldstein, Detroit MI, USA21. SAFETY OF CORONARY ARTERIOGRAPHY IN CLINICALLY STABLE PATIENTS FOLLOWING CORONARY BYPASS SURGERY
F.L. Gobel, W.J. Stewart, L. Campeau, A. Hickey, J.A. Herd, S. Forman, C.W. White, Y. Rosenberg, Minneapolis MN, USA22. THORACIC IMPEDANCE EVALUATES ADMISSION CHEST X-RAY CHANGES IN ACUTE HEART FAILURE PATIENTS
D.P. Milzman, A. Zlindenny, A. Battiata, T. Janchar, R. Samaddar, Washington DC, USA23. ACOUSTICAL DETECTION OF DIASTOLIC STENOSIS SOUND IN PATIENTS WITH CORONARY ARTERY STENOSIS
T. Nogimura, K. Chinn, Y. Honda, Y. Gotou, O. Tateishi, S. Mochizuki, Tokyo, Japan24. MYOCARDIAL FRACTIONAL FLOW RESERVE CALCULATED FROM CORONARY PRESSURE MEASUREMENTS CORRELATES OF MYOCARDIAL ISCHEMIA AND EVALUATION OF THE EFFECTIVENESS OF PTCA IN CHILDREN WITH KAWASAKI DISEASE
S. Ogawa, Y. Katsube, T. Ohkubo, Y. Kuramochi, D. Fukumi, Y. Uchikoba, Y. Hino, Tokyo, Japan25. ASSESSMENT OF LEFT ANTERIOR DESCENDING CORONARY FLOW RESERVE WITH ADENOSINE TRIPHOSPHATE TEST BY TRANSESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY: CORRELATION WITH QUANTITATIVE CORONARY ANGIOGRAPHY
G. Ugliengo, F. Margaria, F. Casasso, G. Leonardi, A. Dellavalle, E. Menardi, A. Vado, E. Uslenghi, Cuneo, Italy26. USEFULNESS OF CORONARY ANGIOGRAPHY FOR ASSESSING LEFT VENTRICULAR FUNCTION
B. Wandt, A. Kahari, J. Zizala, L. Bojo, B. Wranne, Orebro, Sweden
TUESDAY, MAY 18, 1999
13:45 - 17:30
P114: Poster Session
ACUTE MYOCARDIAL INFARCTION, THROMBOLYSIS AND REPERFUSIONBoard No.
27. PREHOSPITAL TREATMENT OF NON-Q-WAVE MYOCARDIAL INFARCTION WITH INITIAL ST SEGMENT DEPRESSION
T.B. Baltabaev, M.T. Beishenculov, N.T. Kudaibergenova, Bishkek, Kyrgyzstan28. RANDOMIZED CLINICAL TRIAL OF MEGADOSE HEPARIN IN THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
M.J.D. Garcia, D.R. Flores, R.V. Anastacio, E.S. Caguioa, C.M. Mendoza, Manila, Philippines29. CAN ELECTROCARDIOGRAPHIC Q-WAVES BE USED AS AN INDICATOR OF PAST MYOCARDIAL INFARCTION?
L.L. Sandler, E.E. Pinnow, J. Lindsay Jr., Washington DC, USA30. PLASMINOGEN-ACTIVATOR-INHIBITOR TYPE 1 (PAI-1) AND THE OUTCOME OF FIBRINOLYSIS WITH STREPTOKINASE OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
A. Sinkovic, V. Urlep-Salinovic, Maribor, Slovenia31. ACCELERATED STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION - OUR THREE YEARS CORONARY CARE UNIT'S EXPERIENCE
G. Tatu-Chitoiu, C. Teodorescu, P. Capraru, A. Tatu-Chitoiu, M. Guran, V. Chioncel, A. Bumbu, Bucharest, Romania32. DOUBLE BOLUS OF 750000 I.U. STREPTOKINASE IS A MORE EFFICIENT REGIMEN THAN THE STANDARD 1 500 000 I.U. OVER 60 MINUTES REGIMEN IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, P. Capraru, M. Guran, M. Dan, C. Teodorescu, A. Tatu-Chitoiu, A. Bumbu, V. Chioncel, Bucharest, Romania33. BOLUS ADMINISTRATION OF 750000 I.U. STREPTOKINASE IN ASSOCIATION WITH ENOXAPARIN IN THE PREHOSPITAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, M. Oprisan, O. Cismara, T. Sfiriac, A. Marinescu, R. Marinescu, R. Turcu, Bucharest, Romania34. SAFETY AND EFFICACY OF COMBINATION BETWEEN ACCELERATED STREPTOKINASE AND ENOXAPARIN IN ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, M. Guran, A. Tatu-Chitoiu, P. Capraru, M. Dan, A. Bumbu, V. Chioncel, Bucharest, Romania35. FEMALE DEATHS FROM ISCHEMIC HEART DISEASE IN AND OUTSIDE HOSPITAL - A STUDY OF INTRA-URBAN VARIATIONS IN THE CITY OF MALMO, SWEDEN
P. Tyden, G. Engstrom, O. Hansen, B. Hedblad, L. Janzon, Malmo, Sweden
TUESDAY, MAY 18, 1999
13:45 - 17:30
P120: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATIONBoard No.
36. INFLAMMATORY RESPONSE AND BASELINE CHOLESTEROL IN ACUTE MYOCARDIAL INFARCTION
S. Arvanitakis, E. Siniorakis, P. Hatziandreou, G. Voyatzopoulos, G. Plataris, P. Bonoris, Athens, Greece37. EFFECT OF ATENOLOL AND ENALAPRIL ON PATIENTS WITH MYOCARDIAL INFARCTION
N. Wu, Z. Fan, Beijing, China38. EFFECTIVENESS OF A PLANNED STRATEGY FOR THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS WITH CORONARY ARTERY DISEASE
J.M. Griffiths, A. Fernando, D.E. Mooney, S. Hare, M.P. Senaratne, Edmonton, Alberta, Canada39. CRACOVIAN PROGRAM FOR SECONDARY PREVENTION OF ISCHAEMIC HEART DISEASE; MANAGEMENT FOLLOWING DISCHARGE
K. Kawecka-Jaszcz, A. Pajak, P. Jankowski, D. Czarnecka, J. Dubiel, J. Maciejewicz, W. Piotrowski, W. Smielak-Korombel, W. Tracz, K. Zmudka, Cracow, Poland40. ASSOCIATION OF SERUM ANTIBODIES TO HEART-SHOCK PROTEIN 65 WITH CAROTID ATHEROSCLEROSIS: CLINICAL SIGNIFICANCE DETERMINED IN A FOLLOW-UP STUDY
Q. Xu, S. Kiechl, M. Mayr, B. Metzler, G. Egger, F. Oberhollenzer, J. Willeit, G. Wick, Innsbruck, Austria41. QUALITY ASSESSMENT IN OPEN HEART SURGERY BASED ON PARSONNET'S RISK STRATIFICATION MODEL
N. Radovanovic, D. Jakovljevic, B. Mihajlovic, Z. Potic, M. Popov, M. Potic, Novi Sad, Yugoslavia42. DIFFERENCE IN PLASMA HOMOCYSTEINE LEVELS IN SOUTH ASIAN VERSUS EAST ASIAN PATIENTS WITH CORONARY ARTERY DISEASE
M.P. Senaratne, D. deSilva, K. MacDonald, Edmonton, Alberta, Canada43. DOCTORS' REGISTRATION AND MANAGEMENT OF SMOKING BEHAVIOR OF PATIENTS WITH CORONARY ARTERY DISEASE: THE EUROASPIRE SURVEY
D.F.M. van Berkel, D. De Bacquer, D.A. Wood, Rotterdam, The Netherlands44. MOTIVATION TO CHANGE SMOKING BEHAVIOR IN PATIENTS WITH CORONARY ARTERY DSIEASE IN EUROPE: THE EUROASPIRE SURVEY
D.F.M. van Berkel, D. De Bacquer, D.A. Wood, Rotterdam, The Netherlands45. EPIDEMIOLOGICAL SIGNS OF CORONARY HEART DISEASE AS PREDICTOR OF DEATH
O. Volozh, A. Deev, T. Kalyuste, R. Kaup, E. Solodkaya, J. Abina, Tallinn, Estonia
TUESDAY, MAY 18, 1999
13:45 - 17:30
P124: Poster Session
HYPERTENSION, BASIC AND CLINICALBoard No.
46. HYPOTENSIVE EFFECTS OF STATINS: PRELIMINARY DATA WITH ATORVASTATIN
S. Bandinelli, A. Bertolotto, L. Pucci, R. Navalesi, G. Penno, Pisa, Italy47. ECG CHANGES AFTER RAPID REDUCTION OF BLOOD PRESSURE IN HYPERTENSIVE EMERGENCIES
P. Bara, A. Dibra, G. Ndrepepa, T. Sinjari, L. Bica, Tirana, Albania48. ARTERIAL HYPERTENSION, HYPERCHOLESTEROLAEMIA AND ENDOTHELIAL DYSFUNCTION
D. Czarnecka, M. Malczewska-Malec, K. Kawecka-Jaszcz, A. Dembinska-Kiec, Krakow, Poland49. BLOOD PRESSURE PROFILE AND VARIABILITY IN HYPERTENSIVES TREATED WITH L-ARGININE INFUSION
D. Czarnecka, K. Kawecka-Jaszcz, M. Malczewska-Malec, A. Dembinska-Kiec, Krakow, Poland50. GENETIC MODE IN HEREDITARY HYPERTENSION
Z. Fan, L. Rui, C. Ma, Yichang City, China51. EFFECT OF TRANDOLAPRIL-VERAPAMIL COMBINATION ON FIBRINOLYTIC FUNCTION IN OVERWEIGHT HYPERTENSIVE PATIENTS
R. Fogari, L. Corradi, L. Poletti, A. Zoppi, A. Mugellini, G.D. Malamani, Pavia, Italy52. LEFT VENTRICULAR DIASTOLIC FUNCTION IN DIFFERENT PATTERNS OF LEFT VENTRICULAR HYPERTROPHY AND GEOMETRY IN HYPERTENSION
J. Jaroch, K. Loboz-Grudzien, A. Kowalska, A. Kostecka-Pokryszko, A. Wojszwillo, K. Poczatek, Wroclaw, Poland53. HIGH PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ABDOMINAL ANEURYSM
S.E. Kranendonk, M. Wullink, M. den Heyer, S.J. Graafsma, Tilburg, The Netherlands54. COMPARISON OF BLOOD PRESSURE DYNAMICS FOR TREATMENT BY CAPTOPRIL AND LOSARTAN AND DURING ITS ABRUPT WITHDRAWAL IN MILD-TO-MODERATE ESSENTIAL HYPERTENSION PATIENTS
V.I. Metelitsa, I.V. Savina, A.D. Deev, Moscow, Russia55. ANTIHYPERTENSIVE COMBINATION TREATMENT WITH VERAPAMIL SR 180 mg/ TRANSOLAPRIL 2 mg PRESERVES LEFT VENTRICULAR FUNCTION IN NYHA CLASS I AND II HEART FAILURE PATIENTS
V. Mitrovic, M. Parzeller, T. Notter, P. Zilles, S. Eberle, Ludwigshafen, Germany56. EFFECTS OF LOSARTAN ON CARDIAC PERFORMANCE DURING TREADMILL EXERCISE IN HYPERTENSIVE SUBJECTS
S. Paterna, G. Parrinello, A. Pinto, G. Follone, A. Cardinale, P. Bologna, A. D'Angelo, G. Licata, Palermo, Italy
TUESDAY, MAY 18, 1999
13:45 - 17:30
P124: Poster Session
HYPERTENSION, BASIC AND CLINICAL (cont)Board No.
57. IMPAIRMENT OF LONG AXIS FUNCTION IN ARTERIAL HYPERTENSION WITH APPARENTLY NORMAL SYSTOLIC FUNCTION
S. Qirko, T. Goda, L. Rroku, Tirana, Albania58. IS IT POSSIBLE TO REVERSE CARDIAC HYPERTENSIVE REMODELING?
A.M. Szyszka, A. Cieslinski, S. Paradowski, A.H. Szyszka, Poznan, Poland59. WHY DOES LEFT VENTRICULAR MASS INCREASE IN HYPERTENSION DESPITE OF BLOOD PRESSURE FALL?
A.M. Szyszka, A. Cieslinski, S. Paradowski, A.H. Szyszka, Poznan, Poland60. ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON OBSTRUCTIVE SLEEP BREATHING OF AROTINOLOL
J. Zhang, R. Hui, X. Ni, Y. Sun, B. Zhao, X. Wang, L. Liu, Beijing, China61. INTERRELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE IN HYPERTENSIVE PATIENTS AND IN NORMOTENSIVE OFFSPRING OF SUBJECTS WITH ESSENTIAL HYPERTENSION
B. Zizek, P. Poredos, L. Zaletel-Kragelj, V. Videcnik, Ljubljana, Slovenia
TUESDAY, MAY 18, 1999
13:45 - 17:30
P133: Poster Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHYBoard No.
62. QT DISPERSION AND VENTRICULAR ARRHYTHMIAS REDUCTION AFTER LEFT VENTRICULAR HYPERTROPHY REGRESSION IN ESSENTIAL HYPERTENSION
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy63. EFFECTS OF ANABOLIC-ANDROGENIC STEROIDS ON WEIGHT-LIFTER'S MYOCARDIUM: AN ULTRASONIC VIDEODENSITOMETRIC STUDY
V. Di Bello, D. Giorgi, A. Bertini, M.T. Caputo, G. Valenti, E. Talini, A. Lorenzi, M. Paterni, C. Giusti, Pisa, Italy64. ULTRASONIC MYOCARDIAL TEXTURE PARAMETERS IN HEMODIALYTIC PATIENTS COMPARED WITH ESSENTIAL HYPERTENSIVE PATIENTS
V. Di Bello, V. Panichi, R. Pedrinelli, D. Giorgi, M. Bianchi, A. Bertini, G. Valenti, D. Taccola, M.T. Caputo, E. Talini, M. Paterni, C. Giusti, Pisa, Italy65. THE DISPERSION OF QT INTERVAL HAS A GOOD CORRELATION WITH LEFT VENTRICULAR MASS
A. Dibra, V. Gjini, E. Pavli, E. Maci, A. Sinani, P. Cina, S. Qirko, Tirana, Albania
TUESDAY, MAY 18, 1999
13:45 - 17:30
P133: Poster Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY (cont)Board No.
66. THE INCREASE OF QT DISPERSION OCCURS BEFORE THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS
A. Dibra, V. Gjini, E. Pavli, E. Maci, A. Sinani, P. Cina, S. Qirko, Tirana, Albania67. HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM) AND DDD PACING WITH SHORT AV DELAY
O.T. Greco, A. Cardinalli Neto, S.A.C. Garzon, A. Parro Jr., J. Vitola, N.C.S. Machado, R. Costa, R.V. Ardito, Sao Paulo, Brazil68. ENDSTAGE HEART FAILURE IN CATS WITH HYPERTROPHIC CARDIOMYOPATHY
S.K. Liu, P. Fox, Y.C. Chiu, J.J. Shyu, New York NY, USA, Taiwan-R.O.C.69. IS TILT-TABLE TEST OF ANY VALUE IN IDENTIFYING HYPERTROPHIC CARDIOMYOPATHY PATIENTS AT RISK FOR SYNCOPE?
S. Mohiddin, D. Bedley, D. McAreavey, L. Fananapazir, Bethesda MD, USA70. A COMPARISON OF BLOOD PRESSURE CHANGES TO TREADMILL AND BICYCLE EXERCISE TESTS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
S. Mohiddin, G. Rowe, J. Arevalo, D. Tripodi, S. Biddle, L. Fananapazir, Bethesda MD, USA71. EFFECT OF VERAPAMIL ON SYSTOLIC AND DIASTOLIC CORONARY BLOOD FLOW VELOCITY IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
P. Petkow-Dimitrow, M. Krzanowski, R. Nizankowski, A. Szczeklik, J.S. Dubiel, Krakow, Poland
TUESDAY, MAY 18, 1999
13:45 - 17:30
P141: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC AND CLINICALBoard No.
72. PROVOCATIVE TESTING WITH SL NTG IN TILT TABLE STUDIES: ROLE IN PATIENTS WITH CAD
L.S. Adams, J. Reynolds, S. Hessen, C. Movsowitz, S.P. Kutalek, Philadelphia PA, USA73. AMLODIPINA CAN PREVENT THE "REVERSE-USE DEPENDENCE" EFFECT OF SOTALOL
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy74. COMBINATION OF SOTALOL AND DILTIAZEM REDUCES QT SEGMENT DISPERSION IN PATIENTS WITHOUT STRUCTURAL HEART DISEASE
A. Dibra, V. Gjini, G. Ndrepepa, E. Pavli, E. Maci, P. Cina, Tirana, Albania
TUESDAY, MAY 18, 1999
13:45 - 17:30
P141: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG
THERAPY - BASIC AND CLINICAL (cont)Board No.
75. CLINICAL FEATURES ARE PREDICTORS OF NEW CONDUCTION DISTURBANCES DURING THE POSTOPERATIVE PERIOD OF CARDIOVASCULAR SURGERY
R. Iglesias, A. Baranchuk, C. Muratore, M.A. Gonzalez, V. Daru, R. Rabinovich, A.S. Liprandi, Buenos Aires, Argentina76. REDUCTION OF QT INTERVAL DISPERSION BY SUCCESSFUL CORONARY ANGIOPLASTY
P. Konecna, R. Dvorak, P. Kala, B. Semrad, Brno, Czech Republic77. ELECTROPHYSIOLOGICAL EFFECTS OF MELATONIN IN ISOLATED GUINEA PIG HEARTS
P. Lercher, S. Fleck, U. Haiden, I. Schwarzl, K. Stoschitzky, W. Klein, G. Stark, Graz, Austria78. DISPERSION OF VENTRICULAR REPOLARIZATION VERSUS SITE OF MYOCARDIAL INFARCTION AND OCCURRENCE OF VENTRICULAR ARRHYTHMIAS
L. Poposka, L. Dobrkovic, M. Vavlukis, I. Trajkov, N. Kostova, Skopje, Macedonia
TUESDAY, MAY 18, 1999
13:45 - 17:30
P144: Poster Session
INTERNAL DEFIBRILLATION, IMPLANTABLE
ANTIARRHYTHMIC DEVICES, PACINGBoard No.
79. DEFIBRILLATION THRESHOLDS ARE NOT SIGNIFICANTLY INCREASED BY RIGHT-SIDED IMPLANTATION OF ICDs
M. Achtelik, B. Voigt, L. Obergassel, P. Pfitzner, H.J. Trappe, Herne, Germany80. SUBCUTANEOUS VERSUS SUBMUSCULAR IMPLANTATION OF ICDs - DOES IT MAKE ANY DIFFERENCE?
M. Achtelik, B. Voigt, L. Obergassel, P. Pfitzner, H.J. Trappe, Herne, Germany81. TEMPORARY SCREW-IN PACEMAKER ELECTRODES: SECURITY YOU CAN COUNT ON
C. Burbidge, S. Cone, J. Konrad, J. Reynolds, C. Saari, F. Padder, C. Movsowitz, S.P. Kutalek, Philadelphia PA, USA82. HOLTER MONITORING IN THE EVALUATION OF THE AUTOCAPTURE SYSTEM DURING THE FOLLOW-UP
T. Centella, E. Oliva, A. Hernandez-Madrid, I. Garcia Andrade, A. Epeldegui, C. Moro, Madrid, Spain
TUESDAY, MAY 18, 1999
13:45 - 17:30
P144: Poster Session
INTERNAL DEFIBRILLATION, IMPLANTABLE
ANTIARRHYTHMIC DEVICES, PACING (cont)Board No.
83. THRESHOLDS VARIATIONS WITH ACTIVE FIXATION LEAD ON ACUTE ATRIAL AND VENTRICULAR PACING WITH STEROID
O.T. Greco, R.V. Ardito, R. Costa, M. Martinelli Filho, M.J.C. Pachon, P.T.J. Medeiros, Sao Paulo, Brazil84. RECORDING OF MONOPHASIC ACTION POTENTIAL BY USING IMPLANTABLE PACEMAKER AND ENDOCARDIAL LEADS - FIRST CLINICAL DATA AFTER ONE YEAR FOLLOW UP
T. Lawo, S. Wagner, V. Lang, B. Lemka, J. Barmeyer, Bochum, Germany85. EVALUATION OF SPONTANEOUS SUSTAINED VENTRICULAR TACHYCARDIA TREATED BY ANTITACHYCARDIA PACING IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
M.F. Martinelli, H. Moreira, A. Pedrosa, S. Nishioka, R. Costa, E. Sosa, M. Scanavacca, A. d'Avila, S. Siqueira, J. Ramires, A. Jatene, Sao Paolo, Brazil86. AUTONOMIC NERVOUS SYSTEM - CONTROLLED CLOSED-LOOP CARDIAC PACING VERSUS ACCELEROMETER SENSOR - COMPARATIVE ANALYSIS
A.S. Menezes Jr., W.L. de Carvalho, F.P. Cazorla, J.C. Dourado, C.F.M. Queiroz, Goiania, Brazil87. INCREASED PACEMAKER LIFETIME DUE TO VENTRICULAR CAPTURE CONTROL
A. da Silva Menezes Jr., C.F.M. Queiroz, F. da Paz Cazorla, W.L. de Carvalho, J.C. Dourado, M. Schaldach, Goiania, Brazil, Erlangen, Germany88. A NEW HIGH IMPEDANCE SMALL DIAMETER PACING LEAD FAMILY WITH 1.3MM2 FRACTALLY STRUCTURED TIPS: ACUTE AND CHRONIC CLINICAL PERFORMANCE
N. Vijay, Denver CO, USA
TUESDAY, MAY 18, 1999
13:45 - 17:30
P158: Poster Session
MISCELLANEOUSBoard No.
89. LEFT ATRIAL MYXOMA ITS CLINICAL PROFILE AND ECHOCARDIOGRAPHIC FEATURES PHILIPPINE HEART CENTER EXPERIENCE 1976-1998
A.M.L.A. Delos-Reyes-Javier, G.T. Catalan, R.D. Jara, L.W.S. Rondilla, E. Vicaldo, Manila, Philippines90. RIGHT-SIDED INFECTIVE ENDOCARDITIS: IMPACT OF ECHOCARDIOGRAPHIC FINDINGS ON A NEW DIAGNOSTIC APPROACH
G. Diaz, C. Rios, A. Diaz, H. Acuna, M. Petrozi, A. Centurion, E. Guevara, Chiclayo, Peru
TUESDAY, MAY 18, 1999
13:45 - 17:30
P158: Poster Session
MISCELLANEOUS (cont)Board No.
91. ISCHEMIC HEART DISEASE - DIFFERENCES BETWEEN THE TWO SEXES
A. Felix, C. Barradas, V. Mendes, M. Monteiro, A. Sousa, L. Joao, J. Sa Nogueira, A. Aleixo, A. Sales Luis, Lisbon, Portugal92. INCREASED AORTIC COMPLIANCE MAINTAINS LEFT VENTRICULAR PERFORMANCE AT LOWER ENERGETIC COST
P. Kolh, B. Lambermont, P. Gerard, C. Gommes, P. Potty, R. Limet, V. D'Orio, Liege, Belgium93. CORRELATION BETWEEN THE NORMAL MITRAL ANNULUS AREA AND BODY SURFACE AREA
N. Radovanovic, V. Torbica, D.D. Zecevic, M. Kovac, L. Petrovic, B. Mihajlovic, Z. Potic, Novi Sad, Yugoslavia94. ROSE-HIP GIVEN AS A STANDARDISED DRY POWDER EXERTS ANTI-INFLAMMATORY PROPERTIES, WITHOUT INFLUENCING PLATELET AGGREGATION AND THE COAGULATION CASCADE
E. Rein, A. Kharazmi, K. Winther, Copenhagen, Denmark
TUESDAY, MAY 18, 1999
13:45 - 17:30
P160: Poster Session
NEUROHUMORAL ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDESBoard No.
95. NESIRITIDE IMPROVES HEMODYNAMICS IN PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILURE: HEMODYNAMIC SUBGROUP ANALYSIS
R.C. Bourge, W.T. Abraham, L.E. Wagoner, P. Horton, T.H. LeJemtel, Birmingham AL, USA96. PROGRESSIVE RENIN ANGIOTENSIN SYSTEM ACTIVATION DURING CHRONIC ALCOHOL CONSUMPTION: A POTENTIAL MECHANISM OF ALCOHOLIC CARDIOMYOPATHY
C-P. Cheng, Winston-Salem NC, USA97. ALPHA- AND BETA-ADRENERGIC PATHWAYS DIFFERENTIALLY REGULATE CELL TYPE-SPECIFIC APOPTOSIS IN RAT CARDIAC MYOCYTES
K. Hasegawa, E. Iwai-Kanai, M. Araki, T. Kakita, T. Morimoto, S. Sasayama, Kyoto, Japan98. MATURE FORM OF CIRCULATING ADRENOMEDULLIN - AN EVALUATION IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ITS SECRETION AND CLEARANCE SITES
N. Hirayama, K. Kitamura, T. Imamura, Y. Koiwaya, T. Eto, Miyazaki, Japan
TUESDAY, MAY 18, 1999
13:45 - 17:30
P160: Poster Session
NEUROHUMORAL ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDES (cont)Board No.
99. MODULATION OF TRANSMEMBRANE SIGNALING BY DOMAIN-SPECIFIC ANTIb1 -ADRENOCEPTOR ANTIBODIES
R. Jahns, V. Boivin, T. Krapf, N. Roethlein, F. Boege, M.J. Lohse, Wuerzburg, Germany100. AUTOANTIBODIES SENSITIZING THE CARDIAC b1 -RECEPTOR ARE NOT PRESENT IN CARDIOMYOPATHIES SECONDARY TO VALVULAR OR HYPERTENSIVE HEART DISEASE
R. Jahns, V. Boivin, C. Siegmund, M. Jensen, M.J. Lohse, G. Inselmann, Wuerzburg, Germany101. IMPROVING ACUTE PULMONARY EDEMA REDUCES ATRIAL NATRIURETIC PEPTIDES LEVELS IN HOSPITALIZED PATIENTS WITH HEART FAILURE
P. Somasundaram, B.H. Sung, S.A. Mousa, M.F. Wilson, Buffalo NY, USA102. EFFECTS OF AN ADENOSINE DEAMINASE INHIBITOR (EHNA) AND CAFFEINE ON ENDOTOXIN-INDUCED RELEASE OF CYTOKINES AND HEART PERFORMANCE CHANGES IN VIVO IN RATS
S.P. Tofovic, L. Zacharia, E.K. Jackson, J.A. Carcillo, Pittsburgh PA, USA
WEDNESDAY, MAY 19, 1999
08:30 - 10:45 HALL A
PL14: Plenary Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATION
Chairpersons: B.M. Meiser, Munich, Germany
E.A. Rose, New York NY, USA08:30 PROGRESS IN LONG-TERM MECHANICAL CIRCULATORY SUPPORT (Invited Lecture)
E.A. Rose, New York NY, USA08:45 NEW DEVELOPMENTS IN THE SURGICAL TREATMENT OF HEART FAILURE (Invited Lecture)
W. Piccione, Chicago IL, USA09:00 PERICARDIECTOMY FOR CHRONIC CONSTRICTIVE PERICARDITIS - LOW MORTALITY AND SUSTAINED LONG TERM FUNCTIONAL IMPROVEMENT
I. Mehta, G. Tellides, G.S. Kopf, L.S. Cohen, J.A. Elefteriades, New Haven CT, USA09:15 RECOVERY OF CARDIAC FUNCTION IN END-STAGE DILATED CARDIOMYOPATHY BY PROLONGED LEFT VENTRICULAR ASSIST DEVICE APPLICATION (Invited Lecture)
J. Mueller, Y. Weng, M. Dandel, T. Drews, H. Bieda, M. Loebe, R. Hetzer, Berlin, Germany09:30 IS XENOTRANSPLANTATION THE FUTURE OF HEART TRANSPLANTATION? (Invited Lecture)
B. Reichart, M. Schmoeckei, J. Wallwork, D.J.G. White, Munich, Germany09:45 DYNAMIC CARDIOMYOPLASTY FOR PATIENTS WITH ADVANCED DILATIVE OR ISCHEMIC CARDIOMYOPATHY AND SEVERE RHYTHM DISTURBANCES (Invited Lecture)
V.S. Chekanov, S. Deshpande, Milwaukee WI, USA10:00 NEW TRENDS IN IMMUNOSUPPRESSION AFTER HEART TRANSPLANTATION (Invited Lecture)
B.M. Meiser, M. Pfeiffer, D. Schmidt, P. Ueberfuhr, H. Reichenspumer, D. Paulus, W. von Scheidt, D. Seidel, B. Reichart, Munich, Germany10:15 INTRAMYOCARDIAL IMPEDANCE MEASUREMENTS FOR DIAGNOSIS OF ACUTE CARDIAC ALLOGRAFT REJECTION
R. Pfitzmann, J. Muller, O. Grauhan, R. Hetzer, Berlin, Germany10:30 PARTIAL LEFT VENTRICULECTOMY: RESULTS ON 48 CASES OPERATED ON A 4 YEARS INTERVAL (Invited Lecture)
F.A. Lucchese, J.D. Frota Filho, C. Blacher, C. Halperin, W.M. Pereira, E.A. Lucio, P.E. Leaes, Porto Alegre, Brazil10:45 C o f f e e B r e a k
WEDNESDAY, MAY 19, 1999
08:30 - 10:30 HALL B
PL15: Plenary Session
NATRIURETIC PEPTIDES, ENDOTHELIN: ROLE IN HEART FAILURE
Chairpersons: U. Elkayam, Los Angeles, CA, USA
A. Lerman, Rochester MN, USA08:30 THE ROLE OF ENDOTHELIN IN CARDIOVASCULAR DISEASES (Invited Lecture)
A. Lerman, Rochester MN, USA08:45 ENDOTHELIAL FUNCTION AND HEART FAILURE (Invited Lecture)
U. Elkayam, Los Angeles CA, USA09:00 ENDOTHELIN IN HEART FAILURE (Invited Lecture)
A. Caspi, Rehovot, Israel09:30 ANTIHYPERTROPHIC, CARDIOVASCULAR AND NEUROHUMORAL EFECTS OF KC 12792, A NOVEL DUAL INHIBITOR OF NEUTRAL ENDOPEPTIDASE AND ENDOTHELIN CONVERTING ENZYME, IN ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY IN RATS
S.P. Tofovic, B. Rominski, Pittsburgh PA, USA09:45 "NESIRITIDE (SYNTHETIC HUMAN B-TYPE NATRIURETIC PEPTIDE): A NEW THERAPEUTIC AGENT FOR TREATING PATIENTS WITH HEART FAILURE" (Invited Lecture)
R.E. Hobbs, Cleveland OH, USA10:00 NESIRITIDE (HUMAN B-TYPE NATRIURETIC PEPTIDE) IMPROVES SYMPTOMS AND HEMODYNAMICS IN NYHA CLASS III AND IV HEART FAILURE
W.T. Abraham, A.D. Johnson, L. Wagoner, M.M. Givertz, D.P. Horton, Cincinnati OH, USA10:15 MOLECULAR DETERMINANTS OF THE SIGNALING MECHANISMS OF ATRIAL NATRIURETIC PEPTIDE RECEPTOR-A
K.N. Pandey, New Orleans LA, USA10:30 C o f f e e B r e a k
WEDNESDAY, MAY 19, 1999
08:30 - 10:15 HALL C
S51: ACUTE MYOCARDIAL INFARCTION: THROMBOLYSIS AND REPERFUSION
Chairpersons: B.I. Jugdutt, Edmonton, Canada
D. Zahger, Jerusalem, Israel08:30 NEW THROMBOLYTIC AGENTS: UPDATE, 1999 (Invited Lecture)
D. Zahger, Jerusalem, Israel08:45 IN-HOSPITAL AND LONG-TERM MORTALITY AND MORBIDITY ASSOCIATED WITH RIGHT VENTRICULAR INFARCTION IN A DEFINED GEOGRAPHIC POPULATION
R.S. Wright, J.G. Murphy, R.J. Gumina, J.P. Grill, S.L. Kopecky, Rochester MN, USA09:00 ENHANCED SURVIVAL IN OLDER PATIENTS (>75 YEARS) UNDERGOING PRIMARY PTCA FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION
W.L. Miller, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA09:15 EFFECTIVENESS OF A SPECIALIST CARDIAC 'THROMBOLYSIS' NURSE IN IMPROVING DELAYS TO THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
J.D. Somauroo, P. McCarten, B. Appleton, E. Rodrigues, Liverpool, UK09:30 PREDICTION OF REPERFUSION AFTER STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BY A NEW TEST FOR FUNCTIONALLY NEUTRALISING STREPTOKINASE ANTIBODIES
S. Gill, S.R. Kristensen, B. Haastrup, T. Haghfelt, Odense, Denmark09:45 CARDIOPROTECTIVE EFFECTS OF HUMAN PLACENTA ANTIISCHEMIC COMPOUND (PLAFERON-LB) IN A CANINE MODEL
W.D. Johnson, N.N. Kipshidze, N. Javakhishtvili, Z. Tsagareli, V. Bakhutashvili, Milwaukee WI, USA10:00 EARLY DEATHS WITH THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION IN CORTICOSTEROID-DEPENDENT RHEUMATOID ARTHRITIS
P. Kotha, M.J. McGreevy, A. Kotha, M. Look, M.H. Weisman, San Diego CA, USA10:30 C o f f e e B r e a k
WEDNESDAY, MAY 19, 1999
08:30 - 10:30 HALL E
S63: HYPERTROPHIC CARDIOMYOPATHY
Chairpersons: G.A. Mensah, Augusta GA, USA
M.A. Rossi, Sao Paulo, Brazil08:30 THE RESULTS OF DUAL CHAMBER PACING FOR MID-CAVITY LEFT VENTRICLE OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
D. Begley, S. Mohiddin, L. Fananapazir, Bethesda MD, USA08:45 ASSESSMENT OF QUANTITATIVE HYPERTROPHY SCORES IN HYPERTROPHIC CARDIOMYOPATHY: MAGNETIC RESONANCE IMAGING VERSUS ECHOCARDIOGRAPHY
J.L. Posma, E.E. van der Wall, Groningen, Leiden, The Netherlands09:00 CORRELATION BETWEEN BRUCE PROTOCOL TREADMILL EXERCISE TEST AND BICYCLE MAXIMAL OXYGEN UPTAKE EXERCISE TEST IN HYPERTROPHIC CARDIOMYOPATHY
S. Mohiddin, J. Arevalo, G. Rowe, S. Biddle, D. Tripodi, L. Fananapazir, Bethesda MD, USA09:15 SUSTAINED BENEFICIAL EFFECT OF LONG-TERM SEQUENTIAL PACING IN SEVERE HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
J.C. Tascon, A. Albarran, F. Hernandez, M. Alonso, J. Andreu, R. Coma, J. Rodriguez, R. Gascuena, P. Hernandez, M. Lazaro, Madrid, Spain09:30 EFFECT OF OCTREOTIDE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
E. Demirtas, C. Sag, H. Kursaklioglu, M. Uzun, S. Kose, Ankara, Turkey09:45 MORPHOLOGIC DESCRIPTION OF THE COLLAGEN MATRIX IN THE MYOCARDIUM OF PIGS WITH SPONTANEOUSLY OCCURRING HYPERTROPHIC CARDIOMYOPATHY
S.K. Liu, Y.-T. Chiu, M. Liu, J.J. Shyu, R. Chu, New York NY, USA10:00 ELECTROPHYSIOLOGIC ASSESSMENT OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY PRESENTING WITH ATRIAL FIBRILLATION: RELATION OF INDUCED TO SPONTANEOUS ATRIAL FIBRILLATION
D. Begley, L. Fananapazir, Bethesda MD, USA10:15 EFFECTS OF PERMANENT DUAL-CHAMBER PACING ON MYOCARDIAL PERFUSION IN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY
J.L. Posma, E.E. van der Wall, Groningen, Leiden, The Netherlands10:30 C o f f e e B r e a k
WEDNESDAY, MAY 19, 1999
10:45 - 12:45 HALL A
PL16: Plenary Session
NEW APPROACHES TO SURGICAL REVASCULARIZATION
Chairpersons: J.A. Elefteriades, New Haven CT, USA
T.A. Sanborn, New York NY, USA10:45 NEW DEVELOPMENTS IN CARDIOPULMONARY BYPASS FOR NEONATES AND INFANTS - THE IMPORTANCE OF pH AND HEMATOCRIT (Invited Lecture)
R.A. Jonas, Boston MA, USA11:00 THE BRAIN AND CARDIAC SURGERY (Invited Lecture)
J.G. Reves, Durham NC, USA11:15 MECHANISMS OF ANGIOGENESIS AND PROSPECTS FOR ANGIOGENIC THERAPY (Invited Lecture)
J.M. Isner, Weston MA, USA11:30 PERCUTANEOUS ENDOCARDIAL GENE THERAPY: IN VIVO ADENOVIRAL MEDIATED MARKER GENE TRANSFER AND EXPRESSION (Invited Lecture)
T.A. Sanborn, N. Tarazona, E. Deutsch, L. Lee, N. Hackett, T. El-Sawy, R.G. Crystal, T.K. Rosengart, New York NY, USA11:45 THE CHANGING PRACTICE OF CORONARY BYPASS SURGERY: IMPACT ON RISKS AND RESULTS (Invited Lecture)
N.M. Katz, Washington DC, USA12:00 MINIMAL ACCESS CORONARY BYPASS SURGERY (Invited Lecture)
V.A. Subramanian, New York NY, USA12:15 SURGERY IN ENDSTAGE CORONARY ARTERY DISEASE (Invited Lecture)
H. Hausmann, R. Hetzer, Berlin, Germany12:30 THE EFFECTS OF GLYCEMIC CONTROL ON CARDIAC SURGERY OUTCOMES
(Invited Lecture)
A.P. Furnary, K.J. Zerr, G. Grunkemeier, Portland OR, USA
WEDNESDAY, MAY 19, 1999
10:45 - 12:30 HALL B
PL17: Plenary Session
DRUG THERAPY IN CARDIAC FAILURE
Chairpersons: B.H. Greenberg, San Diego CA, USA
M.R. Johnson, Chicago IL, USA10:45 VENTRICULAR REMODELING - IMPLICATIONS FOR PHARMACOLOGIC INTERVENTIONS (Invited Lecture)
B.H. Greenberg, San Diego CA, USA11:00 PHARMACOLOGIC MODIFICATION OF DIASTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION (Invited Lecture)
B.I. Jugdutt, Edmonton, Alberta, Canada11:15 TREATMENT OPTIONS FOR THE PATIENT WHO HAS FAILED CONVENTIONAL HEART FAILURE THERAPY (Invited Lecture)
M.R. Johnson, Chicago IL, USA11:30 DRUG INTERACTIONS WITH DIURETICS IN CHRONIC CONGESTIVE HEART FAILURE (Invited Lecture)
A.J. Reyes, Montevideo, Uruguay11:45 THE EMERGING PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN IN CARDIOVASCULAR DISEASE
E.H. Ohlstein, King of Prussia PA, USA12:00 RENAL DOPAMINERGIC SYSTEM IN HEART FAILURE (Invited Lecture)
M. Cerqueira-Gomes, Porto, Portugal12:15 SUPERIORITY OF 'TRIPLE' DRUG THERAPY IN HEART FAILURE: INSIGHTS FROM THE PROVED AND RADIANCE TRIALS
K.F. Adams, Jr., J.B. Young, M. Gheorghiade, B.F. Uretsky, H. Patterson, T.A. Schwartz, Chapel Hill NC, USA
WEDNESDAY, MAY 19, 1999
10:45 - 13:15 HALL C
S61: ATHEROSCLEROSIS: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: O. Abdel-Aziz, Cairo, Egypt
S. Stern, Jerusalem, Israel10:45 NEW DEFINITIONS FOR MYOCARDIAL ISCHEMIA WITHOUT CLINICAL MANIFESTATIONS
S. Stern, Jerusalem, Israel11:00 EFFECT OF ENHANCED EXTERNAL COUNTERPULSATION ON NITRIC OXIDE PRODUCTION IN CORONARY DISEASE
X.-X. Qian, W.-K. Wu, Z.-S. Zheng, C.-Y. Zhan, B.-Y. Yu, W.E. Lawson, J.C.K. Hui, Stony Brook NY, USA11:15 HIGH PREVALENCE OF CORONARY CALCIFICATIONS DETECTABLE BY ELECTRON BEAM CT IN YOUNG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AS THEIR FIRST MANIFESTATION OF CORONARY ARTERY DISEASE
S. Achenbach, D. Ropers, G. Muschiol, W. Moshage, W.G. Daniel, Erlangen, Germany11:30 PURPLE GRAPE JUICE IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE
J.H. Stein, J.G. Keevil, S. Aeschlimann, J.D. Folts, Madison WI, USA11:45 DOES LOW FLUID INTAKE INCREASE THE RISK OF CORONARY HEART DISEASE?
J. Chan, S. Knutsen, Loma Linda CA, USA12:00 LIFELONG ENDURANCE TRAINING IS ASSOCIATED WITH ENHANCED CARDIOVASCULAR EFFICIENCY AND IMPROVED AUTONOMIC CARDIOVASCULAR MODULATION IN THE ELDERLY
F. Galetta, F. Franzoni, C. Palombo, M. Kozakova, F. Cinotti, D. Taccola, C. Giusti, Pisa, Italy12:15 THE RELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND INSULIN SENSITIVITY IS MODULATED BY LIPID PROFILE
S. Bandinelli, G. dell'Omo, L. Pucci, M. Mariani, R. Navalesi, R. Pedrinelli, G. Penno, Pisa, Italy12:30 EXPRESSION OF PAI-1 AND TPA IS STIMULATED BY PHYSIOLOGICAL DOSES OF INSULIN IN THE FOREARM VASCULAR DISTRICT OF NORMAL SUBJECTS
F. Carmassi, F. De Negri, L. Ferrini, G. Dell'Omo, R. Pedrinelli, R. Fioriti, A. De Giorgi, Pisa, Italy12:45 INFLUENCE OF METABOLIC CONTROL IN TYPE 2 DIABETES MELLITUS ON LIPID PEROXIDATION
D.D. Trifunovic-Zamaklar, M. Zamaklar, S. Markovic, N. Rajkovic, T. Milicic, Belgrade, Yugoslavia13:00 DIETARY L-ARGININE SUPPLEMENTATION INHIBITED PLATELET AGGREGATION IN PATIENTS WITH CORONARY ARTERY DISEASE
E. Noeva, A. Sozykin, M. Menshikov, T. Balahonova, Moscow, Russia
WEDNESDAY, MAY 19, 1999
10:45 - 12:30 HALL F
S68: VALVULAR HEART DISEASE / HEART VALVE SURGERY - ADULT
Chairpersons: H. Boudoulas, Columbus OH, USA
D.M. Meyer, Dallas TX, USA10:45 CARDIOMYOCYTE CYTOSKELETON CHANGES IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY UNDERGOING AORTIC VALVE REPLACEMENT USING COLD CRYSTALLOID OR WARM BLOOD CARDIOPLEGIA
M. Caputo, S. Di Somma, G. Salvatore, G. Cudemo, M. Marotta, C. Rosati, M. Di Benedetto, G. Caputo, D.G. Angelini, Naples, Italy11:00 NEW TECHNIQUE FOR CORRECTION OF ATRIAL FIBRILLATION - REDUCTION OF ATRIAL SIZE
M.C.S. Abreu, J. Carvalho, L.C. Sampaio, C. Alves, C.A.P. Alves, A.R. Filho, C. Cueva, A. Rabelo Jr., Salvador, Brazil11:15 SURGICAL CORRECTION OF AORTIC DISEASE USING INTRALUMINAL RING - TEN YEARS EXPERIENCE
R. de Castro Bernardes, L.C. Moreira Lima, L.A. D'Avila Goncalves, F.A.R.R. Filho, Belo Horizonte, Brazil11:30 EXPERIMENTAL HYPERCHOLESTEROLEMIA INDUCES APOPTOSIS IN THE RABBIT AORTIC VALVE
N. Rajamannan, K. Arnold, A.J. Tajik, R. Schwartz, Rochester MN, USA11:45 PREDICTION OF COMMISSURAL MORPHOLOGY BY ECHOCARDIOGRAPHY AND ITS ROLE IN DETERMINING OUTCOME FOLLOWING INOUE BALLOON MITRAL VALVOTOMY
A. Kapoor, R.K. Singh, N. Sinha, A.S. Kumar, S. Radhakrishnan, S. Shrivastava, Lucknow, India12:00 THE FREESTYLE STENTLESS BIOPROSTHIS HAS OPTIMAL HEMODYNAMICS FOR THE SMALL AORTIC ROOT
L.H.B. Baur, X.Y. Jin, A.P. Kappetein, J. Braun, C.H. Peels, Y. Houdas, P. Voogd, E.E. van der Wall, S. Westaby, H.A. Huysmans, Leiden, The Netherlands12:15 NEW SCORE INDEX FOR PREDICTION OF SIGNIFICANT MITRAL REGURGITATION AFTER BALLOON MITRAL VALVOTOMY
O. Rifaie, A. Saleh, A. El Fiky, N. Farag, T. Zaki, Cairo, Egypt
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P113: Poster Session
ACUTE MYOCARDIAL INFARCTION, THROMBOLYSIS AND REPERFUSIONBoard No.
1. THE DYNAMICS OF ECG CHANGES IN ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH STREPTOKINASE (SK)
I. Balla, A. Kondili, G. Ndrepepa, N. Kuka, P. Vargu, Tirana, Albania2. ACUTE MYOCARDIAL INFARCTION (AMI) IN THE YOUNG, RISK FAXTORS EVOLUTION AND PROGNOSIS IN COMPARISON WITH AMI IN OLDER PATIENTS
C. Carp, A. Jalba, C. Ginghina, D. Rogozea, M. Tarlea, Bucharest, Romania3. MYOCARDIAL INFARCTION WITH AND WITHOUT REPERFUSION IN SHEEP: CARDIAC, NEUROHUMORAL AND HEMODYNAMIC EFFECTS
C.J. Charles, J.M. Elliott, M.G. Nicholls, M.T. Rademaker, A.M. Richards, Christchurch, New Zealand4. VALUE OF THE INITIAL ELECTROCARDIOGRAM IN PATIENTS WITH INFERIOR WALL ACUTE MYOCARDIAL INFARCTION FOR PREDICTION OF NEED FOR MULTIVESSEL CORONARY ARTERY REVASCULARIZATION
A. Mager, S. Sclarovsky, I. Herz, Y. Adler, B. Strasberg, Y. Birnbaum, Petah Tikva, Israel5. EARLY PERICARDITIS AFTER ACUTE MYOCARDIAL INFARCTION, WITH AND WITHOUT THROMBOLYTIC THERAPY
M.M. Mendes Pedro, A. Paz Monteiro, A. Laureano-Santos, J.T.S. Soares-Costa, Lisbon, Portugal6. PRIMARY REPERFUSION ASSOCIATED WITH IMPROVED IN-HOSPITAL AND LONG-TERM SURVIVAL OF KILLIP CLASS IV ACUTE MYOCARDIAL INFARCTION PATIENTS
W.L. Miller, T.C. Kim, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA7. THROMBOLYTIC THERAPY IN ELDERLY (>75 YRS) MI PATIENTS IS ASSOCIATED WITH INCREASED MORTALITY IN A COMMUNITY-BASED POPULATION
W.L. Miller, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA8. IN-HOSPITAL AND LONG-TERM OUTCOMES OF NON-Q WAVE MYOCARDIAL INFARCTIONS WITH AND WITHOUT THROMBOLYTIC THERAPY
J. Nagendran, S.M. Shaben, M.P. Senaratne, Edmonton, Alberta, Canada9. CAPTOPRIL DOES NOT AFFECT PLASMA ENDOTHELIN-1 DURING THROMBOLYSIS AND REPERFUSION
P. Di Pasquale, S. Paterna, V.G. Parrinello, V. Bucca, S. Cannizzaro, F. Pipitone, G. Maringhini, S. Scalzo, G. Licata, Palermo, Italy10. ST-SEGMENT DEPRESSION PATTERNS IN ACUTE MYOCARDIAL INFARCTION, AN ANALYSIS OF SIGNIFICANCE
A. Prasetyo, E. Caguioa, Quezon City, Philippines
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P128: Poster Session
PRIMARY PREVENTION OF CORONARY ARTERY DISEASEBoard No.
11. CLINICAL PREDICTORS OF THE LIKELIHOOD OF SIGNIFICANT CAD IN YOUNG MEN AND WOMEN ADMITTED WITH CHEST PAIN: INFLUENCE OF GENDER
K.O. Akosah, B. Gower, J. Cool, A. Schaper, La Crosse WI, USA12. REVISITING PREMATURE CORONARY ARTERY DISEASE IN YOUNG WOMEN: IS ANYBODY PAYING ATTENTION?
K.O. Akosah, B. Gower, B. Rooney, K. Paul, R. Sundaram, A. Schaper, La Crosse WI, USA13. IS ACUTE MYOCARDIAL INFARCTION MORE FREQUENT IN YOUNG MEN IN RURAL COMMUNITIES: THE GUNDERSEN LUTHERAN EXPERIENCE?
K.O. Akosah, C. Paul, A. Schaper, La Crosse WI, USA14. CAROTID ARTERY STENOSIS AND OTHER RISK FACTORS FOR STROKE
E.S. del Fuerte, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, M.J.D. Garcia, R.A. Naranjilla, Manila, Philippines15. THE FUNCTIONAL CHARACTERIZATION OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEM OF THE HEART DURING VALSALVA MANEUVER
V.R.F.S. Maraes, E. Silva, T.F. Ribeiro, J. Petto, M.S.A. Moura, A.M. Catai, L. Oliveira, L.C. Trevelin, L. Gallo Jr., Sao Paulo, Brazil16. STUDY OF MEDICAL PERFORMANCE IN THE PREVENTION AND DETECTION OF CARDIOVASCULAR RISK FACTORS IN A URBAN POPULATION OF FLORENCIO VARELA (BS. AS. ARGENTINA)
H. Navas, J. Vujocevich, A. Moiso, S. De Lena, M. Tavella, La Plata, Argentina
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P147: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASEBoard No.
17. DIRECT MYOCARDIAL REVASCULARIZATION WITHOUT EXTRACORPOREAL CIRCULATION
J.G. Lobo Filho, J.M.A.C. de Albuquerque, C.B.G. Gomes, M.C. Leitao, E.B. Pinheiro, N. Paes Jr., R.P. de Siqueira, R.M. Landim, R.R. Oliveira, Fortaleza, Brazil18. PERFUSION FOR CARDIAC SURGERY USING VENOUS ARTERIAL SHUNT AND PURE OXYGEN IN MEMBRANE OXYGENATORS: 40 TO 50% OF THE VENOUS BLOOD RECIRCULATE ONLY
M.C.J. Moraes, J.R.J. Dias, Z.J. Moraes, S.L. Azevedo, N.M. Holanda, D.J. Moraes, Rio de Janeiro, Brazil
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P147: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE (cont)Board No.
19. GENDER DIFFERENCES FOR PERCUTANEOUS CORONARY INTERVENTIONS
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil20. DOES AGE INFLUENCE THE OUTCOME OF CORONARY INTERVENTIONS?
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil21. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR CORONARY ARTERY DISEASE
G.C. Vilela, P.P. San Diego, Quezon City, Philippines22. PROGNOSIS AND QUALITY OF LIFE AFTER CABG IN THE ELDERLY
M.O. Shapira, J.D. Alkon, R. Chartrand, K. DeAndrade, S. Roy-Cutter, D. Whalen, J.L. Lazar, R.J. Shemin, Boston MA, USA
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P132: Poster Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIESBoard No.
23. FAMILY STUDY IN IDIOPATHIC DILATED CARDIOMYOPATHY
Z.T. Bilinska, E. Michalak, B. Kusmierczyk-Droszcz, J. Grzybowski, M. Skwarek, W. Rydlewska-Sadowska, W. Ruzyllo, Warsaw, Poland24. IGF-I AND IGFBP-3 RESPONSES TO THE LOWEST EFFECTIVE rhGH DOSE IN PATIENTS WITH DILATED CARDIOMYOPATHY (DCM)
F. Broglio, G. Aimaretti, E. Arvat, A. Benso, C. Gottero, M.F. Boghen, M. Bobbio, E. Ghigo, Turin, Italy25. A STABLE MODEL OF CHRONIC BILATERAL HEART FAILURE INDUCED BY ARTERIO-VENOUS ANASTOMOSIS AND DOXORUBICIN ADMINISTRATION
V.S. Chekanov, G.V. Tchekanov, M.A. Rieder, Milwaukee WI, USA26. CHAGAS HEART DISEASE PATIENTS AND RATE RESPONSIVE PACING (VVIR) REGULATED BY RIGHT VENTRICULAR CONTRACTILITY
O.T. Greco, R.V. Ardito, S.A.C. Garzon, N.C.S. Machado, M. Schaldach, Sao Paulo, Brazil27. DETECTION OF ADENOVIRAL DNA IN ENDOMYOCARDIAL BIOPSIES OF ADULT PATIENTS WITH MYOCARDITIS OR DILATED CARDIOMYOPATHY
G. Hufnagel, C. Busse, B. Ihsche, S. Pankuweit, B. Maisch, Marburg, Germany28. NONINVASIVE DETERMINANTS OF MORTALITY IN NON-ISCHEMIC DILATED CARDIOMYOPATHY
G. Kazianis, C. Michaelidis, A. Gournizakis, A. Economou, Athens, Greece
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P132: Poster Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES (cont)Board No.
29. CLINICAL CHARACTERISTICS IN PATIENTS WITH DILATED PHASE OF HYPERTROPHIC CARDIOMYOPATHY
T. Morooka, N. Kotooka, K. Yoshida, K. Kido, K. Yoshida, T. Ogata, S. Tsuji, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan30. DETERMINATION OF MITOCHONDRIAL DNA POINT MUTATIONS IN PATIENTS WITH DILATED CARDIOMYOPATHY
V. Ruppert, B. Maisch, Marburg, Germany31. ANOTHER FORM OF INTRAVENTRICULAR CONDUCTION DELAY: A VECTORCARDIOGRAPHIC STUDY OF THE LEFT-MIDDLE (SEPTAL) FASCICULAR BLOCK
P.J. Moffa, P.C.R. Sanches, C.A. Pastore, N.M.M.O. Tobias, A.P. Moraes, E.V. Lima, G. Belotti, Sao Paulo, Brazil32. ECHOCARDIOGRAPHIC CORRELATES OF INCREASED LEFT VENTRICULAR CHAMBER SIZE
M. Baber, B.H. Sung, M.F. Wilson, K. Shah, A. Goldfarb, Buffalo NY, USA
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P135: Poster Session
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOMEBoard No.
33. GENDER DIFFERENCES IN SELF-ASSESSED QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE
F. Bonaguidi, C. Palombo, C. Michelassi, E. Barberini, A. L'Abbate, Pisa, Italy34. PROGNOSTIC VALUE OF HEART RATE VARIABILITY IN TIME AND FREQUENCY DOMAIN ANALYSIS IN CONGESTIVE HEART FAILURE
S. Boveda, M. Galinier, J. Fourcade, P. Lagrange, P. Massabuau, A. Patack, N. Prouteau, M. Delay, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France35. DOES EXERCISE OXYGEN CONSUMPTION ADD PROGNOSTIC INFORMATION TO REST ECHOCARDIOGRAPHY IN AMBULATORY PATIENTS WITH DILATED CARDIOMYOPATHY
G.R. Ciliberto, G. Piccalo, E. Lobiati, G. Cataldo, M. Frigerio, M. Mangiavacchi, A. Moreo, G. Cataldo, M. Frigerio, M. Mangiavacchi, A. Moreo, G. Masciocco, E. Gronda, Milan, Italy36. CHANGES IN PEAK OXYGEN CONSUMPTION OVER TIME AS INDEPENDENT PROGNOSTIC MARKER IN PATIENTS WITH CHRONIC HEART FAILURE
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, D.G. Gibson, A.J.S. Coats, London, UK
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P135: Poster Session
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME (cont)Board No.
37. PROGNOSTIC SIGNIFICANCE OF ABNORMAL SIGNAL-AVERAGED ELECTROCARDIOGRAM IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
G. Kazianis, A. Economou, C. Michaelidis, P. Kalogeropoulos, S. Feggos, Athens, Greece38. CLINICAL USE OF LACTATE TO IDENTIFY OCCULT PERFUSION DEFICITS IN HEART FAILURE PATIENTS
D. Milzman, R. Samaddar, W. Strudwick, Washington DC, USA39. QUALITY OF LIFE OF CONGESTIVE HEART FAILURE PATIENTS AT THE PHILIPPINE GENERAL HOSPITAL
G.C. Vilela, P.P. San Diego, Jr., Quezon City, Philippines40. WHICH EXERCISE PARAMETER BEST PREDICTS THE MORTALITY IN CHRONIC HEART FAILURE?
W. Shamim, M. Yousufuddin, S. Varney, C. Addison, J.S. Chambers, F.R. Amin, S.D. Anker, A.J.S. Coats, London, UK41. LONG TERM RESULTS OF RIGHT VENTRICULAR OUTFLOW TRACT PACING EXPRESSED IN ECHOCARDIOGRAPHY
E. Krzyminska-Stasiuk, R. Wilczek, J. Staniewicz, G. Swiatecka, Gdansk, Poland
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P137: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKERBoard No.
42. EPROSARTAN REDUCES CARDIOMYOPATHY, IMPROVES ULTRASOUND AND MRI INDICES OF CARDIAC FUNCTION, IMPROVES RENAL FUNCTION AND ELIMINATES MORTALITY IN STROKE-PRONE RATS
R.W. Coatney, S. Chandra, A.H. Nelson, E.H. Ohlstein, G.Z. Feuerstein, R.N. Willette, D.P. Brooks, F.C. Barone, King of Prussia PA, USA43. EFFECTS OF AT-1 RECEPTOR ANTAGONISTS ON OXIDATIVE STRESS, IN PATIENTS WITH CHRONIC HEART FAILURE
O. Burta, A. Salajan, A. Lazar, V. Salajan, L. Lazar, L. Burta, M. Farcas, Oradea, Romania44. DO WE SELECT THE RIGHT PATIENTS IN CLINICAL TRIALS, IN CONGESTIVE HEART FAILURE?
P. Duc, V. Massuelle, J.M. Juliard, M.C. Aumont, Paris, France
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P137: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKER (cont)Board No.
45. SAFETY, TOLERABILITY, AND NEUROHORMONAL CHANGES OF THE COMBINATION CAPTOPRIL PLUS LOSARTAN IN THE EARLY POSTINFARCTION PERIOD: A PILOT STUDY
P. Di Pasquale, V. Bucca, S. Scalzo, G. Parrinello, A. Pinto, A. Tuttolomondo, E. Capodieci, G. Follone, A. Cardinale, T. Maniscalchi, S. Paterna, Palermo, Italy46. EFFECTS OF LONG TERM TREATMENT OF LOSARTAN ON RENAL HAEMODYNAMIC AND FUNCTION IN HYPERTENSIVE SUBJECTS
S. Paterna, R. Costa, R. Seaglione, V. Accardo Palumbo, A. Bova, G. Follone, A. Cardinale, T. Maniscalchi, G. Licata, Palermo, Italy47. IRBESARTAN COMPARED WITH LISINOPRIL IN HEART FAILURE
N.K. Vijay, I.A. Alhaddad, D.M. Denny, D. Ruff, M. Yasin, L. Yellen, S. Lyver, C. Bryson, C.-S. Lin, R.A. Wolf, Denver CO, USA
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P146: Poster Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASEBoard No.
48. THE VALUE OF 24-HOUR AMBULATORY ECG MONITORING IN CHILDREN WITH CARDIAC ARRHYTHMIAS DUE TO OPERATIONS OF CONGENITAL CARDIAC ANOMALIES
K. Baysal, F. Ozturk, R. Agac, B. Akkin, F. Kolbakir, H.I. Yaman, Samsun, Turkey49. M MODE ECHOCARDIOGRAPHY EVALUATING CARDIOVASCULAR PERFORMANCE, AND VENTRICULAR FUNCTION IN VASOVAGAL SYNCOPE INDUCED BY TILT TEST
A. de Dios, E. Fischman, B. Zuchiatti, E. Flores, I. Abella, I. Torres, L.B. Lianes, P. Ziotsky, B. Zarlenga, E.A. Kreutzer, Buenos Aires, Argentina50. SIGNIFICANCE OF PERFUSION ABNORMALITIES ON MYOCARDIAL SCINTIGRAPHY FOR PREDICTION OF THE SYSTEMIC RIGHT VENTRICULAR FAILURE IN PATIENTS AFTER ATRIAL SWITCH FOR COMPLETE TRANSPOSITION
B. Lubiszewska, E. Gosiewska, J. Rozanski, P. Hoffman, W. Poplawska, A. Teresinska, W. Ruzyllo, Warsaw, Poland51. EXTRACARDIAC REPAIR OF COMPLEX UNROOFED CORONARY SINUS
J.A.M. van Son, G.S. Haas, J. Hambsch, F.W. Mohr, Leipzig, Germany
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P149: Poster Session
NEW APPROACHES TO SURGICAL PROCEDURES, MINIMALLY INVASIVE SURGERY, TMLRBoard No.
52. A NEW LOOK IN THE SURGERY OF THE JEHOVA'S WITNESS - SUPPORTING TECHNIQUES
M.C.S. Abreu, J.L. Carvalho, M. Granato, M.F. Fereira, C.A.P. Alves, A.R. Filho, C.N. Cueva, A. Rabelo Jr., Salvador, Brazil53. "L"-SHAPE MINI-STERNOTOMY VERSUS MEDIAN COMPLETE STERNOTOMY FOR AORTIC VALVE OPERATIONS
J.L. Carvalho, L.C. Sampaio, M.C.S. Abreu, A. de J. Ribeiro, G. Pieracciani, C. Cueva, A. Rabelo Jr., Salvador, Brazil54. INFLUENCE OF MEDIAN STERNOTOMY ON SURGICAL TREATMENT OF CORONARY ARTERY MULTIVESSEL DISEASE - A PROSPECTIVE CLINICAL TRIAL
V. Gulielmos, M. Brandt, T. Jost, M. Knaut, R. Cichon, M. Dangel, S. Schueler, Dresden, Germany55. SELECTIVE APPLICATION OF CARDIOPULMONARY BYPASS AND MEDIAN STERNOTOMY FOR LESS MORBIDITY IN CORONARY ARTERY BYPASS SURGERY
U. Kappert, V. Gulielmos, T. Jost, K. Matschke, R. Cichon, M. Knaut, S. Schueler, Dresden, Germany56. HYBRID REVASCULARIZATION
J.E. Rodriguez, M.J. Lopez Gude, J.J. Rufilanchas, L.C. Maroto, J. Tascon, A. Albarran, Madrid, Spain57. TRIAL ON ADVANTAGES OF PRONE POSITIONING ON STROKE VOLUME IN HEALTHY VOLUNTEERS
D. Milzman, L. Moskowitz, A. Zlindenny, Washington DC, USA58. EARLY AND MEDIUM TERM RESULTS OF AORTO-VENOUS BY-PASS GRAFTING ON MYOCARDIAL PERFUSION, VENTRICULAR FUNCTION AND PATIENT SYMPTOMS
P. Neary, A.D. Small, G. McCurrach, W. Martin, S.K. Naik, Glasgow, UK59. NEW TECHNOLOGY FOR CARDIOPULMONARY BYPASS CANNULATION IN LIMITED-ACCESS CARDIAC SURGERY
J.B. Riebman, R.S. Bertolero, San Jose CA, USA60. HOSPITAL MORTALITY FOLLOWING OPEN HEART SURGERY BASED ON POSTOPERATIVE INOTROPE REQUIREMENTS
L.E. Samuels, M.P. Thomas, P.C. Lin, J. Lee-Llacer, A.S. Wechsler, Philadelphia PA, USA61. TRANSMYOCARDIAL LASER-REVASCULARISATION WITH A HOLMIUM:YAG-LASER: CLINICAL EXPERIENCE
R. Seitelberger, T. Wild, S.C. Beutelspacher, S. Memtsoudis, E. Wolner, J. Wolfram, Vienna, Austria
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P149: Poster Session
NEW APPROACHES TO SURGICAL PROCEDURES, MINIMALLY INVASIVE SURGERY, TMLR (cont)Board No.
62. IS ENDOVASCULAR TREATMENT OF AORTIC ANEURYSMS POSSIBLE AS AN OUTPATIENT PROCEDURE?
H. Sievert, S. Vogt, H. Zeplin, D. Axt-Manz, J. Peters, S. Marzoll, H. Spies, R. Ensslen, R. Schrader, D. Scherer, H. Merle, A. Fach, Frankfurt, Germany63. EARLY MYOCARDIAL HISTOLOGY AFTER TRANSMYOCARDIAL LASER-REVASCULARISATION
T. Wild, K. Schmidt, J. Wolfram, S.C. Beutelspacher, E. Wolner, R. Seitelberger, Vienna, Austria
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P150: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULTBoard No.
64. THROMBOLYTIC THERAPY FOR THROMBOSED MECHANICAL MITRAL VALVE PROTHESIS
V. Koca, T. Bozat, C. Sarikamis, V. Akkaya, Istanbul, Turkey65. THE UTILITY OF PROBE PATENT FORAMEN OVALE IN REPLACING SEPTAL PUNCTURE DURING MITRAL BALLOON VALVULOPLASTY
T. Bozat, V. Koca, C. Sarikamis, V. Akkaya, Istanbul, Turkey66. FACTORS WITH INFLUENCE IN THE REGRESSION OF LEFT VENTRICULAR MASS AFTER AORTIC VALVE REPLACEMENT
M. Vega, A. Amaro, F. Gude, J.R. Gonzalez-Juanatey, M. Gil, Santiago de Compostela, Spain67. CLINICAL AND ECHOCARDIOGRAPHIC MONITORING OF PREGNANTS WITH AORTIC VALVE DISEASES
A. Lesniak, W. Tracz, P. Podolec, M. Pasowicz, Krakow, Poland68. TRICUSPID ANNULOPLASTY IN MULTIVALVULAR DISEASE - RESULTS IN 1515 PATIENTS
B. Mihajlovic, L. Petrovic, M. Kovac, J. Lavac, S. Nicin, D. Kovacevic, D.D. Zecevic, Z. Jonjev, M. Mijatov, V. Scekic, P. Kovacevic, M. Fabri, N. Radovanovic, Novi Sad, Yugoslavia
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P150: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont)Board No.
69. IMPROVEMENT IN CLINICAL OUTCOME AND LEFT VENTRICLE FUNCTION AFTER VALVE REPLACEMENT IN PATIENTS WITH AORTIC STENOSIS AND PREOPERATIVE LOW EJECTION FRACTION
E. Orlowska-Baranowska, D. Zakrzewski, M. Cybulski, T. Hryniewiecki, W. Rydlewska-Sadowska, K. Suwalski, M. Sliwinski, I. Rawczynska-Englert, Warsaw, Poland70. PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY USING THE TRI-LUMEN SINGLE BALLOON CATHETER
C. Weng, Z. Guo, Guangzhou, China
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P152: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULTBoard No.
71. NEW TECHNIQUE FOR CORRECTION OF MITRAL INSUFFICIENCY IN RHEUMATIC FEVER
M.C.S. Abreu, J.L. Carvalho, R.S. Jesus, C. Alves, C.A.P. Alves, A.R. Filho, C.N. Cueva, A. Rabelo Jr., Salvador, Brazil72. DESIRED ANTICOAGULATION LEVELS AMONG PATIENTS WITH MECHANICAL HEART VALVES
G.T. Catalan, A.M.L.A. Delos Reyes-Javier, F.C. Tomacruz, Manila, Philippines73. THROMBOLYTIC THERAPY IN PROSTHETIC VALVE THROMBOSIS
I.M. Coman, E. Apetrei, C.T. Ginghina, C. Macarie, D. Qeshta, D. Filipescu, N. Florica, C. Carp, Bucharest, Romania74. INITIAL EXPERIENCE WITH ATS MEDICAL MECHANICAL BILEAFLET PROSTHESIS
N. Radovanovic, B. Mihajlovic, L. Petrovic, M. Kovac, S. Nicin, M. Mijatov, J. Lavac, Z. Jonjev, M. Popov, M. Golubovic, A. Redzek, A. Milosavljevic, Novi Sad, Yugoslavia75. CARBOMEDICS VERSUS ST. JUDE MEDICAL MECHANICAL AORTIC PROSTHESIS - COMPARATIVE FOLLOW-UP STUDY
B. Mihajlovic, M. Mijatov, L. Petrovic, J. Lavac, S. Nicin, Z. Potic, J. Selestiansky, Z. Jonjev, M. Popov, M. Potic, N. Radovanovic, Novi Sad, Yugoslavia76. QT DURATION AND QT DISPERSION ANALYSIS IN PATIENTS WITH AORTIC STENOSIS - ARE THEY RELATED TO THE PRESENCE OF DECREASED LEFT VENTRICLE EJECTION FRACTION?
E. Orlowska-Baranowska, R. Baranowski, I. Rawczynska-Englert, W. Rydlewska-Sadowska, Warsaw, Poland
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P152: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont)Board No.
77. EVOLUTION OF ECHO PARAMETERS AND MORTALITY IN ELDERLY PATIENTS WITH SEVERE AORTIC STENOSIS. A 5 YEARS FOLLOW-UP
H. Pierri, L.V. Decourt, C. Medeiros, A. Catani, J.B. Serro-Azul, O. Gebara, A. Nussbacher, L.B.P. Pivotto, A.C.P. Barretto, M. Wajngarten, J.A.F. Ramires, Sao Paulo, Brazil78. DIFFERENCES IN LENGTH OF STAY BETWEEN CORONARY BYPASS AND VALVE PROCEDURES
H.F. Tripp, J.A. Obney, D.L. Febinger, Houston TX, USA
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P153: Poster Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATIONBoard No.
79. SHOULD OBESITY BE A CONTRAINDICATION TO CARDIAC TRANSPLANT LISTING?
C.W. Sprowles, P. Singh, P. Cerrito, G. Bhat, Louisville KY, USA80. ENHANCED EXTERNAL COUNTERPULSATION PROTECTS CORONARY ARTERY DISEASE PATIENTS FROM FUTURE CARDIAC EVENTS
S. Karim, M. Kasim, R. Suwita, I. Andaningshih, Jakarta, Indonesia81. NON INVASIVE CONTROL OF REJECTION AFTER HEART TRANSPLANTATION USING INTRACARDIAC ELECTROGRAM MONITORING
F.A. Lucchese, P. Brofman, P. Leaes, J.D. Frota Filho, W. Pereira, Porto Alegre, Brazil82. INFLUENCE OF ACUTE CARDIAC ALLOGRAFT REJECTION ON TRANSMURAL DISPERSION OF REPOLARISATION
A.Z. Pietrucha, B. Stobierska-Dzierzek, D. Mroczek-Czernecka, I. Pietrzak, M. Wegrzynowska, A. Paradowski, W. Piwowarska, Cracow, Poland83. CHANGES IN LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN END-STAGE DILATED CARDIOMYOPATHY AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICES - TEE STUDY
N. Radovanovic, L. Petrovic, M. Kovac, B. Mihajlovic, M. Mijatov, S. Nicin, Z. Konstantinovic, S. Popovic, M. Preradovic, M. Popov, D.D. Zecevic, Novi Sad, Yugoslavia84. THE PATHOLOGICAL STUDY OF CENTRIFUGAL IMPELLER PUMP AS LEFT VENTRICULAR ASSIST DEVICE (LVAD) IN CALF
J.J. Shyu, S.H. Chu, S.S. Wang, N.K. Chou, K.X. Qian, S.K. Liu, Taipei, Taiwan-R.O.C.
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P153: Poster Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATION (cont)Board No.
85. HEMODYNAMIC EFFECTS OF ENHANCED EXTERNAL COUNTERPULSATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
I. Taguchi, K. Ogawa, A. Oida, H. Kuga, H. Suzuki, I. Nagao, N. Kaneko, H. Sakio, Tochigi, Japan86. SIGNAL AVERAGED ELECTROCARDIOGRAM IN PATIENTS SUBMITTED TO THE LEFT VENTRICULAR PARTIAL VENTRICULECTOMY (BATISTA OPERATION)
N. Tobias, P.J. Moffa, C.A. Pastore, P. Sanches, E. Bochi, F. Bacal, M.A. Silva, N. Stolf, J.F. Ramires, Sao Paulo, Brazil
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P159: Poster Session
DRUG THERAPY FOR ISCHEMIC HEART DISEASEBoard No.
87. OXIDATIVE STRESS IN PATIENTS WITH UNSTABLE ANGINA: THE EFFECTS OF TALINOLOL, A CARDIOSELECTIVE BETA-BLOCKERS
A. Campeanu, R. Olinescu, M. Vasile, V. Teodorescu, O. Zaharia, Bucharest, Romania88. EFFECTS OF VERAPAMIL ON e-NOS mRNA EXPRESSION FOLLOWING ISCHEMIA-REPERFUSION IN ISOLATED WORKING RAT HEARTS
P. Di Napoli, A. Maggi, A.A. Taccardi, A. Di Crecchio, R. Spina, G. Ranalli, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy89. EFFECTS OF ADENOSINE ON eNOS mRNA EXPRESSION IN RAT HEARTS SUBMITTED TO ISCHEMIA - REPERFUSION
P. Di Napoli, A.A. Taccardi, A. Maggi, R. Spina, G. Torge, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy90. EFFECTS OF LOSARTAN ON e-NOS AND i-NOS mRNA EXPRESSION AND ON MYOCYTES APOPTOSIS IN ISOLATED WORKING RAT HEART
P. Di Napoli, A. Maggi, A.A. Taccardi, G. Contegiacomo, R. Spina, S. Volpe, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy91. ROLE OF INTRAVENOUS METOPROLOL IN ACUTE MYCARDIAL INFARCTION
P. Kumar, B.S. Kushwaha, Jhansi U.P., India92. NEW IN SUSTAC-FORTE METABOLISM IN CAD PATIENTS
A.P. Sisetskiy, Kiev, Ukraine
WEDNESDAY, MAY 19, 1999
08:30 - 12:30
P163: Poster Session
VASCULAR BIOLOGY, BASIC RESEARCH IIBoard No.
93. COMPARATIVE PROSPECTIVE B-MODE ULTRASOUND IMAGING STUDIES OF CAROTID AND FEMORAL ARTERY WALLS IN PATIENTS WITH CORONARY, CEREBROVASCULAR OR FEMOROPOPLITEAL ARTERY DISEASE
E. de Groot, R.J.G. Peters, L.M. Blok, M.H. Prins, A.H. Zwinderman, H.R. Bueller, Amsterdam, The Netherlands94. INHIBITION OF NEOINTIMA HYPERPLASIA OF MOUSE VEIN GRAFTS BY LOCALLY-APPLIED SURAMIN
Y. Hu, Y. Zou, B. Metzler, H. Dietrich, G. Wich, Q. Xu, Innsbruck, Austria95. ACTIVATION OF STRESS-ACTIVATED PROTEIN KINASES/C-JUN N H 2- TERMINAL PROTEIN KINASES (SAPK/JNK) IN ATHEROSCLEROTIC LESIONS: ROLE OF LDL
B. Metzler, Y. Hu, H. Dietrich, Q. Xu, Innsbruck, Austria96. IMPAIRED SHEAR-MEDIATED COLLATERAL DEVELOPMENT IN RESISTANCE ARTERIES OF HYPERTENSIVE RATS
V.K. Murthy, S.W. Fath, H.M. Burkhart, M.C. Dalsing, J.L. Unthank, Indianapolis IN, USA97. SMOOTH MUSCLE CELL PHENOTYPE INFLUENCES APOPTOSIS IN RAT AORTIC NEOINTIMA AFTER ENDOTHELIAL INJURY
A. Orlandi, M. Marcellini, L. Anemona, L.G. Spagnoli, Rome, Italy98. 8-CHLORO- cAMP INHIBITS SMOOTH MUSCLE CELL PROLIFERATION IN VITRO AND NEOINTIMA FORMATION INDUCED BY BALLOON INJURY IN VIVO
C. Perrino, C. Indolfi, E. Di Lorenzo, A. Rapacciuolo, G. Esposito, O. Arcucci, M. Pascotto, A. Cioppa, G.P. Tortora, F. Cardiello, M. Chiariello, Naples, Italy99. ANTI-PROTHROMBIN ANTIBODIES ARE FREQUENTLY FOUND IN PATIENTS WITH ARTERIAL THROMBOSIS WITHOUT BIOLOGICAL RISK FACTORS FOR THROMBOPHILIA
J.C. Reverter, F.J. Munoz, D. Tassies, J. Font, G. Escolar, M. Ingelmo, A. Ordinas, Barcelona, Spain